Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 137.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.8	33.7	7.3	14.7	9.9	11.5	13.5	13.4	9.8	15.3	13.6	23.1	14.6	37.7	17.1	11.6	24.6	18.4	27.7	15.4	20.7	19.1	20.7	17.5	13.3	16.1	12.1	28.1	14.9	10.1	27.7	19.7	17.6	13.6	11.0	18.4	24.2	11.3	13.2	15.2	30.9	21.3	9.3	12.0	12.9	20.0	22.1	20.2	12.7	18.4	15.9	6.9	19.7	8.1	18.0	16.8	14.1	14.5	12.3	11.8	20.0	25.0	42.0	12.8	18.2	28.4	14.7	21.0	20.8	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0											20.8	28.8	32.8	36.7	38.8	12.4	16.1	28.1	36.1	40.9	24.4	21.6	62.0	8.3	31.9	21.4	24.3	32.8	23.3	41.6	49.6	22.2	22.9	46.2	13.9	41.7	17.5	15.4	8.6	24.5	50.0	21.9	36.5	27.0	64.9	22.6	26.9	40.2	25.9	21.9	36.9	22.5	32.3	37.3	47.2	30.2	38.3	137.1	42.4	29.3	33.1
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 2.3;Cytotrophoblasts: 3.3;Extravillous trophoblasts: 3.7;Hofbauer cells: 3.1;Syncytiotrophoblasts: 4.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA066071: AB_2685609, HPA068764: AB_2686028"	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.7	3.7	5.7	11.9	3.3	3.8	6.8	4.3	3.8	6.0	7.7	6.4	8.7	5.0	4.9	5.0	7.1	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.6	8.5	2.6	5.0	7.9	2.3	7.3	6.4	6.8	1.8	4.1	8.5	6.5	11.9	5.0	7.1	7.1	7.3	4.5	1.6	2.2	4.9	5.4	7.9	5.0	6.0	7.7	5.8	3.8	3.5	10.8	3.9	4.2	4.5	3.1	5.7	7.5	4.4	6.8	7.5	13.8	11.2	4.2	6.2	5.2	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621296-88632282	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.4	10.4	6.5	10.2	7.2	14.8	11.2	2.8	5.0	8.0	7.8	4.9	13.4	5.0	9.3	10.2	8.9	7.0	23.0	8.2	4.7	8.5	7.9	17.4	9.1	15.4	13.1	3.1	11.2	18.8	6.7	21.3	11.0	7.8	11.6	9.1	4.3	14.5	9.1	18.8	5.9	8.0	10.6	9.3	14.2	11.1	14.3	4.6	14.0	16.6	10.9	13.7	12.5	5.4	9.3	4.1	0.6	3.6	3.0	15.0	7.6	4.9	22.1	13.8	11.8	6.1	7.4	29.3	17.7	16.2	13.6	16.8	18.1	9.7	21.3	5.7	9.6	12.3	7.1	50.8	14.3	11.5	5.2	20.0	11.4	8.9	29.9	15.1	9.4	11.5	9.1	12.7	17.0	14.0	4.9	11.4	7.1	17.9	12.1	16.6	11.5	11.6	7.9	33.3	10.3	12.8	15.3	9.8	15.7	5.7	10.7	10.9	10.0	7.1	8.2	13.6	33.0	6.8	10.9	10.3	13.9	19.4	5.6	23.8	23.5	15.7	18.2	12.8	10.6	27.2	0.0	1.8	0.6	5.3	3.1	10.0	9.3	9.1	6.9	4.1	9.3	10.0	8.8	0.4	3.0	3.6	2.4	15.0	7.6	6.5	7.2	2.8	5.0	4.7	8.5	13.1	3.1	7.8	4.6	6.0	7.2	11.2	18.2	16.6	0.4	3.4	10.2	2.7	12.5	1.8	0.0	3.4	3.3	12.4	19.8	4.4	2.9	0.0	6.4	13.5	6.7	23.7	2.3	5.0	4.1	1.6	8.6	1.8	5.9	39.3	4.0	5.1	13.5	20.8	5.8	2.3	9.5	5.8	2.5	5.0	0.8	12.9	17.0	6.3	15.0	24.7	5.1	7.2	6.0	24.5
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell type enriched"	"Detected in many"	21	"Hepatocytes: 4646.2"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 52.5;OE19: 40.2"					"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	230000000	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.3	3.4	0.8	0.0	8.6	10.3	0.1	1.4	3.0	0.4	1.4	2.0	1.8	0.1	0.4	4.2	2.9	1.3	0.9	1.0	0.4	5.8	1.3	0.3	1.9	52.5	1.8	1.3	0.1	8.3	0.8	0.5	1.8	4.3	2.0	1.5	0.0	9.6	1.2	0.2	0.2	0.4	0.2	40.2	3.8	0.2	1.3	3.9	0.8	1.0	0.0	0.1	1.5	0.6	2.3	1.9	1.4	0.2	1.7	0.5	1.0	0.5	0.2	2.0	1.6	0.2	1.1	0.6	1.6	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4	26.8	12.4	18.0	36.0	24.2	0.0	0.6	219.1	60.2	18.2	10.4	0.0	1.5	10.0	27.6	0.7	12.2	37.1	23.3	27.7	3.3	31.0	52.1	0.0	4646.2	15.9	0.0	68.2	70.0	110.5	1.1	65.9	16.0	21.9	1.0	138.3	9.1	26.8	17.3	22.6	45.5	0.6	12.9	18.6	0.7	1.0	45.8	7.8	12.1	44.2	29.8
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 16.6"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.5	3.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.9	0.0	0.0	0.9	3.4	3.2	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.6	0.4	0.0	2.3	0.0	3.1	1.7	0.0	7.0	1.6	0.3	0.3	4.3	0.1	0.8	3.6	5.8	2.0	0.0	6.3	6.3	2.1	1.9	1.5	3.0	2.3	0.5	0.1	7.4	2.5	7.9	4.3	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9	0.0	1.0	0.0	1.8	0.6	3.9	6.5	0.0	17.4	5.7	1.8	2.0	0.0	1.7	4.4	4.9	0.0	0.7	0.0	2.0	0.1	0.0	2.0	0.0	0.5	0.1	0.0	4.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	3.6	13.3	3.7	2.9	0.4	0.1	33.7	0.0	0.1	25.6	2.0	1.5	0.0	0.0	2.3	0.7
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.6	16.4	12.5	10.8	12.8	11.2	16.6	14.5	15.1	17.7	19.6	21.8	7.7	16.9	8.7	12.1	11.0	11.5	20.3	19.4	22.0	22.8	8.3	10.0	23.5	22.2	14.8	16.1	9.6	15.0	23.8	20.3	26.4	11.3	16.9	13.1	15.1	16.9	16.5	9.3	14.4	23.7	19.1	14.2	17.7	13.1	8.7	12.0	14.5	13.2	8.7	7.3	13.3	11.9	9.7	12.1	13.5	6.6	10.4	9.9	13.2	17.1	14.9	7.3	12.0	16.9	14.7	13.2	7.9	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5	17.9	31.9	15.7	18.7	14.8	13.6	12.9	28.1	25.4	19.4	8.7	9.8	23.7	24.9	20.4	49.1	11.9	11.6	0.0	24.6	22.8	12.6	16.4	16.1	17.4	16.5	12.7	16.1	6.7	15.2	35.4	12.4	14.5	13.5	20.8	12.6	17.8	24.5	3.5	9.9	24.1	16.2	12.9	12.2	35.9	27.0	18.4	23.3	14.1	15.1	20.4
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Smooth muscle cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 73.1;RPMI-8226: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.5	0.8	0.9	2.2	1.4	4.9	1.7	1.5	0.8	0.2	0.2	1.0	0.8	2.6	1.3	0.4	0.0	0.5	73.1	1.1	1.8	0.3	1.7	1.0	1.2	1.4	0.6	1.6	1.4	0.2	1.5	1.5	2.2	1.5	11.1	0.6	0.8	2.4	4.3	0.9	0.4	0.0	3.3	3.0	32.2	0.2	0.7	0.6	0.3	0.1	0.1	1.1	0.4	0.0	2.7	1.4	1.5	1.9	1.7	1.2	6.8	5.3	0.9	0.8	3.0	1.4	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2	3.0	28.9	11.8	34.4	46.5	17.4	12.2	5.1	10.7	11.4	3.5	29.5	3.6	3.3	29.9	14.9	43.6	3.2	0.0	27.0	7.0	17.5	22.9	58.0	22.2	62.8	0.0	0.0	22.1	29.8	23.3	3.4	64.4	55.6	95.6	5.4	6.2	24.8	5.3	6.0	5.0	24.7	45.3	294.5	2.7	17.6	28.4	3.3	91.4	2.6	17.8
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.3;U-2197: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.9	5.6	1.2	0.4	1.1	3.4	17.7	7.8	10.3	5.1	8.0	5.3	17.1	0.2	4.4	3.7	15.8	9.1	3.6	27.4	13.1	35.3	4.7	4.2	3.7	4.4	1.5	8.5	1.8	1.2	2.4	17.8	14.0	8.8	23.9	5.3	2.1	9.0	5.8	2.6	4.6	4.6	9.7	7.5	19.7	8.6	20.7	1.3	4.3	12.6	4.1	0.7	4.0	0.6	0.1	3.1	0.8	2.8	16.2	16.6	9.6	48.3	32.2	1.3	2.4	0.0	14.3	6.9	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3	3.0	2.2	0.0	32.7	0.7	1.1	0.8	17.8	0.0	7.9	8.7	0.0	1.3	0.0	22.0	3.3	4.2	0.7	0.0	23.8	3.5	2.3	33.6	0.0	4.2	1.3	0.0	1.2	3.1	2.8	3.0	0.0	5.0	1.7	26.2	2.7	0.0	57.8	0.0	0.0	0.6	0.0	0.0	2.1	3.4	4.9	1.9	3.5	0.0	0.6	126.8
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 644.1;Intestinal endocrine cells: 855.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 39.9;SuSa: 49.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.1	0.3	12.3	2.6	1.2	3.2	39.9	4.4	3.5	3.8	9.1	8.1	4.6	0.1	2.0	0.2	20.8	3.4	7.3	1.1	6.3	29.1	7.1	0.4	3.6	2.9	22.6	2.6	6.9	5.5	19.8	10.6	24.7	0.7	0.7	7.1	2.8	23.2	0.5	0.8	7.9	1.6	8.8	3.3	2.6	2.3	8.2	5.2	0.5	0.9	5.5	5.6	5.7	10.3	17.3	49.4	6.0	1.9	0.7	1.1	5.9	3.7	2.0	18.3	7.7	2.1	3.6	1.4	3.2	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4	393.1	144.2	7.7	234.8	180.1	3.7	604.8	73.9	128.5	135.4	52.4	0.0	136.7	1.7	158.3	2.8	136.2	500.9	0.0	108.1	256.8	236.1	644.1	77.3	21.2	99.6	1.6	855.0	28.8	13.4	2.5	16.1	211.8	165.4	55.1	427.3	12.1	155.6	312.1	1.1	1.2	2.5	97.0	421.2	0.3	2.1	177.2	351.7	6.9	216.0	169.1
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	8.1	9.1	17.7	11.9	25.1	5.5	9.1	33.7	29.5	14.8	13.5	12.9	10.3	8.2	20.5	9.8	11.1	11.0	12.1	11.8	18.0	11.0	9.1	10.1	14.8	11.6	21.1	17.7	10.7	10.3	18.4	11.6	10.3	16.4	14.2	8.5	9.8	8.4	14.0	26.3	12.0	8.3	19.1	16.1	11.4	10.3	8.1	25.6	4.6	11.8	12.5	7.4	11.7	11.3	0.4	0.8	4.4	1.7	0.1	2.5	0.8	3.4	2.0	0.7	0.0	3.5	4.8	4.6	3.7	8.7	2.3	2.7	2.1	2.2	0.1	5.0	7.1	3.0	3.2	0.2	2.3	3.3	1.9	3.6	0.5	3.2	6.7	5.7	3.2	5.6	3.7	4.5	4.8	4.1	8.9	4.6	0.7	0.0	4.1	1.9	1.7	0.2	3.6	0.7	1.1	3.3	0.2	4.6	3.0	3.1	5.8	0.2	2.0	3.4	4.3	7.0	7.0	2.8	5.5	7.0	3.2	4.9	3.7	3.3	24.3	13.9	0.1	2.0	3.3	7.8	0.7	1.7	0.4	2.5	1.3	1.9	0.4	1.7	2.4	0.8	0.1	0.2	1.5	4.4	0.1	0.7	0.4	1.3	0.8	17.7	25.1	33.7	29.5	18.0	11.0	21.1	17.7	16.4	25.6	44.7	20.4	14.9	54.4	81.3	39.6	30.2	25.5	22.7	26.1	10.4	94.2	0.3	6.6	15.9	3.6	15.7	12.5	0.0	7.4	3.0	26.7	57.3	38.1	25.3	20.8	36.5	1.2	20.3	33.9	1.8	9.8	33.2	30.4	28.9	12.3	24.2	22.2	13.5	26.5	7.7	108.3	51.8	35.3	0.9	1.3	42.7	0.3	44.9	6.8	52.7
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.6	14.0	7.5	13.2	5.6	5.2	15.8	6.5	6.0	9.1	7.8	20.6	11.3	15.0	10.1	6.7	10.9	13.9	11.7	10.2	4.1	14.7	19.2	9.7	11.8	14.9	9.6	11.1	10.8	5.1	17.8	9.3	11.5	8.0	6.0	11.0	24.1	8.3	4.1	25.8	12.0	7.7	17.1	11.7	8.6	22.7	6.8	20.8	6.8	5.7	17.1	10.5	12.4	13.9	20.5	5.9	9.2	14.2	6.7	9.0	9.7	10.3	9.4	9.6	9.3	18.3	4.3	7.4	8.8	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6	3.0	11.3	5.2	5.3	16.4	4.9	5.0	5.1	6.7	6.8	3.5	0.0	3.1	0.0	6.1	1.0	6.7	18.6	0.0	6.1	20.3	5.9	9.4	10.4	4.7	6.5	4.8	10.4	4.3	7.5	1.3	4.9	5.9	10.1	3.6	14.5	3.7	8.8	11.9	4.6	2.1	5.4	12.9	5.3	4.4	7.6	13.2	3.1	7.7	11.8	8.7
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686418-212699985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8"	"Group enriched"	"Detected in many"	36	"dendritic cells: 16.5;monocytes: 26.8"	"Cell line enriched"	"Detected in some"	12	"HDLM-2: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	10.4	1.3	6.7	6.3	9.4	5.4	3.5	0.4	5.2	2.0	2.4	3.3	0.2	1.4	1.8	0.4	1.8	2.6	3.8	4.1	5.5	2.1	2.6	2.3	7.2	8.7	9.5	2.8	3.1	3.2	1.2	1.3	4.6	4.3	2.3	1.6	0.5	2.2	1.2	1.5	1.1	4.3	3.7	4.7	9.5	3.2	1.1	7.1	5.0	2.1	2.6	4.9	3.0	6.0	0.2	16.5	0.6	26.8	0.3	0.4	2.4	0.3	0.9	0.1	0.0	0.0	0.6	0.7	0.5	1.1	1.1	1.2	0.0	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.2	0.8	93.1	2.2	0.0	0.3	0.0	0.2	4.2	0.6	0.1	0.0	2.2	0.3	0.1	0.0	7.7	0.1	1.1	0.2	0.0	3.2	1.7	0.4	0.0	1.5	0.6	0.4	0.0	1.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	3.0	0.0	0.5	2.1	0.1	2.4	0.1	0.2	0.5	1.5	3.8	1.1	0.0	4.1	0.0	0.0	18.0	0.0	0.2	0.0	0.0	16.5	0.0	0.0	0.0	0.6	0.3	26.8	0.0	0.4	2.4	6.7	9.4	0.4	5.2	5.5	2.1	9.5	2.8	4.3	7.1	3.0	1.1	0.5	2.2	5.0	0.1	0.3	0.0	4.0	2.3	0.0	0.0	0.8	0.0	0.7	0.3	5.8	0.0	0.0	0.3	36.2	8.5	6.6	4.7	0.2	4.6	0.0	0.0	6.2	10.5	0.8	0.9	24.9	1.7	98.2	0.0	0.2	1.3	0.0	0.0	0.5	0.4	0.0	25.8	1.1	4.3	2.5	3.8	1.0	0.0	0.9
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2, RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849904	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.6	10.3	8.4	8.3	9.9	19.0	12.1	9.8	17.9	12.8	11.0	8.7	9.7	7.5	14.7	10.4	9.2	12.9	8.6	17.0	9.9	8.6	8.7	8.8	9.0	11.6	10.2	10.7	20.2	16.2	8.4	11.1	12.9	9.5	14.8	8.5	11.4	10.6	13.3	32.4	11.9	8.1	12.4	7.4	11.0	9.5	13.1	9.9	21.7	10.7	10.7	9.0	11.5	19.0	12.8	8.3	10.2	8.8	16.6	19.1	10.2	9.8	7.6	7.5	10.0	10.4	7.7	8.8	11.8	9.2	15.7	10.8	9.8	7.1	12.0	17.3	7.3	6.3	10.3	9.6	7.3	7.8	7.6	9.8	14.9	6.4	8.0	10.9	5.9	9.0	10.2	9.6	15.7	6.7	8.1	5.1	11.1	18.2	10.8	5.0	5.8	18.6	8.5	12.9	7.2	9.7	11.6	8.7	6.2	5.7	6.6	6.4	8.5	5.6	8.2	13.2	11.3	17.2	13.0	6.8	8.5	11.3	18.2	12.0	13.5	18.1	14.2	11.6	9.1	14.8	10.2	8.8	9.5	12.7	7.8	12.7	12.7	13.3	12.9	6.9	12.8	19.1	15.3	3.6	16.6	7.2	8.3	11.5	10.2	8.4	9.9	9.8	17.9	9.9	8.6	10.2	10.7	9.5	9.9	11.9	4.5	1.5	3.7	3.9	8.9	0.3	5.1	5.3	2.3	8.7	0.0	18.8	6.6	7.4	0.3	5.6	7.7	46.7	9.7	8.6	7.1	2.8	2.3	1.7	10.0	7.9	6.3	4.9	7.8	1.6	8.6	3.5	3.3	9.0	7.1	11.4	5.0	0.0	9.9	4.0	6.8	6.5	6.6	10.0	10.5	3.3	11.8	8.7	6.2	2.1
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 144.6;Exocrine glandular cells: 122.2;Pancreatic endocrine cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 113.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA052185: AB_2681753"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.2	24.6	9.0	71.4	12.4	11.1	15.0	15.4	13.9	19.9	16.3	34.0	30.1	26.0	8.1	16.5	34.3	16.0	20.7	14.9	18.4	18.2	24.0	11.3	28.7	13.7	15.7	31.7	16.6	10.0	17.2	17.5	15.9	10.1	12.8	21.5	44.7	48.2	17.2	35.1	19.9	43.6	21.5	51.7	28.3	17.8	17.6	113.3	22.0	16.1	27.3	20.5	20.6	55.0	22.8	9.3	34.6	25.4	13.7	17.2	21.9	21.7	32.9	16.7	29.2	43.7	39.4	24.2	35.9	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5	41.7	53.9	0.0	0.0	0.0	0.0	0.0	0.0	144.6	78.5	43.6	0.0	64.0	82.9	81.2	0.0	0.0	0.0	0.0	122.2	66.3	0.0	0.0	43.0	0.0	62.2	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	36.9	0.0	0.0	97.5	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	0.0	89.2	0.0	0.0	0.0
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037413: AB_2675463, HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	17.1	20.1	15.9	13.3	17.9	31.5	17.2	13.9	26.5	15.4	16.3	12.4	15.4	14.7	14.9	14.6	13.8	13.9	12.4	15.8	14.9	15.6	28.4	29.8	14.4	21.0	14.8	16.8	14.9	27.3	12.5	25.3	18.6	17.0	14.8	13.9	8.6	13.5	14.0	29.4	11.7	19.2	12.2	17.2	16.4	15.1	13.8	18.6	17.4	18.0	16.4	14.7	13.2	20.0	20.0	16.1	32.1	19.6	22.6	19.7	9.4	21.9	12.3	15.4	12.9	15.6	19.8	20.5	28.5	19.7	20.0	16.5	21.5	24.7	27.7	17.4	19.0	21.2	10.8	18.1	13.3	31.2	29.5	21.8	32.5	10.5	24.6	15.8	40.3	34.5	16.3	22.4	15.0	14.3	24.4	15.3	26.2	25.8	24.2	18.3	11.1	26.8	34.9	16.5	20.4	15.3	16.9	18.3	21.8	18.1	15.9	13.5	15.5	10.4	18.2	28.2	18.6	13.3	27.4	17.0	17.3	19.9	21.1	25.0	23.2	25.8	35.0	22.0	25.1	19.6	28.1	14.3	32.1	15.9	18.5	18.7	20.0	18.0	13.2	16.1	17.2	19.6	19.7	29.0	22.6	19.6	15.0	19.0	9.4	15.9	17.9	13.9	26.5	14.9	15.6	14.8	16.8	17.0	18.6	71.5	36.3	61.4	75.3	75.6	34.8	30.5	61.1	75.0	45.5	61.1	21.6	86.5	198.9	74.3	40.6	40.9	39.1	23.3	52.1	69.0	56.7	67.4	42.8	75.7	76.6	33.4	49.7	40.5	54.7	18.1	51.5	56.0	54.0	76.7	38.4	39.8	54.5	63.3	55.5	180.4	29.5	97.0	44.0	91.4	84.7	75.4	90.2	57.5	31.5	88.7
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.6;Suprabasal keratinocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavorable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	13.8	15.1	12.0	9.3	15.0	9.3	14.5	17.9	20.5	12.9	11.1	11.4	16.2	11.0	15.9	14.3	13.7	13.9	10.5	11.1	13.1	12.9	12.8	12.0	8.8	14.1	13.6	15.0	19.7	19.6	20.5	10.9	14.6	15.9	15.0	7.8	12.9	20.3	14.8	15.2	14.9	8.5	11.6	9.9	10.1	11.1	11.2	12.2	13.1	15.7	9.1	12.6	13.7	12.8	11.4	27.5	3.3	5.0	12.2	16.2	7.5	8.3	9.6	8.3	13.6	7.3	5.2	18.9	10.0	7.1	15.2	11.2	14.6	10.1	11.9	12.1	4.4	7.0	12.2	15.3	10.2	15.6	18.9	17.2	13.5	9.7	9.1	14.1	14.7	8.9	7.1	12.6	14.9	19.5	6.6	7.6	10.5	26.5	14.5	8.6	5.7	14.2	6.5	25.8	8.6	18.5	14.2	17.4	32.5	8.0	7.2	25.1	12.1	8.8	13.7	20.3	8.7	7.7	6.6	5.1	15.3	9.6	12.3	20.3	11.8	13.1	24.3	7.6	14.4	16.0	1.7	5.0	3.3	10.3	3.9	16.1	11.4	12.4	9.9	5.9	10.3	16.2	13.8	0.9	12.2	4.2	27.5	6.2	7.5	12.0	15.0	17.9	20.5	13.1	12.9	13.6	15.0	15.9	12.2	6.0	6.4	16.6	16.0	44.6	9.7	4.5	7.6	6.7	15.9	3.5	9.8	11.8	11.6	8.2	1.2	10.5	4.0	23.3	6.3	11.6	13.5	9.8	11.5	4.9	4.9	15.9	4.1	5.5	4.3	0.2	9.2	4.9	11.8	7.2	4.5	10.1	8.1	7.0	13.1	6.8	12.2	0.0	10.3	10.1	26.6	54.3	6.6	13.8	7.3	9.6
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.3	0.2	1.4	4.5	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.2	0.3	0.3	0.8	0.2	0.1	5.8	0.7	1.0	0.4	0.3	0.1	0.5	0.1	0.6	0.8	1.6	0.3	0.1	0.7	0.3	1.0	5.1	0.6	0.1	0.5	2.6	0.0	0.1	0.2	5.4	0.1	0.6	0.4	1.1	0.2	0.3	0.3	0.0	0.6	2.6	0.2	0.1	1.0	0.6	3.4	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7	14.9	16.0	0.0	0.6	1.4	1.2	1.2	0.0	28.1	6.8	0.0	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.2	0.9	1.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.6	0.0	1.0	0.2	0.2	0.6	0.3	0.0	0.0	0.4
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	5	"olfactory region: 22.0"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.7	6.8	6.4	0.1	3.5	4.5	0.0	16.2	13.9	12.6	17.9	2.5	18.0	41.3	5.3	13.9	25.1	12.2	10.1	16.6	25.5	0.0	6.7	9.9	20.1	1.6	4.5	25.9	0.1	8.3	3.0	9.7	28.5	13.0	24.8	32.3	13.6	0.0	9.7	7.4	32.7	9.3	36.5	3.9	8.4	32.9	22.9	27.5	3.5	3.7	23.5	19.2	7.3	4.5	7.4	8.5	11.0	11.7	10.5	13.8	17.0	23.9	19.5	21.3	14.6	53.4	13.2	35.0	13.5	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3	17.9	20.3	28.9	22.5	24.2	0.2	26.3	2.5	6.7	31.8	0.0	2.0	0.5	3.3	6.7	2.6	3.7	1.5	0.0	5.3	0.2	4.3	7.7	8.1	3.4	9.6	12.7	10.3	2.5	10.2	3.6	3.7	3.5	8.5	0.0	26.4	2.4	4.9	3.5	2.5	0.0	2.1	12.9	12.3	2.7	61.1	6.8	0.2	2.5	24.4	3.9
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.4	12.4	23.5	17.0	1.0	2.0	15.8	21.5	10.8	38.0	27.0	19.4	21.3	34.6	8.7	13.7	15.3	16.2	27.0	14.2	40.4	23.0	12.1	31.1	13.3	15.3	0.2	29.9	16.1	0.8	1.0	21.4	19.0	4.3	16.8	24.9	26.2	37.2	27.4	12.7	27.5	18.4	27.2	16.6	17.2	26.9	32.1	19.8	8.6	11.9	20.9	9.2	23.6	11.1	14.5	21.1	16.3	11.4	10.1	18.7	19.9	10.7	33.5	25.3	32.9	47.2	8.8	27.8	21.4	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7	0.0	0.3	9.3	0.8	3.0	1.1	0.4	5.1	8.1	0.0	0.0	0.0	2.2	0.0	1.1	0.8	0.2	4.2	0.0	0.6	20.9	0.9	0.6	0.0	1.0	9.5	1.6	3.5	1.8	3.1	2.2	1.4	4.6	1.7	2.8	5.1	0.0	1.6	4.9	1.1	0.5	0.8	19.4	0.0	82.1	41.4	2.4	2.4	3.2	6.3	0.9
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 128.1;LHCN-M2: 141.4;RH-30: 445.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.5	11.1	14.6	13.0	13.4	11.8	9.8	5.5	18.0	24.4	20.2	15.8	9.1	13.9	10.0	8.6	14.4	7.4	20.2	128.1	18.5	6.8	9.3	13.0	7.5	11.1	15.7	14.7	9.0	11.6	9.4	14.9	17.2	16.6	15.6	13.3	13.8	12.0	141.4	13.9	14.1	12.0	17.2	10.0	11.2	12.6	445.0	12.9	7.6	15.1	13.3	12.4	9.8	7.4	14.7	10.5	9.8	17.9	7.1	11.4	10.8	12.9	11.1	6.0	9.7	21.4	10.5	13.7	13.7	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5	20.8	25.0	32.0	62.9	79.7	15.3	0.5	48.4	4.0	23.9	45.4	9.8	64.6	59.7	71.7	10.1	44.2	11.3	23.3	53.6	108.9	77.4	41.8	68.1	32.1	111.7	17.5	43.8	34.4	23.2	6.8	59.2	34.0	50.6	54.1	33.5	51.3	55.4	7.0	59.4	66.3	15.3	32.3	54.2	25.9	40.3	75.3	39.1	34.1	78.3	32.5
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 178.1;Late spermatids: 275.2;Pancreatic endocrine cells: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.2;HEK 293: 56.9;HeLa: 53.2;SK-MEL-30: 53.1"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA			Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.7	35.1	3.5	50.2	7.2	32.3	1.6	0.0	6.0	5.9	36.5	15.9	31.0	56.9	0.0	53.2	2.3	1.5	3.6	3.0	3.8	0.0	19.8	11.0	42.3	2.0	0.0	0.0	33.0	18.0	0.1	0.3	0.0	0.4	4.0	29.3	0.0	13.4	26.5	4.0	0.0	33.1	2.3	38.2	6.3	53.1	1.7	7.5	0.1	6.6	0.1	0.4	0.0	0.1	14.7	8.3	29.5	0.0	9.5	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9	0.0	0.0	1.5	0.7	1.5	0.2	4.0	0.0	14.7	1.2	10.4	0.0	20.9	0.0	32.4	178.1	2.2	6.9	0.0	22.9	52.3	3.6	10.0	4.6	0.0	6.6	0.0	68.2	0.6	8.2	275.2	2.8	1.8	8.5	26.2	6.2	0.8	259.8	10.5	1.8	0.0	0.0	0.0	1.0	5.7	4.1	0.4	7.7	12.5	2.3	34.0
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.5	6.7	10.8	11.5	3.0	2.8	21.3	6.9	3.2	9.5	10.2	8.6	12.7	12.9	9.4	2.8	5.2	12.0	12.1	5.7	9.6	9.4	10.5	18.2	13.2	9.1	3.1	16.6	20.2	1.4	5.7	8.0	5.8	4.5	4.2	17.5	24.5	18.0	7.0	4.9	15.9	20.2	10.5	6.7	11.2	16.3	12.6	12.0	4.8	2.1	18.4	8.5	9.7	8.1	8.0	6.2	7.4	11.9	4.9	7.8	13.0	9.1	10.6	14.2	20.7	16.1	4.8	29.3	14.7	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5	0.0	2.1	0.0	4.2	6.2	9.6	26.8	2.5	1.4	4.5	5.2	11.8	2.0	6.6	1.7	0.8	1.8	3.9	0.0	1.1	3.6	2.1	2.2	2.3	2.5	4.3	0.0	1.7	1.8	5.2	2.3	1.4	4.0	1.7	4.6	3.1	1.3	2.1	3.4	0.4	0.8	10.1	0.0	1.0	43.5	37.7	5.4	34.9	3.5	4.7	3.2
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.3;SCLC-21H: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.9	2.0	26.3	4.6	0.1	0.0	8.3	0.2	0.0	0.9	0.8	4.9	3.7	7.6	0.5	0.0	1.2	2.4	13.5	3.9	0.8	2.9	7.2	17.9	3.3	6.4	1.1	5.4	3.3	0.5	3.0	0.0	4.4	1.6	3.9	6.2	1.3	6.8	0.6	4.0	8.4	6.2	18.0	3.9	0.9	17.6	6.2	2.4	2.0	4.5	24.0	11.9	0.7	3.0	7.3	9.7	5.3	5.1	4.5	0.3	4.3	0.3	2.1	7.3	4.2	11.9	1.5	0.6	6.7	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2	29.8	17.4	46.9	22.3	27.0	32.3	30.7	30.6	20.1	23.9	15.7	227.8	7.1	1.7	15.6	11.9	29.6	17.6	0.0	9.7	5.5	7.1	31.3	38.3	9.5	11.9	66.7	83.8	27.0	12.9	7.6	0.9	10.3	20.3	19.8	30.6	155.9	13.9	22.6	0.4	4.2	196.3	0.0	4.4	4.9	3.4	28.2	5.1	13.8	21.7	25.1
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Syncytiotrophoblasts: 445.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.4	15.8	19.4	9.2	15.3	19.1	28.2	13.6	15.0	14.8	15.7	35.3	22.6	17.3	13.4	11.6	27.3	15.9	11.4	18.9	20.0	22.8	14.4	52.1	12.8	17.7	14.3	13.7	27.7	12.8	18.0	18.8	28.1	20.2	19.6	18.8	32.7	8.8	26.2	25.6	15.8	32.0	46.8	21.8	21.9	11.2	20.3	16.4	17.6	21.4	7.8	13.7	10.7	19.0	15.3	40.7	26.1	18.9	14.2	16.7	13.8	14.7	24.9	6.1	7.8	23.0	27.2	10.8	16.8	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8	11.9	13.7	19.0	62.8	26.0	35.2	62.1	28.1	46.8	28.4	22.7	3.9	144.0	64.6	44.6	10.3	38.6	126.2	116.8	73.5	117.3	40.1	92.3	22.0	56.7	56.8	33.4	40.0	38.6	32.1	12.9	23.6	27.0	42.2	49.5	94.4	20.7	65.2	133.3	26.2	64.8	17.4	19.4	37.0	79.6	93.5	38.9	445.4	22.3	85.9	97.2
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938187-56961054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.8"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 199.1;Late spermatids: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA057480, CAB069400"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Nuclear bodies"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"	"CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	8.7	5.6	7.3	5.5	8.1	10.9	8.2	12.6	8.9	8.9	6.4	7.6	4.9	6.7	8.1	8.1	8.5	6.8	4.9	5.3	5.8	5.7	7.0	8.5	5.3	7.7	7.1	6.5	8.6	9.1	8.5	9.7	9.5	8.2	7.8	7.3	5.8	7.5	9.1	7.9	7.8	7.0	5.9	7.2	8.1	6.4	58.8	6.0	12.3	8.7	5.3	8.5	7.7	7.3	22.5	13.7	14.0	13.4	12.7	17.8	8.6	13.2	10.1	20.8	8.0	7.1	8.6	14.4	9.5	9.0	14.6	15.6	13.8	11.5	16.0	19.4	7.6	10.9	7.8	14.1	11.0	20.9	19.2	17.8	26.1	9.7	15.6	7.7	21.9	16.0	7.9	13.8	11.0	11.9	8.7	12.4	9.5	22.5	13.4	13.7	16.8	17.2	14.0	12.2	14.7	10.2	8.2	25.6	12.8	10.0	13.4	17.7	17.5	6.4	6.4	16.0	12.5	23.1	21.5	8.7	17.0	12.9	8.2	12.3	19.9	24.8	18.8	8.9	12.2	10.3	14.0	11.5	13.9	13.9	10.4	15.6	22.5	15.4	14.6	11.3	21.6	17.8	17.2	6.8	12.7	13.4	13.7	15.2	8.6	7.3	8.1	12.6	8.9	5.8	5.7	7.1	6.5	8.2	6.0	11.9	15.2	21.2	34.1	16.7	35.0	13.4	17.8	20.1	25.0	14.0	35.3	36.2	11.6	24.9	199.1	26.3	12.6	0.0	24.1	27.5	24.2	25.8	21.9	21.5	19.3	23.8	23.0	21.5	14.0	405.7	39.1	13.9	3.3	14.4	16.2	26.1	21.4	17.5	28.7	18.7	47.6	12.9	18.4	95.4	43.3	19.8	24.4	22.3	20.7	27.1
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA		52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.6	12.3	8.5	11.0	32.7	25.5	6.9	16.7	24.9	14.0	15.8	7.9	11.9	9.5	11.1	20.3	8.5	26.8	18.2	17.7	25.2	10.1	14.3	1.5	9.0	9.4	11.3	0.8	0.8	17.3	19.2	15.5	20.6	22.6	17.1	4.9	8.5	18.3	17.2	13.4	16.6	0.5	3.2	28.7	17.8	7.9	7.7	44.4	18.1	24.9	18.0	14.1	14.6	66.7	10.5	10.2	25.4	2.6	18.2	12.5	12.2	16.6	12.9	13.2	15.8	2.6	18.0	3.6	11.5	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1	128.1	76.8	40.4	87.4	72.7	16.8	108.0	79.0	77.6	69.4	66.3	13.7	59.5	84.6	63.4	1.1	55.4	37.1	23.3	72.9	45.8	62.4	110.2	8.1	86.6	42.9	42.9	48.1	57.7	74.2	2.2	79.4	49.0	50.6	32.5	53.7	70.1	62.4	52.6	82.4	99.4	16.5	58.2	55.6	3.0	10.0	79.5	65.2	47.5	69.8	73.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell type enriched"	"Detected in many"	72	"Hepatocytes: 1670.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 90.5;SK-BR-3: 27.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		2100000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0.0	1.0	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0.0	1.9	4.0	90.5	5.6	1.4	2.1	0.0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4.0	0.3	4.4	1.1	0.1	0.2	2.4	0.0	0.6	0.2	5.8	0.5	5.7	0.0	0.1	0.4	15.8	27.3	3.0	8.5	0.0	0.7	3.0	7.0	2.1	2.1	4.9	0.0	0.3	0.0	4.6	4.4	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0.0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0.0	0.0	16.5	22.7	3.6	2.3	1.8	1.7	0.0	0.1	1.4	0.0	0.0	1.1	0.7	2.2	0.0	2.5	0.3	1.1	1.6	17.4	5.0	0.1	0.4
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	25.3	22.8	21.3	21.7	15.5	18.0	16.0	18.9	14.5	18.0	18.5	22.4	24.8	35.3	32.4	19.8	17.8	19.1	28.8	24.2	34.9	33.6	20.5	48.7	13.7	25.4	17.7	19.9	21.0	14.6	16.7	26.5	44.1	11.3	24.9	24.3	32.7	15.5	27.3	20.6	37.8	21.0	32.6	71.8	35.6	24.6	25.9	36.3	26.2	21.2	27.2	25.8	11.8	18.5	21.4	19.6	28.6	13.7	16.4	18.3	29.5	23.6	25.3	17.1	29.8	49.9	24.7	43.6	23.4	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0	14.9	14.2	31.8	57.7	70.6	19.2	17.3	7.6	14.7	31.8	31.4	23.6	50.1	33.2	41.0	33.6	28.9	16.1	0.0	42.0	61.5	36.1	25.3	40.3	14.7	39.5	15.9	13.9	17.2	15.4	10.8	22.5	25.0	25.3	30.7	16.0	25.8	34.4	10.5	16.6	66.3	19.8	12.9	36.3	85.0	87.9	67.2	28.4	26.3	25.4	52.2
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156297-30183640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	29.5	34.6	41.4	15.6	39.4	23.3	32.6	23.6	43.6	21.0	20.6	27.4	15.4	14.2	24.1	27.2	24.1	18.0	20.0	44.5	37.7	35.2	32.8	27.5	20.3	15.3	42.3	36.3	26.3	19.5	31.0	27.7	32.7	41.4	21.9	22.5	16.5	20.3	23.7	20.4	17.5	15.6	26.0	46.2	16.8	19.3	13.9	30.3	15.4	33.7	18.2	17.9	25.7	18.8	7.4	19.8	9.5	15.9	10.2	11.2	6.9	19.1	18.3	23.3	12.2	21.1	29.2	14.9	26.1	30.1	25.4	26.7	11.9	12.8	14.2	28.0	27.2	23.8	14.2	16.1	22.0	30.0	11.4	12.5	20.4	15.8	18.6	16.3	11.5	17.4	24.6	31.4	18.2	19.5	22.1	22.7	20.5	22.8	15.7	27.0	14.5	21.3	16.6	18.9	32.2	11.7	11.4	17.5	12.4	36.1	18.8	38.1	21.6	15.2	18.6	25.8	12.3	18.0	16.3	21.8	13.8	48.3	11.3	18.5	6.7	7.4	18.4	25.5	13.2	24.0	9.5	14.1	4.9	8.6	15.9	9.8	7.4	7.8	10.1	16.8	5.5	9.0	11.2	4.5	10.2	15.1	19.8	8.7	6.9	41.4	39.4	23.6	43.6	37.7	35.2	42.3	36.3	41.4	30.3	23.8	31.2	37.4	81.1	50.8	33.7	73.4	45.9	57.6	37.5	41.8	13.7	76.0	104.5	78.2	11.6	53.1	26.3	0.0	74.2	71.3	55.9	41.2	46.1	41.8	61.9	25.4	39.2	44.2	46.4	7.3	74.8	51.6	65.8	65.9	27.4	43.3	77.1	38.6	70.7	114.8	36.3	51.8	70.0	42.8	48.2	55.6	170.3	40.5	29.2	81.2
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	22.0	50.5	24.0	25.4	24.0	16.6	25.5	27.4	21.1	31.1	19.8	49.1	29.5	27.9	30.1	22.7	29.4	20.0	52.0	24.9	26.7	43.7	27.6	37.0	43.0	22.1	12.9	37.3	33.7	16.0	22.4	33.0	19.8	21.4	25.5	24.8	48.9	25.0	22.6	30.7	35.3	35.4	35.7	31.4	24.0	37.8	28.4	22.2	18.4	31.1	29.6	17.3	27.4	31.5	11.4	25.7	30.8	34.3	22.8	23.6	17.3	11.6	21.7	18.9	26.3	33.7	20.0	26.3	12.9	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0	23.8	25.5	22.4	12.7	11.4	16.9	17.1	22.9	44.2	31.8	12.2	23.6	22.5	13.3	22.3	6.9	21.0	23.3	23.3	33.5	24.6	16.2	21.2	17.4	16.3	16.7	14.3	13.4	17.8	9.9	4.1	22.7	15.0	13.5	24.4	22.7	24.3	28.9	31.6	20.8	10.2	24.0	19.4	18.4	33.8	36.1	13.2	22.2	24.2	23.9	17.1
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.2	4.5	5.4	6.3	3.5	10.6	4.2	6.3	10.7	7.6	8.9	9.8	23.2	6.5	5.2	5.8	11.2	6.4	10.2	6.3	3.1	10.6	8.4	4.8	9.2	8.5	13.1	9.0	6.9	11.2	8.8	8.1	3.7	5.9	15.7	14.9	3.6	4.7	13.8	13.7	18.5	11.1	6.3	6.8	13.5	4.2	24.8	7.5	7.2	9.5	6.4	17.2	4.9	9.3	5.4	9.5	14.4	4.2	4.7	4.0	6.7	6.9	8.2	9.9	22.3	5.8	10.1	6.4	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7	6.0	5.0	7.5	13.5	8.1	4.8	3.1	2.5	2.7	5.7	3.5	0.0	24.0	11.6	9.5	5.9	6.0	1.7	0.0	8.5	9.4	4.2	3.1	3.5	9.7	15.4	3.2	4.6	4.3	10.3	3.1	4.6	6.6	6.8	11.8	2.8	7.2	7.2	4.5	3.2	14.6	3.4	12.9	4.1	20.6	15.1	9.4	83.5	10.1	5.8	10.3
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.0	13.2	6.4	8.8	7.9	7.1	12.6	7.6	7.5	12.0	9.2	14.6	14.6	17.7	6.9	7.1	12.5	19.8	20.2	8.9	9.7	10.8	7.5	9.6	11.7	7.6	9.5	17.0	7.8	6.3	12.2	12.3	17.3	4.6	7.8	13.2	17.6	6.9	9.9	15.2	11.8	9.3	15.9	21.0	13.5	12.5	11.4	20.3	10.9	6.8	11.6	8.3	13.9	12.4	10.5	7.8	25.9	5.0	6.6	20.4	9.2	11.5	11.7	3.4	10.7	13.8	7.3	10.8	15.3	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3	6.0	5.9	3.4	3.1	4.9	3.4	3.1	0.0	6.7	15.9	7.0	3.9	4.6	1.7	4.1	2.1	3.9	0.7	0.0	4.6	5.8	2.6	4.1	1.1	3.2	4.6	1.6	23.6	3.1	2.4	2.4	16.7	2.8	1.7	4.6	3.7	1.5	4.7	0.0	12.4	4.3	3.1	0.0	2.1	11.2	15.7	5.5	2.5	4.1	5.7	2.6
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 21.7;Exocrine glandular cells: 15.4;monocytes: 16.2;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.7	17.2	16.9	13.7	16.7	16.4	28.9	17.1	19.7	36.6	34.3	26.0	25.7	20.5	6.7	23.2	22.7	26.0	24.2	19.7	41.3	28.9	17.4	18.7	12.8	14.8	14.2	21.3	12.1	15.8	18.8	21.7	18.0	28.8	28.1	16.2	18.1	4.6	20.0	14.2	17.2	14.8	74.3	18.5	10.6	19.2	32.9	12.4	22.3	28.7	7.4	18.8	20.8	13.4	17.0	43.8	5.4	16.1	12.6	14.8	35.9	9.5	25.7	6.5	11.8	37.1	15.7	11.2	17.0	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8	3.0	8.0	0.9	2.5	1.9	0.8	0.1	0.0	10.7	13.6	0.0	0.0	1.3	1.7	21.7	0.1	1.6	2.0	0.0	15.4	1.6	1.0	1.6	11.5	0.8	0.7	0.0	4.6	1.3	0.6	0.0	0.6	1.3	0.0	16.2	4.5	1.4	18.4	2.9	0.4	0.6	1.3	6.5	0.5	0.2	0.6	1.6	1.1	5.0	6.2	2.0
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		150000	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	55.1	20.8	63.0	39.9	58.4	55.0	40.1	54.7	70.6	67.1	67.2	22.5	33.8	80.9	31.4	71.8	47.8	32.9	67.8	62.9	75.9	28.7	48.7	52.6	15.9	17.2	42.8	66.9	56.1	61.9	54.3	61.3	47.8	37.4	71.6	69.9	41.7	69.1	51.7	32.8	139.9	19.5	36.7	50.9	64.3	87.6	66.6	56.9	41.1	26.5	44.3	74.3	53.1	51.5	66.6	56.7	48.2	37.7	50.3	40.8	45.6	43.9	56.6	38.6	76.1	142.8	43.2	32.9	48.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8	497.3	661.1	481.3	1231.3	781.2	369.6	221.7	262.4	725.4	624.4	350.7	316.1	372.7	283.5	416.6	432.3	643.3	503.6	116.8	366.6	307.8	528.8	417.0	836.7	222.3	399.0	397.3	638.0	483.1	539.2	80.3	384.6	631.0	410.0	779.1	366.4	576.1	376.0	445.4	411.5	208.8	514.0	485.0	599.5	374.0	341.8	652.0	741.9	719.3	310.9	1106.4
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 210.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.8	9.9	1.0	9.8	5.5	4.9	4.2	6.5	5.8	8.6	8.3	5.0	1.8	2.7	4.5	4.3	1.8	4.4	10.9	7.1	11.5	6.5	12.3	6.1	6.2	4.0	5.4	7.8	3.2	5.1	7.3	5.6	6.9	4.1	9.8	2.7	0.8	1.9	5.0	1.5	11.7	4.0	5.6	2.7	0.4	7.6	8.6	5.0	9.7	5.4	7.2	5.8	7.8	1.8	4.8	5.7	3.4	6.0	6.6	7.0	4.4	3.6	7.4	2.4	3.9	5.5	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5											38.7	19.5	26.1	27.2	30.7	28.6	28.7	28.1	28.1	38.7	26.2	31.4	30.7	29.9	64.6	210.7	26.3	24.7	0.0	45.3	25.7	21.9	24.4	26.5	32.8	22.8	44.5	25.2	29.4	23.8	70.2	22.7	23.7	16.9	47.7	26.7	23.2	47.9	21.0	22.6	32.3	32.6	25.8	12.6	28.9	57.6	29.1	20.9	34.4	36.5	43.1
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.5	1.6	4.4	2.0	2.0	6.8	7.3	3.7	8.3	7.3	13.2	7.6	13.5	9.5	2.7	11.4	13.1	3.3	7.3	1.5	5.0	20.8	8.9	13.0	10.1	3.6	9.3	5.0	2.9	5.3	7.4	4.6	1.5	4.2	5.0	18.3	3.8	5.3	10.1	4.7	8.6	11.1	6.6	19.3	3.8	7.2	5.3	4.7	8.2	5.2	8.4	9.6	15.0	5.5	1.3	10.9	9.6	8.9	6.8	9.9	4.6	18.3	12.4	19.0	19.4	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9	14.9	25.3	16.0	20.1	15.1	25.2	10.8	12.7	24.1	34.2	21.0	13.7	48.6	23.2	34.9	39.1	23.8	26.9	0.0	28.4	38.8	18.4	15.9	27.7	27.7	31.4	6.4	17.7	18.4	10.1	30.0	19.5	17.4	13.5	32.5	19.6	20.6	31.1	20.1	18.7	40.8	23.2	12.9	20.6	30.2	29.0	17.3	39.5	18.7	27.0	18.1
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 43.2;Extravillous trophoblasts: 23.7;Horizontal cells: 14.3;Rod photoreceptor cells: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: AB_2681985"	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.29e-5)"	4.7	4.1	6.0	5.0	7.8	3.8	4.0	13.2	7.8	3.8	4.3	4.2	2.0	12.5	5.9	1.5	3.1	4.9	4.2	4.1	4.1	1.8	2.9	2.0	3.5	2.9	5.4	4.1	6.7	9.3	1.3	8.7	4.8	2.9	3.0	1.6	4.3	3.3	3.3	1.9	2.3	5.6	2.6	3.0	5.6	4.1	1.7	6.3	2.8	3.2	1.0	5.6	4.7	3.4	3.1	6.3	6.9	8.2	2.7	6.4	3.7	3.1	2.9	1.4	4.0	0.9	1.0	0.9	2.7	0.9	3.0	2.9	1.7	1.3	1.2	1.8	0.6	0.3	0.9	0.4	1.7	0.2	7.3	7.5	11.0	1.2	1.6	2.6	6.0	8.6	0.5	0.3	2.7	0.1	0.8	3.3	4.9	6.1	1.3	0.7	0.9	6.6	3.6	2.2	1.1	6.3	5.5	2.3	2.4	0.6	0.4	2.9	5.0	2.0	3.0	8.3	0.0	0.7	3.6	5.0	1.2	1.0	5.8	2.4	2.4	3.6	3.4	1.4	9.4	1.7	5.3	5.5	6.9	4.7	5.1	2.9	3.1	3.0	3.8	6.3	1.2	2.8	4.5	1.7	2.7	8.2	0.1	6.4	3.7	6.0	7.8	13.2	7.8	4.1	1.8	5.4	4.1	2.9	6.3	3.0	5.8	0.0	1.0	0.6	4.4	0.8	2.5	1.4	2.3	1.8	43.2	3.0	1.7	1.9	0.8	2.1	2.0	0.0	1.4	23.7	2.1	0.7	0.0	1.6	2.5	14.3	2.4	3.1	5.3	1.1	1.1	1.9	0.0	0.0	4.1	3.5	1.6	0.0	4.6	2.2	19.3	0.0	0.5	1.8	3.2	0.3	1.1	3.2	3.7	0.7
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440912-5469060	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	10.0	10.4	11.6	11.0	14.6	7.0	12.9	15.8	22.0	9.0	8.7	14.1	8.6	8.6	12.4	7.9	11.2	11.2	9.2	7.7	9.7	7.0	8.2	13.4	8.0	10.1	11.0	13.2	11.1	12.1	16.5	7.3	11.5	10.3	10.0	10.7	11.3	10.4	10.8	13.9	12.5	8.7	11.1	8.0	11.1	9.6	10.1	11.7	8.4	9.5	9.4	10.3	9.6	9.5	3.7	3.4	2.6	3.5	3.0	2.5	0.7	10.3	15.4	9.8	17.6	4.1	8.4	12.3	10.3	6.4	15.9	12.8	9.6	4.5	25.5	7.2	8.4	6.3	12.3	20.0	16.1	20.4	8.2	19.2	10.1	12.6	16.3	8.2	13.5	9.1	7.1	9.8	16.9	23.2	4.7	11.7	12.4	13.4	12.6	8.7	7.3	13.6	7.4	21.8	6.9	7.8	18.3	14.5	13.8	7.2	8.1	8.6	12.4	10.7	9.3	15.9	8.7	7.2	7.1	10.9	11.0	11.6	8.7	21.7	4.7	5.1	13.1	7.8	16.0	15.7	0.6	3.5	1.8	2.2	1.4	2.1	2.5	2.5	1.4	1.4	3.7	2.5	2.4	2.6	3.0	1.3	3.4	1.8	0.7	11.6	14.6	15.8	22.0	9.7	7.0	11.0	13.2	10.3	11.7	11.9	10.4	3.0	12.0	18.7	16.4	13.4	20.4	5.3	11.4	7.0	19.6	7.3	1.7	6.5	40.0	11.1	5.7	0.0	13.2	7.9	14.1	7.4	3.5	25.4	5.4	12.7	8.7	12.3	15.3	4.8	7.2	8.2	13.5	1.0	10.6	14.7	9.5	3.5	9.2	6.3	10.1	0.0	11.3	11.2	15.2	17.3	4.2	4.5	11.0	10.8
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		97000	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.7	35.0	50.3	27.6	26.3	20.4	49.7	31.7	29.1	46.1	31.3	39.1	27.6	57.4	31.0	28.4	27.6	31.0	76.3	34.3	51.7	23.3	37.9	38.2	28.7	26.4	14.8	55.3	26.2	18.1	17.3	45.2	12.3	20.9	36.0	29.5	60.0	20.6	36.9	31.4	55.9	13.6	63.7	38.5	21.6	51.0	46.9	32.8	29.8	41.6	36.3	41.6	44.9	28.4	18.5	44.2	33.3	31.3	28.1	28.6	32.0	29.0	42.9	21.7	35.4	68.1	18.0	30.4	38.8	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4	38.7	64.9	41.5	53.0	47.7	55.9	37.2	35.7	72.3	69.4	48.8	49.1	40.4	16.6	39.6	17.1	44.9	31.7	0.0	43.7	37.7	35.9	40.6	42.8	24.3	35.2	27.0	51.6	38.1	37.7	32.0	55.8	34.4	28.7	27.1	33.8	42.7	42.4	25.9	44.2	33.5	72.8	38.8	45.7	63.0	65.2	41.3	41.4	32.4	45.7	48.7
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.6	8.8	16.1	21.0	11.9	15.8	16.0	18.7	7.1	14.5	15.4	14.2	15.6	30.1	17.2	13.9	15.7	11.4	10.8	11.1	18.4	21.3	18.9	20.6	11.5	11.8	14.3	16.9	15.9	13.7	9.0	14.1	13.8	14.4	12.6	19.8	20.9	13.9	14.8	14.7	24.9	26.1	15.5	6.5	18.5	16.1	16.2	41.5	13.1	13.5	18.0	15.8	16.0	15.0	16.0	12.0	12.1	15.9	13.9	10.0	10.4	14.2	25.6	18.4	19.1	27.1	15.2	30.5	14.8	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8	3.0	7.4	18.2	65.3	45.2	5.5	27.9	22.9	13.4	21.6	14.0	9.8	38.5	18.3	24.9	5.1	26.8	3.6	0.0	19.6	38.1	27.3	43.1	12.7	10.9	28.5	0.0	4.6	16.5	16.1	3.6	26.7	17.5	27.0	21.6	11.7	6.0	17.2	2.9	19.1	22.7	4.1	6.5	49.9	12.6	21.1	33.1	29.9	25.4	15.7	57.8
DNAJC21	"DNAJA5, GS3, JJJ1"	ENSG00000168724	"DnaJ heat shock protein family (Hsp40) member C21"	Q5F1R6	5	34929593-34958964	"Disease related genes, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040789	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA040789: AB_10794147"	"unprognostic (1.37e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.77e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.68e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.02e-2)"	13.8	12.2	13.5	12.1	16.5	15.9	20.9	17.2	16.0	20.7	17.9	7.9	13.6	11.6	16.0	11.6	20.1	11.0	10.5	26.7	12.1	11.7	19.0	19.3	13.3	16.6	16.2	12.2	13.6	17.0	16.6	18.7	19.2	17.6	16.6	14.4	6.7	15.4	14.5	50.6	11.6	13.3	23.1	14.5	12.9	15.4	41.9	17.0	17.2	16.5	18.9	14.2	23.8	25.2	5.8	4.8	8.3	3.5	7.5	6.3	1.9	14.3	9.9	12.8	16.9	16.5	19.8	23.8	19.2	15.5	15.1	10.1	16.8	17.3	30.3	8.7	17.7	19.3	10.3	15.0	19.2	17.8	17.9	11.2	16.4	38.0	14.1	27.1	23.5	15.9	14.0	18.1	16.9	27.6	10.9	14.1	11.2	25.5	23.9	11.1	12.1	20.1	17.8	8.9	15.9	8.8	18.3	31.8	13.4	15.4	18.3	7.0	7.2	51.0	24.0	16.1	15.1	16.4	26.3	17.2	19.1	19.0	11.5	15.2	17.2	15.5	20.6	15.6	28.6	10.1	4.0	2.9	8.3	3.6	2.4	5.1	5.8	5.1	3.2	4.8	3.7	5.2	5.1	0.6	7.5	3.5	4.6	6.3	1.9	13.5	16.5	17.2	16.0	12.1	11.7	16.2	12.2	17.6	17.0	71.5	99.0	29.6	53.2	32.7	48.1	137.7	43.3	29.4	46.6	34.9	41.2	41.7	74.6	18.3	74.9	35.9	26.2	0.0	26.3	24.2	33.6	57.4	8.1	50.8	21.3	71.5	17.3	35.0	23.5	29.9	37.4	29.5	35.4	47.7	33.5	29.1	23.4	29.8	35.7	52.4	61.9	12.9	29.3	68.3	51.3	40.8	54.9	29.8	33.3	61.6
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.5	33.6	8.5	25.3	11.2	39.9	15.5	9.9	16.5	16.6	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	11.5	14.6	12.4	8.5	8.7	14.8	27.2	14.7	27.9	7.6	11.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	9.2	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8	14.9	18.5	22.9	37.2	22.7	18.5	17.9	12.7	24.1	21.6	24.4	3.9	56.0	43.1	57.6	31.1	21.1	32.8	0.0	66.5	35.6	23.6	31.5	5.8	16.8	62.7	19.1	21.4	22.7	26.5	10.6	26.2	33.7	15.1	86.6	70.1	42.1	70.4	51.8	25.5	33.4	24.1	0.0	24.5	77.5	33.7	24.1	48.3	18.1	31.6	54.5
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.3	6.8	10.1	20.2	10.7	9.3	10.8	17.5	13.3	9.9	15.1	8.2	2.8	5.7	15.6	18.8	36.7	9.3	13.5	6.9	4.7	8.1	3.5	13.3	10.9	20.5	3.8	6.3	14.8	12.5	14.3	7.9	7.8	12.9	4.1	8.6	4.6	14.3	25.4	3.1	3.2	8.8	14.8	12.0	3.2	9.0	11.2	11.9	7.8	6.3	7.0	14.3	11.8	6.3	6.7	20.6	5.1	10.7	12.0	4.3	15.1	8.8	4.4	10.8	2.9	11.3	3.5	9.1	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0	6.0	2.6	1.5	3.2	1.5	9.0	3.0	7.6	6.7	3.4	7.0	7.9	21.7	0.0	14.1	10.7	8.3	6.2	0.0	12.3	14.0	5.6	3.1	1.1	8.3	11.4	4.8	1.2	17.2	6.9	2.8	11.2	2.7	3.3	1.8	3.8	11.2	10.4	5.8	5.6	7.2	6.5	0.0	4.1	24.0	14.9	1.1	15.2	1.9	5.5	1.7
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	20.0	12.9	40.1	14.7	37.2	35.9	22.7	35.2	27.5	29.7	32.4	22.4	20.0	18.4	31.0	41.8	40.7	20.4	31.5	33.8	39.0	6.9	14.2	16.1	16.6	25.3	18.6	18.3	17.3	27.8	32.2	36.7	23.7	41.6	52.0	18.0	25.3	5.1	58.6	12.6	15.6	14.9	18.5	29.5	13.2	15.8	36.1	13.3	39.5	32.3	25.1	28.3	19.5	15.7	20.9	31.9	15.3	17.9	56.3	45.3	22.5	18.0	21.0	6.3	12.0	14.9	30.8	14.9	33.1	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2	184.6	55.8	68.6	52.1	45.0	68.0	67.4	196.1	111.1	96.7	160.5	60.9	85.6	111.0	177.4	58.5	118.7	140.2	70.0	139.8	89.1	77.0	39.2	96.2	130.7	90.2	76.3	80.9	188.4	142.1	30.8	119.0	94.7	33.7	151.5	111.3	91.1	161.5	106.7	129.7	165.2	120.2	109.9	79.3	209.8	92.5	52.4	96.7	52.4	94.0	47.0
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 8.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.2	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	5.5	12.6	10.7	1.0	8.4	9.5	8.7	4.9	2.4	4.0	0.0	7.4	11.8	0.2	0.0	1.9	0.6	0.5	13.0	10.1	10.3	13.7	3.7	6.9	14.6	9.3	4.0	16.1	6.0	15.9	8.2	9.5	4.0	9.6	3.8	4.3	3.5	7.0	0.8	2.4	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	1.5	0.0	1.0	0.0	2.0	0.0	8.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	23.3	0.0	1.4	0.6	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.1	0.3	0.2	0.0	2.6	0.6
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 69.1"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 291.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6"	"Low region specificity"	"Detected in single"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059367: AB_2683992"	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	1.7	1.7	2.0	2.9	2.7	3.0	1.7	4.0	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1.0	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.2	0.3	1.0	2.3	2.4	2.0	9.5	7.8	4.6	7.8	0.2	0.5	0.1	0.1	2.1	2.1	0.2	0.3	0.8	6.8	0.6	0.1	1.9	8.6	1.5	3.4	0.2	0.5	3.2	0.0	2.9	0.6	0.4	0.7	0.4	0.1	0.6	2.8	0.1	3.4	1.4	0.5	0.2	2.0	0.3	0.0	0.1	2.5	0.3	0.1	0.0	6.3	0.4	0.2	0.2	0.0	0.0	1.4	0.1	0.3	2.3	0.4	0.5	0.2	0.1	0.2	0.0	1.0	0.0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2.0	2.7	4.0	2.6	1.9	1.9	1.2	2.3	2.2	1.6	0.0	5.9	2.9	50.8	11.8	3.4	1.1	0.0	4.0	1.2	1.8	25.5	2.0	0.0	2.4	44.2	5.2	1.3	0.0	1.2	1.1	8.0	25.2	1.1	1.7	1.7	11.1	0.0	6.2	4.0	12.9	8.1	6.1	1.7	5.4	0.0	7.6	5.0	0.2	4.2	1.0	17.5	6.5	8.2	291.8	33.6	6.8	2.1	10.2	0.7	39.4
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	7.3	12.3	20.1	17.3	24.4	14.2	9.0	26.0	22.9	8.3	11.9	12.1	10.0	10.7	7.7	18.4	14.5	12.0	7.9	10.3	17.7	19.3	12.4	11.4	7.9	15.2	15.1	14.5	5.8	11.6	14.2	20.8	8.0	13.6	7.7	10.9	10.5	9.9	7.4	10.9	9.2	9.3	9.4	12.4	12.0	9.3	9.9	11.5	14.5	20.4	15.5	15.3	11.1	7.7	15.7	23.4	13.9	13.3	16.3	16.9	14.0	10.6	20.1	10.7	12.1	6.8	9.2	24.3	11.2	11.7	13.5	10.3	13.4	13.5	18.7	19.9	11.4	12.8	11.0	8.4	16.2	7.5	14.5	15.9	16.5	12.5	30.9	13.0	16.1	20.6	8.4	14.7	13.7	17.8	7.5	17.1	33.4	18.4	13.0	12.4	19.9	14.9	23.5	12.4	25.2	16.1	17.5	11.4	25.1	16.8	14.8	23.4	27.2	7.9	13.3	12.2	6.0	12.3	15.1	12.0	10.9	5.6	8.9	15.0	14.9	36.0	15.5	12.9	16.8	10.0	13.9	11.8	9.4	16.1	13.3	16.3	13.9	13.4	16.8	21.3	15.7	14.7	15.8	5.0	16.3	11.9	23.4	16.9	14.0	20.1	24.4	26.0	22.9	17.7	19.3	15.1	14.5	13.6	11.5	3.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	11.4	19.2	0.0	43.9	43.1	25.6	0.0	0.0	0.0	0.0	13.9	29.7	0.0	0.0	3.5	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	28.9	0.0	0.0	17.8	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: AB_2679618"	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	36.1	24.0	40.3	30.3	15.8	15.9	22.7	27.0	22.7	40.2	31.5	34.7	21.1	43.6	38.0	29.6	22.6	25.3	44.9	30.9	34.1	38.9	41.7	38.2	17.7	32.3	23.2	36.2	30.6	19.7	18.6	28.0	17.1	19.1	30.7	33.3	39.2	32.7	27.7	26.8	60.5	29.2	35.9	27.2	30.6	68.1	26.3	28.7	25.5	26.7	29.0	21.2	25.6	25.9	20.4	25.4	29.5	28.6	23.0	37.7	26.4	34.9	46.4	33.4	32.3	45.8	21.1	43.6	32.5	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5	23.8	23.9	31.2	59.2	64.3	42.6	27.2	30.6	14.7	13.6	45.4	53.0	76.4	56.3	31.1	188.6	49.4	29.5	0.0	29.2	87.0	49.8	55.0	20.7	78.0	55.5	57.2	40.4	43.0	50.2	108.9	46.6	53.3	49.0	30.7	47.6	43.8	29.8	48.6	53.4	49.4	54.8	51.8	58.0	132.2	59.8	62.0	62.6	49.8	53.0	69.3
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 52.4;Proximal tubular cells: 31.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.8	0.0	0.0	1.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	52.4	0.0	0.0	5.0	0.0	0.8	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.4	15.0	31.5	12.1	16.8	18.6	18.0	23.2	17.1	40.9	37.2	22.1	34.4	23.7	15.1	22.0	18.2	23.4	34.8	25.9	37.6	26.5	34.8	34.4	29.5	22.4	16.5	27.9	27.4	14.6	22.4	40.1	23.7	15.3	25.4	21.2	36.1	21.9	22.5	13.2	27.4	25.8	20.8	18.0	18.0	28.3	26.8	20.7	24.0	12.0	20.3	19.9	25.0	21.7	27.8	23.1	18.9	25.8	23.0	21.9	22.7	19.6	27.1	13.3	20.8	46.9	22.3	41.7	26.2	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7	26.8	16.5	14.1	12.2	11.7	15.3	5.6	10.2	32.1	35.2	5.2	45.2	23.7	8.3	21.4	12.5	17.4	11.3	0.0	27.7	27.8	14.3	7.5	18.6	8.1	21.3	20.6	8.6	12.9	13.8	5.4	27.3	19.0	11.8	23.4	14.7	5.6	24.4	11.9	21.5	6.7	34.8	12.9	11.3	20.9	22.8	11.7	19.0	16.2	16.2	8.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.6	27.9	16.7	14.8	6.0	6.8	12.2	20.5	9.9	20.5	15.9	22.5	11.9	27.2	11.2	11.0	22.6	25.0	26.7	20.4	22.8	16.1	13.0	21.7	27.4	15.6	11.4	32.7	14.4	8.7	7.7	28.8	33.7	7.5	14.5	18.3	23.6	11.8	14.2	24.2	23.0	9.1	20.7	37.4	18.1	18.2	30.7	29.6	9.6	12.7	10.3	11.5	23.9	18.3	10.8	12.2	19.0	11.8	8.9	20.3	15.8	18.0	28.9	6.1	23.8	41.2	14.5	19.1	15.8	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6	6.0	18.6	18.5	10.3	9.4	12.8	7.4	2.5	9.4	5.7	3.5	5.9	14.1	5.0	10.0	1.0	6.8	3.6	0.0	9.8	17.2	9.3	5.7	12.7	8.6	11.5	4.8	1.2	7.4	3.8	0.2	7.8	8.0	6.8	4.6	6.4	10.4	7.3	0.0	7.4	8.7	12.5	6.5	10.8	4.2	13.5	7.3	7.0	10.2	10.5	7.1
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051712	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051712: AB_2681582"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	37.2	42.9	56.2	34.0	37.6	53.1	43.9	33.4	56.2	29.0	39.9	18.7	33.1	50.5	37.2	35.1	41.2	30.9	35.4	32.5	51.6	35.7	39.8	54.9	31.7	35.5	34.9	45.9	30.3	32.5	25.1	24.8	51.1	41.5	30.4	38.8	18.6	34.6	33.4	52.0	42.7	56.7	35.2	45.8	43.2	40.4	24.1	34.3	32.8	33.5	29.8	37.5	40.3	38.9	27.9	41.5	94.9	65.7	27.6	32.2	51.5	29.3	22.6	35.5	22.9	42.0	32.4	33.7	28.6	32.5	35.4	39.0	31.0	35.6	19.5	50.0	36.8	25.5	22.7	36.3	31.2	31.3	25.7	39.9	36.2	20.4	27.4	34.0	45.5	42.6	37.3	32.9	28.3	26.1	31.5	38.1	40.6	28.3	28.9	34.9	39.1	35.1	47.6	51.0	48.9	55.9	37.1	24.6	32.2	38.7	29.5	30.7	46.6	24.1	23.1	30.6	26.7	19.6	52.1	35.3	27.6	16.4	50.3	35.8	34.5	57.0	30.8	40.1	55.5	23.8	41.0	47.8	94.9	24.7	60.1	26.1	27.9	23.7	26.7	41.5	27.8	28.8	31.4	41.0	27.6	65.7	28.5	32.2	51.5	56.2	37.6	33.4	56.2	51.6	35.7	34.9	45.9	41.5	34.3	41.7	44.0	67.1	29.7	41.4	26.9	32.3	50.9	45.5	35.2	34.9	19.6	83.5	77.9	90.3	13.7	55.9	94.4	0.0	90.4	92.4	53.1	40.3	61.2	86.3	76.1	39.7	65.1	40.5	62.3	28.5	35.9	54.8	55.6	104.6	53.1	39.3	101.4	119.3	49.1	57.2	18.8	25.8	42.9	23.5	40.4	46.5	88.4	65.0	48.0	48.7
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.7	9.3	17.8	5.0	0.9	1.4	46.0	8.0	3.6	11.5	9.4	6.9	8.7	17.1	3.8	2.6	9.5	7.6	18.3	6.2	11.5	8.1	12.4	23.3	14.3	6.6	0.1	17.3	14.6	0.4	1.0	13.0	7.2	1.6	6.9	14.7	14.2	19.6	8.7	10.0	14.4	6.7	21.4	6.7	6.5	15.8	14.5	12.1	4.0	9.8	4.9	9.8	9.8	7.7	3.1	13.5	11.8	11.0	4.0	9.6	11.0	5.8	11.6	8.3	16.3	28.9	5.5	17.8	16.3	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6	0.0	0.3	9.7	2.8	4.0	2.8	1.6	0.0	1.4	1.2	1.8	9.8	6.6	0.0	1.6	4.4	1.5	0.7	46.7	2.9	12.7	1.3	2.2	1.1	1.0	5.0	0.0	1.2	3.7	3.4	5.6	2.0	5.2	3.3	7.2	2.0	0.8	1.4	2.8	1.4	0.5	5.8	19.4	0.8	55.1	32.4	2.4	5.8	3.8	5.0	2.3
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47905793	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	18.0	13.8	18.6	15.7	18.8	17.5	26.1	42.2	31.7	21.3	15.3	12.7	15.1	10.4	28.9	16.8	14.5	16.3	15.0	14.1	16.9	13.6	14.3	17.0	22.3	15.0	17.4	21.7	28.9	12.4	25.2	14.4	14.5	19.7	15.3	13.3	12.0	15.6	16.5	22.9	14.5	13.5	19.9	16.4	14.5	13.3	25.1	16.0	14.6	17.3	9.8	17.2	19.3	21.9	4.7	4.3	8.2	2.7	4.8	6.6	2.0	25.5	13.3	31.9	27.2	22.4	21.1	19.0	17.9	24.6	16.7	16.5	11.2	13.0	16.5	23.4	25.1	20.8	12.7	21.8	18.9	24.7	11.0	10.8	15.4	10.9	17.8	21.5	16.0	16.4	20.6	21.3	14.9	25.2	26.6	21.4	8.3	15.0	17.1	20.5	12.3	15.3	15.6	19.4	16.9	13.1	20.0	29.6	12.3	23.9	20.9	22.5	26.6	16.9	15.9	26.1	24.7	7.4	13.7	23.1	20.8	19.2	13.9	19.6	14.8	7.7	30.1	14.1	15.1	21.1	8.2	2.3	4.3	3.8	2.7	3.8	4.7	3.4	4.1	3.1	3.6	6.6	4.1	4.1	4.8	2.4	4.3	3.6	2.0	18.6	18.8	42.2	31.7	16.9	13.6	17.4	21.7	19.7	16.0	14.9	36.6	13.7	38.4	59.5	42.4	7.8	12.7	37.5	23.9	17.4	31.4	16.6	10.0	15.5	22.2	26.9	15.8	0.0	13.2	13.7	43.3	34.1	27.8	17.0	21.7	52.4	23.0	29.4	42.9	29.9	27.9	40.9	33.7	17.2	16.7	30.9	20.6	14.4	37.4	11.3	39.1	19.4	35.3	51.9	40.4	51.6	30.1	26.6	16.9	57.8
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.5	29.0	22.5	20.7	3.4	4.5	28.7	18.7	18.4	37.9	34.4	36.6	25.6	18.5	4.0	26.7	43.1	22.2	33.7	17.1	37.2	34.5	18.0	20.8	27.8	15.6	0.5	16.7	17.1	2.3	1.9	35.2	24.8	9.0	26.7	21.2	11.6	41.5	29.8	26.8	22.7	7.9	49.7	29.7	21.7	16.5	34.2	9.6	8.9	18.3	12.7	20.1	23.9	20.1	10.9	44.4	19.6	18.7	10.7	30.8	46.8	35.9	64.8	5.5	9.1	26.8	14.3	16.1	32.6	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4	0.0	2.2	0.8	0.7	2.6	1.6	0.5	2.5	0.0	1.2	1.8	3.9	1.4	1.7	0.2	16.5	0.3	1.7	23.3	0.0	15.0	1.3	0.8	0.0	0.9	7.3	4.8	0.0	3.1	1.9	20.0	0.9	1.7	0.0	1.8	3.7	0.6	0.2	0.0	0.7	0.0	4.4	0.0	0.0	7.6	5.9	1.3	1.6	2.5	3.7	1.3
FP565260.1		ENSG00000275464			21	5130871-5154734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 17.2"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 38.1"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	3.0	3.0	1.1	3.0	2.2	3.3	1.4	1.1	6.8	1.7	1.9	7.2	1.1	2.8	1.6	2.6	1.9	2.4	4.8	2.9	3.2		1.8	1.1	1.8	4.2	2.4	1.1	1.9	2.0	2.5	1.1	2.3	2.9	1.8	2.7	1.1	1.7	1.1	6.8	1.8	2.2	3.4	1.1	2.8	1.4	1.4	1.1	1.1	1.7	1.1	2.3	2.4	1.1	8.9	6.6	5.0	12.9	7.4	17.2	7.5	11.8	8.9	6.0	9.3	2.6	2.0	3.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	5.5	4.0	8.0	7.9	16.7	7.3	0.0	2.5	5.4	38.1	4.6	4.5	4.2	17.4	11.3	7.2	8.9	10.2	8.0	1.9	7.8	5.9	21.2	4.2	2.5	10.4	12.8	12.0	23.7	13.7	11.1	20.1	5.6	10.5	5.3	9.5	5.7	10.4	9.8	14.8	5.6	1.6	12.3	9.4	3.8	4.5	11.6	0.1	12.3	4.9	5.3	23.9	8.1	23.1	6.3	2.6	5.5	5.0	15.0	9.7	17.2	8.7	9.1	11.0	6.6	8.9	9.2	12.6	3.3	7.4	12.9	4.4	6.0	7.5											0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	2.3	0.0	8.0	0.0	0.0	0.0	0.0	6.9	1.6	0.0	0.0	4.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	7.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Group enriched"	"Detected in some"	4	"Leydig cells: 23.3;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	19.6	3.9	2.1	4.2	0.0	7.5	1.7	3.3	2.1	0.0	0.6	0.0	0.8	3.7	0.5	0.3	5.5	0.0	1.6	0.0	3.5	0.5	4.8	0.0	4.7	0.0	1.5	2.1	0.0	10.6	0.0	2.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.9	1.2	6.0	0.0	2.2	1.2	0.0	0.0	0.8	3.4	3.4	0.0	0.5	4.1	0.0	0.2	5.9	0.0	20.3	2.1	0.0	0.0	0.0	0.0	7.4	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	6.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	23.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	29.0	0.0	0.0	0.0	2.3	0.0	3.8	1.5	0.0	0.0	0.0	0.0
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.2	28.0	5.8	11.9	6.0	4.1	10.7	6.7	4.9	7.6	6.0	23.6	9.3	15.8	13.0	9.7	9.9	11.0	19.3	8.4	10.5	10.9	10.0	15.9	22.4	11.1	4.6	24.6	15.7	5.8	4.1	17.7	10.7	3.1	8.1	9.0	10.3	16.0	7.6	21.8	13.9	5.1	16.7	6.7	15.7	15.0	13.2	15.3	5.7	17.8	9.4	5.7	22.0	13.6	6.3	12.2	17.9	6.3	11.6	13.8	13.8	13.3	11.4	12.0	15.3	20.3	7.1	20.4	15.3	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9	11.9	21.0	11.9	2.9	1.1	9.4	7.0	5.1	12.0	18.2	3.5	11.8	6.4	3.3	6.0	0.2	6.0	4.6	0.0	7.6	5.4	3.3	2.8	10.4	3.9	4.4	7.9	3.4	7.4	11.9	0.0	5.2	6.1	0.0	6.4	4.3	3.7	7.8	3.5	2.8	3.3	8.0	6.5	4.1	1.2	7.4	1.8	4.6	8.2	3.9	3.1
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		1900000	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	29.0	29.2	36.1	48.2	40.3	56.3	23.6	42.2	41.6	18.5	27.8	28.2	19.1	29.2	28.3	19.4	27.0	22.1	22.5	32.2	34.7	33.9	24.9	32.2	33.7	54.8	30.9	29.2	21.8	16.7	21.8	21.8	33.1	26.9	21.4	27.9	21.8	21.2	25.6	27.8	18.6	30.5	30.6	42.6	56.7	22.8	10.8	27.1	45.8	20.4	15.6	53.1	29.8	19.2	24.7	25.0	64.9	42.8	12.0	13.4	20.7	25.3	22.1	15.2	18.3	16.9	15.8	34.7	26.8	21.8	28.3	27.2	19.0	17.1	33.1	15.9	24.4	23.4	15.2	21.9	19.3	29.3	16.3	20.1	35.5	14.6	27.6	15.2	40.8	69.4	14.6	20.2	29.5	14.7	16.3	33.9	31.9	23.9	23.0	20.5	31.6	47.8	39.5	10.5	24.6	22.6	28.6	32.6	24.0	21.5	18.9	18.4	26.6	22.7	22.1	28.3	28.3	24.4	66.0	21.5	27.1	20.6	21.5	27.3	42.3	32.5	53.3	20.9	32.0	19.4	25.1	32.1	38.5	13.4	38.4	11.7	23.7	12.1	13.2	25.0	24.7	12.7	12.0	64.9	12.0	42.8	16.7	13.2	20.7	36.1	40.3	42.2	41.6	34.7	33.9	30.9	29.2	26.9	27.1	56.6	54.7	133.3	29.5	41.8	36.1	52.5	45.9	71.0	58.0	15.7	29.5	59.8	44.7	59.4	2.0	57.8	58.2	23.3	55.2	288.5	37.3	45.6	117.1	36.3	231.5	33.4	40.2	41.7	166.3	4.0	23.3	221.8	43.9	209.2	41.2	45.1	62.3	69.1	39.3	55.3	47.2	6.5	46.7	17.7	47.0	39.1	72.9	66.3	37.4	100.3
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373063	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	7.6	25.8	12.3	7.1	12.5	35.7	6.6	14.1	17.2	8.8	7.1	14.9	8.0	5.4	9.0	7.6	6.1	8.2	7.5	15.6	11.5	10.6	9.2	8.7	7.1	6.5	13.0	10.4	11.4	7.8	12.0	9.8	8.4	12.9	8.3	5.9	7.1	7.7	11.2	10.0	5.8	5.6	10.7	12.4	6.7	6.6	16.5	13.0	7.4	9.6	5.3	6.3	9.3	9.8	3.2	4.4	3.4	4.5	1.3	3.2	2.4	5.6	9.9	6.4	6.4	7.5	7.4	5.1	6.9	6.4	7.1	6.7	7.5	4.5	11.5	6.1	5.9	13.9	10.1	7.3	9.3	8.1	1.9	4.8	10.6	4.0	10.1	9.8	6.3	6.5	7.4	6.9	7.7	11.8	10.0	4.7	8.0	7.2	18.0	10.1	7.4	9.8	7.9	4.7	7.9	13.7	6.5	15.3	7.9	5.3	5.7	9.9	5.7	6.1	11.0	14.4	5.5	7.2	9.2	6.1	11.6	6.7	8.7	7.3	14.7	6.0	10.1	3.4	29.0	6.2	0.0	4.5	2.0	2.0	2.7	1.5	3.2	3.0	3.1	4.4	1.6	3.0	3.2	3.4	1.3	3.2	3.7	0.9	2.4	12.3	12.5	14.1	17.2	11.5	10.6	13.0	10.4	12.9	13.0	6.0	8.1	15.7	2.5	9.6	11.4	16.2	0.0	8.1	4.5	3.5	17.7	4.0	6.6	3.2	14.0	6.7	2.7	0.0	2.9	2.8	5.9	2.4	12.8	4.5	7.4	6.4	5.2	2.5	13.7	21.5	8.6	10.9	1.7	0.0	2.6	10.8	3.5	2.9	7.8	3.8	11.4	0.0	11.2	16.3	8.0	7.3	4.7	2.5	3.3	1.6
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824131-65966295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.3"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3"	"Not detected"	"Not detected"							"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	6.5	0.3	0.5	3.8	0.8	8.1	2.1	0.2	0.6	2.5	7.6	0.4	0.0	2.4	2.7	0.1	1.1	2.4	3.3	0.5	0.3	0.4	1.0	0.4	0.5	0.1	0.3	1.3	2.1	1.7	0.0	1.7	0.3	0.6	0.5	4.6	0.4	0.5	1.8	2.0	0.7	5.1	0.7	1.7	0.8	2.1	25.3	0.0	0.8	1.1	3.0	0.1	0.8	2.8	0.7	0.3	3.8	2.1	1.3	0.7	0.1	9.1	4.0	63.0	9.0	3.0	16.5	0.0	29.1	13.3	5.1	5.1	5.2	3.9	0.0	18.9	1.3	24.0	4.0	10.4	25.1	24.5	0.0	10.9	0.0	0.1	31.5	1.7	0.8	0.1	12.5	1.5	11.0	19.8	46.0	20.1	0.0	0.0	0.1	29.1	0.0	0.0	5.1	36.9	0.8	18.1	2.4	3.1	0.0	13.6	0.0	0.0	0.0	0.0	0.0	16.0	44.3	0.1	0.1	23.5	18.5	5.5	14.1	8.7	0.0	0.0	0.0	22.4	0.0	4.2	3.8	1.0	0.7	0.5	0.6	0.3	0.3	0.4	0.5	0.2	0.7	0.4	0.7	2.5	1.3	2.1	0.3	0.3	0.1	0.5	0.8	0.2	0.6	0.3	0.4	0.3	1.3	0.6	0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	0.0	4.0	0.0	0.0	0.0	0.8	0.0	3.0	15.7	0.1	3.3	0.0	0.7	0.3	0.9	0.4	0.0	0.0	6.8	0.0	0.0	0.6	0.0	6.8	0.3	0.0	0.0	0.0	4.7	0.0	11.8	3.5	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.1	0.7	0.0	8.5	0.9
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	83.3	28.9	83.9	35.2	7.8	18.1	32.8	41.3	23.8	80.9	62.5	29.8	78.2	93.9	39.5	33.6	23.6	48.2	105.8	41.0	68.9	57.8	74.9	100.8	34.3	29.1	14.7	213.4	58.9	19.0	21.6	44.2	26.2	16.9	37.6	62.7	79.7	45.1	42.4	61.6	152.1	97.0	70.3	96.0	53.8	105.9	131.8	57.5	25.4	22.9	83.7	51.9	124.1	34.9	45.7	21.8	57.2	101.2	27.9	40.4	75.5	77.3	68.8	55.2	74.8	104.6	25.9	224.6	80.0	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1	318.6	348.4	323.5	270.1	256.3	146.9	79.2	191.1	714.7	343.5	247.7	133.5	686.4	315.0	197.4	143.3	140.8	163.3	537.3	235.1	491.1	459.0	285.8	361.7	123.4	660.0	89.0	554.4	172.5	336.2	26.8	172.0	473.8	215.9	762.9	372.7	230.4	94.5	305.1	142.8	214.8	300.1	122.9	297.7	273.8	419.4	186.6	772.2	318.1	517.4	227.4
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.4	8.5	8.2	13.4	5.9	9.5	4.8	6.2	4.5	5.6	1.8	9.5	9.5	3.9	4.4	10.7	14.6	11.4	11.6	5.6	5.1	3.9	3.3	3.6	8.8	16.8	4.8	2.8	9.2	11.9	3.4	7.7	10.2	8.6	11.0	9.2	4.0	7.9	9.8	3.7	3.4	3.4	13.8	2.6	5.8	6.4	4.1	8.6	18.3	2.7	3.5	4.5	12.9	5.1	13.9	7.8	5.9	9.1	3.2	1.4	3.9	2.1	16.0	6.8	3.3	1.7	3.5	4.6	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4	6.0	6.5	6.9	14.8	2.5	4.7	6.5	10.2	6.7	9.1	22.7	5.9	6.0	11.6	9.6	220.5	3.5	6.3	0.0	9.5	5.4	4.6	9.3	3.5	4.4	7.6	9.5	3.5	5.5	2.9	54.5	6.4	5.5	3.3	20.8	9.8	6.8	8.8	3.5	7.1	15.1	3.4	6.5	3.8	5.7	4.5	4.4	7.8	2.9	9.3	27.4
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.7	1.1	0.6	5.7	0.0	0.0	0.7	0.0	12.2	0.0	0.7	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	14.4	5.3	3.3	16.8	4.1	0.0	9.2	0.8	0.0	0.0	12.7	0.0	2.8	4.1	4.4	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	1.5	2.2	0.0	0.6	0.0	0.0	0.0	22.7	0.0	0.0	31.5	0.0	0.2	11.7	0.0	0.0	0.0	0.2	1.0	0.9	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.5	31.7	0.0	1.7	0.0	2.1	0.0	0.0	0.0	25.1	2.2	0.0	38.8	0.8	0.7	1.2	1.6	0.0	0.0	4.1	0.5
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	7.0	0.5	2.4	0.1	17.0	56.4	0.0	15.0	40.3	42.3	56.3	0.0	9.1	41.5	12.9	9.2	13.6	20.5	0.3	15.2	16.9	12.8	0.1	10.6	3.1	0.0	31.9	3.6	0.7	53.1	27.3	21.6	30.8	20.3	44.4	36.7	0.2	30.4	23.4	0.0	48.7	3.4	6.5	0.0	5.5	23.0	15.6	47.9	5.9	2.7	1.1	0.0	19.6	0.1	42.6	10.2	0.0	4.3	25.0	10.9	5.1	30.6	6.3	28.4	13.2	39.0	31.3	12.0	26.2	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0	35.7	66.1	149.1	95.2	84.3	0.2	6.9	22.9	58.9	119.4	40.1	0.0	3.0	1.7	32.6	4.0	196.0	5.6	0.0	40.2	1.9	91.8	23.0	129.9	2.9	175.9	0.0	11.6	126.4	165.6	4.9	108.7	168.3	79.2	49.5	16.2	31.8	42.0	24.6	49.8	4.4	0.9	84.1	124.0	2.6	1.9	59.6	2.7	201.5	21.7	108.0
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.7	37.3	60.4	55.2	13.1	18.0	35.2	29.3	24.9	49.2	38.6	42.7	26.6	57.2	29.1	26.3	30.1	41.0	65.2	39.6	44.4	36.5	58.0	74.2	32.9	39.8	18.8	53.4	37.1	17.0	17.7	39.0	43.8	18.8	42.0	33.4	63.3	45.0	28.6	37.7	88.5	85.8	72.5	24.2	41.0	65.2	57.5	39.5	19.6	48.6	66.7	48.5	37.7	30.0	21.8	28.6	25.4	34.3	33.7	40.4	38.4	41.8	57.7	38.6	52.8	69.4	22.6	57.1	43.5	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0	92.3	128.4	63.8	84.3	76.5	92.4	59.0	50.9	96.4	131.9	40.1	80.5	65.6	23.2	66.6	12.8	60.9	40.0	46.7	69.0	90.4	57.8	80.9	92.6	46.1	63.0	89.0	109.3	33.7	53.5	14.4	70.8	66.0	37.1	46.9	68.0	70.5	72.3	56.1	58.7	38.2	92.6	32.3	67.0	108.6	117.8	67.2	59.3	68.2	82.6	87.0
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455023-74457960	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070644			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA070644: AB_2732159"	"prognostic favorable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.56e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	18.7	22.4	31.0	20.5	33.4	21.4	22.6	31.3	48.6	23.3	16.2	15.6	24.8	24.0	28.5	23.4	22.6	26.8	21.5	19.7	39.3	20.0	20.3	22.5	18.7	22.5	19.6	32.6	39.8	31.8	36.6	32.3	14.0	38.2	25.6	16.7	15.5	32.1	37.6	28.1	39.7	18.0	20.0	49.6	19.3	22.1	28.3	25.0	21.3	30.0	15.9	24.7	20.6	23.8	4.9	6.5	6.8	5.4	4.4	3.8	1.3	12.8	14.3	3.9	5.7	8.2	13.3	11.9	12.2	9.8	8.4	7.4	9.2	14.2	22.1	15.0	8.0	8.0	13.6	3.7	8.3	8.0	20.8	14.2	16.6	6.7	8.9	8.4	16.1	7.4	12.0	14.7	12.0	14.7	22.8	10.9	11.5	9.3	7.2	7.2	15.4	18.3	21.3	2.8	8.0	19.7	10.7	15.8	20.1	10.2	9.0	7.3	15.3	6.3	16.2	5.4	5.3	5.4	5.1	9.7	6.9	12.5	14.0	8.7	28.5	22.1	8.0	15.3	9.6	7.0	3.9	5.4	2.0	2.7	3.7	3.2	4.8	2.9	1.5	3.1	4.9	2.7	2.3	6.8	4.4	2.8	6.5	3.8	1.3	31.0	33.4	31.3	48.6	39.3	20.0	19.6	32.6	38.2	25.0	0.0	2.1	4.8	2.3	24.8	13.2	0.8	2.5	9.4	4.5	3.5	11.8	3.7	0.0	13.2	1.7	3.1	6.9	0.0	23.3	3.6	3.3	1.2	5.7	8.9	4.9	12.7	4.6	4.3	7.8	5.1	2.8	5.6	5.0	16.2	7.5	4.9	15.7	3.5	2.8	6.8	15.3	0.0	8.0	4.9	2.3	27.7	4.5	6.4	5.5	1.4
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;U-266/84: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	5.0	6.9	6.2	7.0	5.2	7.2	34.9	5.7	4.7	3.8	2.9	4.7	4.5	10.7	6.6	10.7	4.2	2.8	4.7	3.0	2.8	7.2	9.9	6.3	4.1	20.0	5.7	0.1	2.7	7.1	5.5	7.8	4.4	5.2	3.5	4.4	17.9	11.4	2.6	16.2	4.0	6.8	6.5	4.0	14.1	5.4	2.0	15.4	2.2	6.6	5.4	9.9	4.1	14.4	3.3	5.6	6.1	4.4	9.4	4.2	10.6	3.5	0.7	22.8	31.2	4.2	7.9	3.2	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5	3.0	22.7	41.9	6.8	10.2	106.3	163.4	28.1	12.0	7.9	3.5	182.6	7.8	6.6	5.7	2.1	20.1	2.0	23.3	11.1	36.0	17.8	15.7	14.0	38.5	19.4	222.5	9.8	28.3	52.6	3.4	15.5	24.7	6.8	3.6	13.6	16.7	7.9	0.0	21.2	4.7	119.9	25.8	33.0	1.8	1.5	6.8	18.2	16.2	7.6	10.7
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Cell type enhanced"	"Detected in many"	7	"Urothelial cells: 190.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 44.6"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.7	4.8	8.4	3.2	3.8	4.6	12.6	3.3	3.3	2.4	2.6	18.3	18.0	13.1	8.3	2.7	8.1	3.6	11.5	2.2	3.4	9.6	1.6	18.3	2.4	2.4	7.5	13.2	29.7	2.5	3.4	2.6	4.4	9.6	18.5	9.0	10.4	20.9	2.5	1.3	18.5	5.5	18.0	10.4	2.0	8.6	8.0	5.7	2.3	5.1	3.4	3.0	4.3	2.2	2.3	44.6	7.7	14.6	11.7	2.5	4.0	4.3	3.5	12.7	13.4	16.1	1.3	7.4	2.7	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9	32.8	30.1	76.8	35.9	16.7	12.1	16.6	12.7	10.7	22.7	7.0	9.8	10.5	0.0	11.8	4.8	41.3	43.3	0.0	10.4	2.2	15.8	43.7	43.9	40.9	27.9	17.5	8.6	25.8	50.9	5.2	23.9	40.7	10.1	26.2	12.5	8.5	24.6	14.0	22.3	6.7	15.8	77.6	22.7	5.2	36.4	30.5	4.2	83.0	13.0	190.4
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 5.7;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 8.1;Karpas-707: 8.4"					"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	1.9	1.4	1.0	0.6	1.5	1.2	1.5	0.9	1.2	0.9	4.3	3.3	0.6	0.5	0.9	1.6	1.2	1.3	0.6	0.8	0.5	1.1	2.5	1.0	1.1	2.4	0.9	1.1	1.4	1.1	1.5	1.6	0.5	8.1	0.7	8.4	0.9	2.8	6.4	2.6	0.8	1.0	0.8	4.2	0.3	4.1	0.8	1.4	0.8	1.6	1.4	1.1	0.2	1.4	2.7	1.9	0.5	1.0	0.5	1.6	0.6	4.9	5.0	4.7	1.7	4.7	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5											0.0	0.0	0.0	0.1	0.1	1.5	2.0	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.2	2.7	0.5	1.6	0.0	0.2	0.3	0.5	0.2	5.7	0.4	0.3	3.2	0.0	0.6	0.3	1.1	0.0	0.0	0.0	0.0	1.6	2.4	0.2	0.9	0.0	1.3	1.1	6.5	0.5	0.2	1.4	0.4	0.5	0.0	1.0	0.1
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL3, histone methyl-lysine binding protein"	Q96JM7	6	130013699-130141451	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.5;HUVEC TERT2: 30.6;TIME: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		Yes	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	8.8	16.7	5.2	16.4	8.2	7.5	7.5	2.4	7.7	17.1	5.6	3.6	9.3	3.1	17.5	14.1	5.7	7.4	6.0	4.1	5.4	5.8	6.1	6.4	7.4	11.4	5.2	5.9	12.1	3.8	8.1	17.0	6.5	5.7	10.3	5.7	4.8	5.8	7.5	5.3	4.3	7.6	9.9	5.4	18.5	4.6	7.5	3.9	25.5	10.2	4.3	12.8	10.4	11.6	10.7	10.8	3.9	14.1	1.7	4.2	0.6	0.8	3.2	7.4	1.1	5.1	6.9	1.5	3.7	7.7	1.5	2.7	3.8	4.0	1.3	5.4	4.8	4.6	3.2	4.2	6.6	2.3	2.9	4.3	8.6	1.6	1.0	2.6	5.1	31.5	4.3	4.8	1.7	5.1	7.6	30.6	4.1	6.2	3.5	3.8	0.3	10.8	0.9	3.5	0.7	1.6	4.0	2.1	0.0	4.9	1.2	0.2	1.0	1.4	0.3	3.0	9.5	7.8	4.5	20.9	2.5	3.5	0.4	2.4	0.6	0.0	2.3	1.2	2.1	2.5	3.9	3.5	3.5	2.7	4.0	2.7	7.6	2.7	3.8	1.3	10.7	2.4	3.0	3.7	1.7	14.1	10.8	4.2	0.6	5.2	8.2	2.4	7.7	5.4	5.8	5.2	5.9	5.7	3.9	3.0	9.2	7.5	4.8	4.5	2.9	2.9	2.5	5.3	3.4	8.7	2.0	10.2	1.7	4.3	18.5	5.6	0.7	0.0	4.9	6.0	6.7	4.2	38.3	4.9	3.3	0.0	3.5	7.4	8.2	1.6	8.9	3.6	1.7	4.6	7.2	5.6	7.5	3.5	5.6	4.3	0.7	6.5	5.1	5.4	6.1	3.9	5.1	10.0	4.1	5.2
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	21	"Endothelial cells: 120.7;Ito cells: 249.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7"	"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.1"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	27.9	9.5	14.5	4.6	30.3	0.4	26.8	1.1	45.3	27.1	6.8	2.7	8.0	4.0	54.9	14.4	9.5	15.6	18.3	18.5	16.6	4.8	14.9	15.0	31.3	6.9	5.5	21.7	11.9	4.6	15.2	5.6	33.7	3.4	10.4	5.4	15.4	6.1	8.6	7.5	5.4	6.8	32.8	4.2	32.9	6.7	6.4	3.4	0.7	17.8	7.5	3.0	14.7	13.3	0.2	0.0	0.3	0.0	5.1	0.0	0.6	0.0	0.0	9.7	0.0	5.6	9.3	0.0	5.3	4.1	0.6	1.5	0.0	0.0	0.0	0.0	9.8	0.0	0.0	18.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.2	0.0	6.7	0.0	1.4	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	8.9	13.7	0.0	0.7	0.0	4.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.6	14.5	30.3	1.1	45.3	16.6	4.8	5.5	21.7	3.4	3.4	0.0	8.5	1.9	0.2	7.7	21.5	9.2	5.1	1.4	0.0	0.0	0.0	0.2	0.0	1.7	1.1	120.7	0.0	0.0	0.2	0.2	22.0	0.3	5.7	1.3	0.3	0.0	0.0	249.8	20.4	1.5	35.4	2.3	8.5	0.0	0.0	9.8	0.3	0.0	47.4	0.0	1.7	6.5	13.4	0.0	0.6	5.9	0.1	5.4	0.0	0.1
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 36.5;Peritubular cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.8	4.6	12.8	8.0	9.8	0.0	7.1	8.8	9.7	13.6	0.0	11.7	0.0	5.6	11.6	9.6	14.0	5.0	10.4	6.9	0.0	9.2	0.0	16.1	0.0	3.1	0.0	2.8	17.3	5.4	8.4	4.5	7.8	8.2	0.0	0.2	0.0	8.7	40.1	0.0	0.0	4.8	0.0	50.3	0.0	4.1	0.0	11.9	7.0	0.0	4.0	0.0	6.2	0.0	2.6	7.9	0.0	14.8	0.0	9.6	0.0	29.9	0.0	0.0	0.0	5.0	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6	0.0	4.0	0.0	15.7	5.4	25.2	1.6	22.9	5.3	10.3	22.7	7.9	1.9	36.5	12.0	0.5	11.3	0.0	0.0	12.3	1.6	11.7	14.6	2.3	0.0	0.8	19.1	5.2	11.1	0.8	0.9	20.4	1.6	3.3	0.0	0.2	20.6	11.6	0.0	36.4	26.8	9.6	12.9	19.4	0.9	7.7	5.9	1.3	5.7	0.0	14.0
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	14.1	2.8	0.0	0.0	73.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.8	0.0	8.8	0.0	0.0	0.0	6.8	10.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.3	0.0	0.0	1.5	1.7	12.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	13.5	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.3	6.0	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	5.9	66.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	67.8	0.0	0.0	0.0	0.0	8.0	1.6	0.0	0.0	0.0	17.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	6.5	0.0	5.8	9.2	0.0	46.7	0.0	0.0	0.0
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 279.7;Rod photoreceptor cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA037766: AB_10672609, HPA057533: AB_2683459"	"prognostic favorable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.2	10.1	1.7	3.8	7.6	5.9	6.0	2.1	7.2	3.5	6.7	2.1	10.7	4.6	2.3	5.5	10.1	1.3	3.1	4.4	7.5	3.6	1.5	3.2	4.0	4.1	6.2	1.7	3.1	4.1	8.2	6.7	6.1	9.1	4.7	11.3	1.9	2.6	4.0	5.8	4.0	1.2	1.1	7.7	3.0	3.7	8.4	5.3	7.1	1.5	2.8	6.6	3.3	4.5	6.3	11.2	2.3	4.1	2.0	3.5	9.2	3.9	2.3	2.5	1.7	3.8	8.5	2.3	5.0	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4	0.0	28.5	7.0	9.6	5.8	17.2	7.5	22.9	279.7	46.6	12.2	47.1	7.2	31.5	10.7	32.5	6.2	4.2	23.3	15.1	9.4	10.8	6.9	5.7	6.4	11.8	12.7	17.2	9.2	8.6	32.8	7.8	8.7	8.5	8.2	7.9	28.7	13.0	3.5	11.7	28.1	113.4	12.9	10.0	62.1	12.6	5.1	3.8	9.6	6.5	6.3
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.8	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.7	1.4	2.6	1.4	0.4	0.7	1.9	1.0	0.9	1.1	1.1	1.9	3.6	0.3	0.3	1.6	1.1	0.0	0.8	1.0	1.1	0.3	1.3	18.2	3.1	0.4	0.5	0.7	1.0	6.3	0.4	1.1	0.5	3.5	2.1	8.0	10.0	4.3	1.5	0.1	0.7	1.3	1.0	1.6	0.8	1.5	3.1	0.2	0.1	1.5	0.5	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9	47.6	151.9	14.5	37.6	3.9	89.0	4.0	12.7	12.0	67.1	12.2	37.3	4.4	8.3	9.1	28.4	2.1	1.1	0.0	1.4	0.2	2.6	4.4	1.1	3.9	0.8	7.9	1.2	2.5	0.3	46.6	3.1	1.0	3.3	0.0	3.7	9.3	4.6	1.1	16.6	5.1	18.6	6.5	4.1	17.9	16.4	5.8	1.7	0.0	2.4	3.8
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	12.1	16.6	11.0	13.3	14.4	35.7	13.8	16.5	24.4	12.2	21.3	10.1	6.3	18.1	12.9	14.1	17.0	13.4	13.2	19.2	11.9	12.1	18.3	18.9	11.4	18.2	11.0	12.6	11.3	18.5	11.5	12.8	12.6	14.0	12.6	22.0	13.6	24.2	11.3	25.1	11.9	22.0	12.4	9.8	17.5	16.8	17.6	7.9	29.0	18.9	13.9	19.9	14.3	13.2	27.9	27.6	39.7	22.2	26.8	39.8	21.4	15.9	7.4	11.7	13.0	10.2	11.1	7.1	9.6	15.6	21.4	20.1	15.1	6.5	12.5	5.5	11.3	19.5	10.5	18.2	13.4	16.5	11.4	14.1	15.4	8.2	13.0	11.0	9.0	9.3	11.2	16.5	15.9	9.7	10.8	16.0	10.1	19.7	6.7	14.8	15.0	8.0	16.8	7.2	66.4	9.6	9.3	9.1	11.8	15.2	12.8	14.0	14.2	6.9	10.7	45.4	9.3	12.5	24.2	8.7	11.5	9.6	7.5	15.3	8.7	7.4	29.3	10.4	15.3	12.6	39.7	22.2	25.0	25.7	22.1	25.8	27.9	30.8	28.4	27.6	25.6	32.3	29.0	18.6	26.8	19.9	18.3	39.8	21.4	11.0	14.4	16.5	24.4	11.9	12.1	11.0	12.6	14.0	7.9	23.8	10.1	16.1	16.9	12.8	12.1	10.4	10.2	21.4	21.6	3.5	11.8	18.1	23.2	24.8	36.4	11.3	26.9	23.3	18.5	17.9	15.3	9.1	30.1	11.3	15.5	9.5	16.7	14.7	10.8	27.8	11.2	13.0	27.0	20.8	15.1	12.4	20.4	25.9	11.3	16.5	12.0	25.8	12.2	18.4	18.8	8.4	5.1	15.4	19.2	21.6
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 383.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	12.4	10.1	15.4	15.7	15.6	37.9	13.7	15.5	13.5	10.0	10.5	14.5	11.9	8.6	10.4	11.8	9.8	9.9	10.3	17.3	13.2	11.2	13.2	34.4	12.9	18.3	19.6	9.7	14.6	23.0	5.8	11.1	8.2	12.4	11.8	6.1	8.4	21.0	9.2	23.0	12.0	7.4	11.5	15.0	11.9	12.4	37.0	15.8	42.1	12.0	10.4	19.0	11.9	13.4	19.5	46.9	13.8	31.7	13.2	29.8	27.7	11.7	10.8	18.2	20.5	5.6	11.0	7.3	10.9	12.3	21.5	19.2	14.0	11.4	16.6	13.4	11.4	12.6	5.2	22.5	11.3	12.5	25.0	25.0	7.4	16.7	17.1	9.9	15.0	12.3	7.1	11.6	15.7	13.6	8.4	9.7	22.4	30.5	26.6	10.6	17.4	69.0	70.9	46.8	4.8	17.6	46.9	20.0	20.4	7.8	2.5	33.8	23.7	18.2	7.0	31.6	13.1	10.2	32.6	5.1	17.9	22.7	16.6	15.4	21.4	14.9	43.0	13.2	52.7	13.7	11.9	29.4	13.8	29.8	31.7	23.9	19.5	20.1	23.1	34.0	15.9	13.7	20.3	12.5	13.2	27.2	46.9	22.9	27.7	15.4	15.6	15.5	13.4	13.2	11.2	19.6	9.7	12.4	15.8	0.0	5.3	24.6	22.8	34.3	5.5	13.9	12.7	4.0	5.7	14.0	3.9	14.0	43.1	34.8	122.4	28.4	2.1	70.0	66.1	41.4	31.5	29.1	13.9	52.9	36.0	11.1	32.6	23.9	40.3	383.8	28.7	45.0	45.5	100.0	10.5	7.5	37.7	3.5	15.9	23.1	3.9	38.8	30.9	46.4	40.3	30.4	7.0	38.7	7.5	12.9
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.6	15.0	0.0	24.3	14.7	0.2	16.2	15.0	4.5	12.1	0.0	3.4	0.0	22.3	16.3	8.5	2.2	5.6	6.1	7.1	18.7	0.9	5.0	0.0	2.0	8.0	0.2	6.5	12.2	0.5	2.6	1.9	4.2	6.8	5.4	2.8	20.1	4.9	9.6	13.3	4.3	4.2	0.0	3.1	8.4	1.9	10.5	8.2	0.0	0.1	11.4	0.0	4.4	6.7	11.8	2.1	3.8	7.9	6.2	7.2	3.7	0.8	12.0	15.1	2.1	11.5	7.0	7.8	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3	6.0	11.8	20.4	7.1	7.1	37.4	7.9	22.9	9.4	18.2	12.2	9.8	2.2	11.6	27.6	0.8	20.5	1.0	0.0	9.3	1.3	39.5	9.9	12.7	13.6	12.7	35.0	15.2	30.7	2.5	2.1	43.7	7.1	20.3	10.8	6.4	51.7	5.9	7.0	60.1	14.4	15.4	25.8	37.6	1.2	1.7	5.5	1.4	10.7	4.5	3.0
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33484750-33501260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044417, HPA050574"	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA044417: AB_2678935, HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	22.3	11.0	10.6	14.9	15.3	13.5	15.2	11.5	17.6	13.2	11.5	12.5	8.3	9.1	20.8	9.1	15.2	13.6	11.3	13.1	10.5	13.4	17.9	20.0	10.5	17.3	11.4	10.3	24.8	15.7	10.4	19.2	13.1	19.2	14.2	11.3	8.9	10.6	10.3	25.2	12.4	10.8	19.7	13.1	17.3	11.9	9.5	7.1	20.3	14.8	14.3	17.4	16.8	11.3	3.8	4.0	0.9	9.4	5.7	6.2	3.3	6.0	8.5	6.0	13.7	7.1	8.5	9.0	10.9	7.2	11.9	11.3	12.6	5.4	21.3	10.9	9.6	10.3	8.0	20.0	12.1	16.1	4.6	5.5	20.2	6.1	11.1	10.6	8.1	12.3	8.8	11.3	15.5	18.3	4.3	8.7	14.8	25.1	12.4	9.9	7.1	28.9	9.8	31.6	15.1	6.0	10.4	9.0	9.6	10.1	10.3	15.3	12.1	6.7	9.6	13.1	7.7	6.5	8.6	7.7	11.3	8.8	14.5	12.5	6.1	6.8	22.0	7.0	17.4	11.9	0.0	3.2	0.9	4.8	6.8	5.4	3.2	4.7	4.1	3.9	3.8	6.0	6.2	0.7	5.7	9.4	4.0	3.6	3.3	10.6	15.3	11.5	17.6	10.5	13.4	11.4	10.3	19.2	7.1	14.9	8.9	13.8	10.9	13.9	4.7	11.0	10.2	14.7	15.9	8.7	2.0	9.5	6.6	9.5	1.1	7.3	3.5	0.0	6.6	12.6	9.2	6.6	9.2	6.0	8.0	9.5	1.7	4.3	4.3	0.8	8.3	7.9	1.7	5.4	4.2	3.8	9.0	3.7	7.1	7.2	4.2	6.5	9.2	11.9	18.8	13.0	6.3	8.7	6.5	8.4
MAPKBP1	KIAA0596	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Cell type enhanced"	"Detected in many"	18	"Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: AB_2673628"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	4.7	6.0	10.6	5.0	13.8	4.4	5.7	48.1	13.9	6.1	5.7	8.8	4.4	10.6	9.3	5.4	12.5	8.0	5.3	4.2	8.6	6.7	3.9	2.3	4.7	4.0	8.6	9.2	15.4	4.3	5.8	9.5	6.1	9.3	5.9	4.3	7.0	5.1	7.1	4.9	26.3	10.5	10.2	6.8	5.7	5.4	19.5	10.7	4.4	8.7	5.2	7.4	8.4	6.6	1.9	1.9	4.3	2.1	2.2	3.3	1.6	4.9	2.6	7.1	6.7	7.9	7.8	4.8	7.1	17.7	6.4	4.7	5.2	1.8	1.2	5.8	5.7	8.9	12.0	6.8	19.7	4.6	4.5	2.0	5.0	8.1	1.7	3.4	3.2	10.3	4.0	15.8	10.2	18.5	10.6	9.4	8.3	3.1	2.3	9.0	1.0	2.6	2.8	0.8	2.9	5.4	2.9	5.1	0.5	3.7	5.6	8.0	4.6	4.1	4.1	3.1	7.6	4.9	2.5	7.4	9.2	4.5	8.9	6.9	5.2	8.5	2.9	6.2	4.3	7.7	4.3	1.3	1.1	3.3	0.7	2.4	1.9	1.9	1.4	1.9	1.8	2.4	2.0	0.7	2.2	2.1	0.7	0.8	1.6	10.6	13.8	48.1	13.9	8.6	6.7	8.6	9.2	9.3	10.7	6.0	13.0	2.2	7.6	48.5	11.4	2.8	2.5	10.7	9.1	3.5	192.4	5.0	0.0	2.7	11.7	7.0	4.0	0.0	3.0	3.5	5.5	3.6	1.1	1.8	3.3	14.3	4.6	4.9	2.1	19.1	6.6	4.6	8.5	4.6	1.4	6.1	3.3	1.5	7.4	0.3	8.2	12.9	3.9	8.1	4.1	46.9	4.5	4.4	2.0	12.1
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.6	8.7	18.7	18.8	18.8	18.2	14.1	14.3	17.8	19.0	20.0	17.8	16.8	15.8	21.9	18.4	10.0	12.8	19.6	13.2	23.4	22.8	14.7	9.2	8.7	30.3	20.5	18.8	10.3	18.6	20.4	12.4	16.1	19.7	11.8	22.2	15.8	19.8	14.0	16.0	18.0	15.3	15.8	14.3	26.0	8.7	16.3	11.0	21.4	12.9	28.0	11.1	11.8	11.4	18.9	16.7	18.6	12.3	9.2	21.2	13.8	15.5	14.7	16.4	18.9	24.8	8.1	9.7	14.6	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8	202.5	218.5	10.4	31.7	80.1	24.3	9.4	2.5	50.9	169.5	24.4	2.0	20.7	49.7	17.7	2.7	17.7	14.6	0.0	16.6	17.7	24.9	20.7	12.7	21.2	15.9	87.4	30.2	15.4	9.9	2.5	29.7	14.5	20.3	9.0	12.1	23.6	16.8	17.5	25.5	38.3	22.5	12.9	21.2	42.9	36.4	57.2	16.6	14.9	17.7	12.9
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.7	15.5	18.4	13.9	0.6	1.1	8.0	14.4	2.2	16.2	16.9	15.1	9.8	20.7	6.5	3.6	6.0	16.1	25.8	8.5	15.0	10.8	12.3	25.8	6.9	10.0	0.0	13.2	11.7	0.2	0.3	16.4	1.5	1.3	5.2	16.8	30.4	14.2	8.8	12.3	31.3	5.7	10.9	13.2	3.8	24.8	16.3	12.8	3.7	5.0	3.7	14.0	11.6	8.3	2.2	10.0	10.4	9.1	3.2	10.3	19.4	15.5	15.5	4.4	17.1	27.2	6.6	14.6	8.0	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3	0.0	0.0	1.5	0.2	1.4	0.0	1.2	0.0	0.0	1.2	0.0	0.0	4.1	0.0	0.4	1.1	0.1	0.0	23.3	0.2	17.2	1.0	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	1.9	5.9	14.0	0.4	2.9	1.0	1.8	0.0
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.1;NTERA-2: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.6	4.6	4.8	4.5	7.9	7.5	4.8	3.2	2.4	3.6	4.5	10.6	1.7	14.0	3.7	3.3	3.9	4.1	12.4	4.3	6.5	5.5	8.2	15.2	5.9	6.9	3.0	19.6	3.8	4.6	3.7	9.7	9.0	2.2	6.4	6.4	27.1	3.4	3.5	5.6	3.0	7.4	26.4	3.9	4.0	6.1	9.1	3.5	3.2	6.6	8.7	3.9	4.5	2.7	2.9	6.6	1.9	8.7	8.2	2.4	4.5	3.2	7.4	3.9	4.3	6.9	3.3	11.2	4.2	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7	26.8	15.5	8.5	5.2	26.1	24.4	30.7	7.6	13.4	25.0	14.0	23.6	4.9	0.0	5.9	6.0	13.3	4.6	23.3	6.9	5.7	10.0	7.3	5.8	41.4	5.9	17.5	7.5	9.2	3.3	2.5	6.6	6.6	11.8	2.8	6.9	7.8	5.6	3.5	8.1	1.8	19.5	0.0	9.5	21.7	50.0	26.3	2.9	9.6	9.3	8.7
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.1	15.9	18.4	14.6	13.2	12.2	15.5	16.8	22.4	33.8	26.5	23.8	13.1	16.0	11.4	17.5	22.6	29.4	25.4	23.9	22.2	17.2	15.0	12.0	16.7	14.1	19.8	21.5	15.2	13.4	16.5	26.6	27.3	10.7	17.6	23.5	17.5	13.4	24.6	25.7	23.1	12.5	18.7	15.9	27.1	20.4	26.0	19.6	13.6	9.0	34.4	13.9	21.7	11.2	11.2	12.3	17.8	10.1	14.7	34.4	15.1	25.4	25.3	5.4	16.6	28.4	19.1	15.0	23.4	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0	14.9	8.5	3.0	11.2	5.4	24.5	5.9	5.1	6.7	10.3	12.2	17.7	28.2	11.6	13.9	12.9	10.6	2.1	0.0	14.5	17.3	8.9	5.1	10.4	4.9	15.2	20.6	5.1	5.5	3.7	5.4	13.3	8.8	6.8	11.8	4.2	23.3	12.9	0.0	15.9	6.0	17.8	6.5	8.3	20.7	22.2	4.4	45.8	10.2	4.7	10.7
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: AB_2681393"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	12.0	21.3	4.7	11.0	7.7	2.3	6.8	3.1	8.8	6.2	4.2	7.5	13.6	18.8	5.6	4.9	7.3	9.6	5.7	10.8	4.7	9.3	14.6	9.3	9.3	6.6	8.5	8.1	10.8	2.2	16.9	4.3	17.7	8.5	12.8	21.2	12.2	23.0	1.6	23.5	25.8	19.4	2.1	13.9	10.4	16.9	6.0	25.6	12.5	6.5	7.1	10.4	6.3	16.6	15.4	11.4	30.8	19.0	4.9	3.2	7.7	4.0	6.1	33.5	8.7	15.8	5.9	14.4	4.2	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9	0.0	11.2	26.7	11.3	10.2	3.8	4.0	25.5	13.4	10.3	12.2	0.0	12.2	18.3	40.4	24.1	17.9	11.2	0.0	38.2	7.9	11.3	11.9	32.2	7.2	42.0	1.6	15.0	11.1	45.6	9.9	8.6	38.5	15.1	48.7	15.0	22.4	20.7	21.6	14.9	22.6	5.3	19.4	24.2	20.0	17.4	16.6	7.8	34.5	16.9	11.4
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"	"Group enriched"	"Detected in some"	15	"NB-4: 36.7;THP-1: 69.4;U-937: 45.4"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		110000	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3	32.8	82.3	20.5	0.0	2.2	0.6	0.7	10.2	14.7	17.0	0.0	0.0	0.8	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.9	2.3	0.0	40.7	1.3	203.8	0.0	0.0	6.2	493.3	0.9	1.1	520.9	1.7	25.2	0.0	130.5	0.0	0.0	0.0	1.1	4.7	12.9	9.2	0.3	0.2	1.9	0.8	1.0	0.0	0.0
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.5	16.6	8.7	11.0	16.1	21.2	16.8	9.7	19.2	10.3	8.5	25.9	13.2	17.1	14.5	24.7	13.0	13.8	21.7	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.3	17.1	22.5	13.4	12.6	10.7	10.7	9.9	13.2	17.4	11.6	26.7	14.2	9.6	9.6	10.7	17.7	13.3	17.6	18.7	13.7	17.1	13.2	12.5	7.9	10.2	18.5	13.0	6.6	4.2	6.9	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0	6.0	7.7	13.7	25.1	73.0	17.7	11.3	12.7	6.7	5.7	7.0	11.8	26.7	23.2	29.5	22.2	55.0	43.9	70.0	33.6	25.8	27.0	36.5	25.3	7.4	23.5	41.3	20.1	25.8	15.2	9.0	22.2	20.7	54.0	32.5	29.1	18.0	31.2	63.1	48.1	18.3	17.2	84.1	54.6	22.2	39.4	71.6	49.7	45.0	24.3	28.6
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavorable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favorable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.6	10.7	24.1	11.7	11.7	16.6	13.3	21.2	25.5	18.5	9.0	17.3	11.5	16.2	12.9	11.6	13.7	20.7	22.9	22.0	24.9	12.0	15.0	13.0	9.0	31.1	11.7	32.3	20.2	10.4	19.8	11.0	31.7	9.4	21.2	22.7	30.5	4.6	28.1	15.9	24.8	38.2	22.0	24.5	14.9	30.8	11.1	10.7	16.7	20.7	16.5	7.1	35.7	15.9	15.2	10.3	27.9	20.1	16.6	17.4	17.3	15.3	15.0	6.8	16.4	64.4	15.7	26.6	22.0	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9	17.9	37.6	25.3	34.6	34.5	13.8	29.0	12.7	34.8	35.2	19.2	9.8	52.1	43.1	41.7	4.8	14.3	15.1	46.7	24.5	35.8	39.3	21.5	17.4	13.0	43.1	19.1	8.6	19.0	33.6	7.6	10.3	56.9	30.4	71.3	17.4	31.2	42.3	28.1	9.6	33.9	22.5	19.4	25.8	30.3	54.8	47.2	27.5	22.9	28.6	40.1
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251539-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	17.2	16.5	20.4	16.9	18.5	12.0	21.6	10.7	21.7	12.1	13.8	12.4	10.2	17.5	15.6	15.2	21.6	18.8	11.8	11.7	19.1	15.9	13.6	23.7	10.5	23.0	16.1	19.1	18.7	41.2	10.2	8.8	12.5	15.1	12.2	17.6	10.6	13.2	11.9	22.8	15.3	19.3	17.3	10.0	14.5	13.7	21.6	11.6	14.5	12.9	29.3	22.7	11.4	12.4	14.7	12.8	1.0	8.2	10.6	15.7	7.2	24.3	17.3	14.4	18.8	7.0	11.2	12.7	19.1	10.8	32.7	21.6	24.9	25.3	36.0	16.0	15.8	14.3	19.4	39.7	28.8	33.0	12.8	30.3	26.6	15.5	21.4	8.8	35.1	11.2	9.8	19.1	36.9	19.2	8.7	18.3	16.4	40.2	11.6	19.3	17.8	28.5	25.4	18.4	25.6	26.4	26.8	17.5	27.8	17.8	8.3	23.1	17.0	14.6	20.1	20.1	10.7	14.3	20.7	12.0	17.9	22.2	27.4	32.4	9.5	16.5	47.4	17.4	45.1	28.5	0.7	7.5	0.7	7.9	8.2	15.7	14.7	9.6	10.8	11.4	13.1	13.0	11.6	1.0	10.6	6.2	12.8	6.7	7.2	20.4	18.5	10.7	21.7	19.1	15.9	16.1	19.1	15.1	11.6	6.0	12.6	26.1	38.7	33.2	19.2	9.0	35.7	17.4	23.9	7.0	9.8	42.2	34.9	44.9	14.5	23.3	5.4	0.0	47.2	51.2	28.2	15.4	25.4	14.4	42.9	14.3	20.7	11.6	12.1	27.6	21.3	21.7	18.6	39.7	19.8	19.2	44.4	14.0	19.1	30.1	13.8	19.4	28.8	37.0	43.7	29.4	21.7	14.6	31.2	31.2
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 229.1;Endothelial cells: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	21	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"A549: 29.7;AN3-CA: 26.1;HUVEC TERT2: 77.2;SK-MEL-30: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	45.0	20.8	20.9	6.8	38.2	0.4	21.8	51.0	27.7	19.8	19.0	56.5	9.9	16.9	16.9	12.6	20.3	12.8	20.0	44.3	27.4	17.3	14.4	29.3	20.9	4.4	34.7	18.0	28.2	47.1	43.8	15.0	36.1	33.7	17.5	21.1	10.3	24.3	14.0	49.7	12.2	17.4	20.5	48.3	8.2	21.4	6.5	49.3	0.7	15.7	10.9	7.5	21.4	26.7	0.2	0.0	0.0	0.0	0.0	4.8	1.0	5.5	29.7	4.8	26.1	0.0	0.1	8.8	0.2	2.0	0.1	0.6	2.2	2.0	0.7	2.2	0.0	1.2	5.7	8.0	2.8	0.2	3.9	3.4	0.0	5.1	14.1	1.7	0.0	0.1	2.4	4.3	0.6	8.8	0.0	77.2	2.0	0.0	11.3	0.0	1.4	1.0	1.4	6.9	11.2	0.7	0.0	4.4	2.9	1.5	11.4	2.4	0.6	3.8	6.9	21.9	3.0	5.0	0.0	15.7	0.0	6.5	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.0	0.2	4.8	3.6	0.0	0.0	0.0	0.0	0.0	1.0	20.9	38.2	51.0	27.7	27.4	17.3	34.7	18.0	33.7	49.3	65.5	229.1	0.8	50.7	18.7	0.0	122.8	56.0	50.9	106.9	19.2	0.0	16.2	10.0	33.7	16.9	164.1	52.5	0.0	150.0	30.8	30.4	68.9	9.2	60.6	44.7	0.0	14.5	20.9	3.7	19.2	70.8	10.5	27.0	4.6	40.5	0.0	66.3	14.0	53.7	8.9	0.0	19.4	41.9	1.7	5.1	17.8	45.2	4.4	32.2	49.8
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.5	31.3	4.1	18.8	5.3	6.2	14.0	13.6	6.0	13.7	10.6	23.0	8.0	26.7	15.8	8.0	6.8	24.7	17.0	20.4	6.4	13.3	45.9	12.8	19.3	20.4	8.6	15.0	11.7	9.0	11.7	20.1	10.0	3.7	9.1	15.4	20.9	12.3	5.8	16.9	17.5	5.9	18.8	6.1	16.4	22.7	6.9	17.7	3.2	15.7	8.7	16.7	13.9	9.7	9.2	2.7	9.3	6.1	11.7	11.9	10.7	11.1	38.8	11.1	7.5	10.9	11.3	17.6	15.3	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6	8.9	16.4	12.7	5.2	11.4	7.6	3.6	15.3	10.7	19.4	3.5	11.8	2.6	0.0	8.1	0.4	10.8	5.9	0.0	10.7	4.1	5.9	5.4	4.7	6.6	5.7	9.5	10.9	8.6	3.4	0.4	5.2	5.0	3.3	3.6	8.1	3.5	7.2	3.5	11.3	2.2	5.7	6.5	10.3	2.6	12.0	10.5	0.9	6.9	10.3	5.1
MYSM1	KIAA1915	ENSG00000162601	"Myb like, SWIRM and MPN domains 1"	Q5VVJ2	1	58654739-58700092	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054291, HPA057306"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA054291: AB_2682438, HPA057306: "	"unprognostic (2.95e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (8.12e-3)"	"unprognostic (9.63e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-2)"	13.2	12.3	14.1	14.4	15.7	24.4	17.3	16.9	24.3	14.3	13.7	11.4	11.9	12.5	17.5	14.3	13.5	13.0	9.9	14.1	11.7	8.1	11.0	11.0	12.9	14.3	14.0	13.3	18.1	14.0	16.5	19.2	11.3	18.0	14.4	11.6	9.3	15.5	15.2	23.2	20.4	14.6	13.7	15.2	14.2	11.5	8.3	14.7	11.9	15.5	10.6	12.9	13.3	14.7	1.1	0.7	2.2	2.1	0.2	2.3	0.5	8.3	2.4	6.2	6.6	5.7	7.3	8.9	5.0	5.6	5.0	4.3	4.2	3.7	8.7	1.5	3.8	5.9	6.4	6.8	2.9	9.6	5.8	4.6	10.5	1.1	4.6	6.9	15.8	8.0	5.2	5.0	6.4	3.3	6.6	1.2	5.6	11.1	5.6	5.7	2.8	7.7	13.2	9.8	3.4	4.5	6.6	14.9	5.3	4.1	3.2	5.1	5.0	4.2	8.3	11.7	11.7	2.5	9.0	4.0	8.9	4.0	6.8	9.5	10.2	4.8	11.6	5.2	11.5	9.7	0.8	0.7	0.5	2.0	1.0	1.4	0.9	1.4	1.6	0.6	1.1	2.3	1.1	2.2	0.2	2.1	0.7	1.4	0.5	14.1	15.7	16.9	24.3	11.7	8.1	14.0	13.3	18.0	14.7	20.8	28.9	12.6	19.3	16.9	20.3	24.6	10.2	22.7	48.9	10.4	23.6	7.0	13.3	7.0	3.2	17.3	18.0	0.0	8.1	4.8	11.6	20.1	54.4	12.4	9.7	17.5	15.5	31.3	13.2	4.0	11.8	14.6	8.5	15.4	16.2	12.0	10.3	14.4	16.3	6.3	26.3	25.8	14.1	13.0	20.4	16.2	9.5	25.5	13.6	22.6
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	22.1	20.5	22.1	16.0	5.8	6.0	25.8	15.3	12.3	24.8	20.1	18.5	23.6	23.3	4.6	10.0	21.0	19.6	36.4	17.9	47.4	42.2	20.4	21.3	23.5	10.5	2.4	26.4	15.4	3.8	6.7	19.3	19.8	11.4	16.3	15.0	13.5	9.5	21.9	11.0	29.9	17.4	34.5	20.9	16.0	25.6	50.3	12.4	8.3	12.4	9.1	9.6	22.8	10.8	8.1	36.0	4.7	16.6	10.2	16.3	26.8	11.0	29.7	7.4	10.0	33.2	9.6	15.3	20.2	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4	6.0	6.1	13.0	3.2	3.2	3.6	2.9	7.6	5.3	3.4	1.8	7.9	6.8	0.0	4.1	14.9	2.6	5.2	46.7	3.3	16.2	3.1	2.8	3.5	2.6	8.6	4.8	1.2	9.2	10.8	20.4	5.5	5.4	0.0	5.4	6.3	10.0	4.5	5.7	5.6	2.0	7.6	0.0	3.6	17.7	10.0	3.0	5.3	6.9	8.0	3.0
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Club cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	10.0	8.4	13.4	10.0	4.4	8.0	7.2	9.7	6.1	5.4	3.6	7.6	6.6	13.3	5.3	3.1	7.6	10.6	9.8	4.3	7.5	2.6	6.2	20.4	7.4	5.6	8.0	12.9	7.5	12.6	7.8	4.4	11.2	14.7	4.7	13.2	6.9	10.7	3.9	6.4	11.1	7.6	13.9	8.9	10.8	9.1	10.6	6.9	6.1	8.9	9.3	13.6	5.5	7.0	15.9	10.4	8.0	11.1	9.4	7.5	7.5	2.7	6.8	10.6	8.2	15.7	12.0	10.3	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8	8.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	17.4	0.0	15.4	14.9	12.5	0.0	0.0	0.0	0.0	11.1	12.4	0.0	0.0	16.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	16.2	0.0	0.0	12.4	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	15.1	10.8	9.2	12.2	12.1	11.0	13.7	13.7	11.1	24.1	17.7	17.4	16.4	27.7	15.4	12.7	10.1	15.2	17.3	21.8	30.7	7.3	13.9	14.4	7.7	22.8	11.9	31.6	9.5	11.8	17.4	22.1	24.5	7.5	13.2	15.0	28.5	5.0	16.6	18.6	19.0	23.2	26.8	14.0	12.6	27.6	9.5	25.3	14.8	11.3	11.7	16.7	27.5	8.8	16.9	10.9	12.0	19.4	11.5	17.6	15.5	13.1	25.3	15.3	11.6	67.8	10.2	18.9	17.5	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5	3.0	10.1	24.6	46.2	47.7	8.2	4.8	17.8	29.4	18.2	19.2	15.7	27.5	18.3	30.3	29.3	22.4	13.8	0.0	22.6	28.1	22.2	16.9	17.3	9.6	21.6	11.1	2.9	18.4	10.8	29.4	15.8	15.5	18.6	16.2	11.7	8.8	30.2	17.5	16.3	21.4	6.9	12.9	19.8	31.2	39.4	45.9	21.4	27.7	16.6	36.0
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	11.0	11.2	6.6	7.7	5.8	5.9	10.1	6.7	5.5	9.1	9.9	11.9	9.5	19.6	11.8	5.8	7.8	13.0	27.7	10.3	11.2	9.8	18.9	10.3	13.4	7.9	5.4	20.0	8.0	6.2	8.5	10.5	12.3	6.2	9.2	9.7	11.1	8.3	8.1	17.0	12.7	16.0	14.8	16.1	12.6	10.0	9.5	20.1	12.0	8.2	10.9	9.1	9.4	14.7	9.9	7.2	6.2	12.2	7.5	5.8	6.2	12.4	16.8	6.8	8.2	20.7	6.0	22.4	6.5	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5	6.0	6.2	9.0	9.2	17.2	13.3	4.0	10.2	2.7	2.3	5.2	25.5	11.6	1.7	3.8	0.1	4.5	2.6	0.0	3.1	13.2	6.2	8.4	14.9	3.4	5.6	7.9	10.3	4.3	6.0	0.0	7.2	7.8	5.0	6.4	3.8	4.0	3.1	0.0	6.3	3.7	8.3	0.0	8.2	0.5	1.1	22.5	12.5	7.0	5.7	8.7
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.2	20.0	6.7	12.0	4.2	6.3	10.8	7.4	7.0	13.3	11.0	13.8	8.0	18.2	10.2	6.2	9.7	11.0	15.3	19.0	9.1	2.9	23.8	8.2	9.6	17.2	5.7	15.7	6.6	7.1	10.2	13.7	21.0	5.9	8.5	17.9	22.0	6.7	7.8	11.3	24.1	12.8	12.7	6.9	8.9	19.5	11.8	20.1	7.8	8.0	13.9	8.4	7.0	7.2	8.8	6.5	17.6	11.4	7.6	7.2	10.1	6.9	24.8	5.2	4.0	15.3	5.0	13.0	13.7	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4	3.0	0.6	12.4	6.2	7.7	4.1	2.0	12.7	4.0	3.4	3.5	2.0	9.0	0.0	8.7	0.6	4.2	1.6	0.0	12.9	16.0	8.2	4.0	3.5	5.5	6.7	1.6	4.7	4.3	2.8	4.7	3.7	2.2	1.7	3.6	7.8	1.4	9.4	2.9	4.6	5.6	2.9	0.0	4.1	3.6	5.3	8.8	4.1	4.4	12.0	5.1
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.9	12.8	12.7	12.9	15.9	21.9	17.5	25.2	19.1	18.8	22.0	21.7	18.2	28.0	32.2	17.6	13.2	14.5	20.2	18.5	29.5	29.0	12.4	28.8	11.3	13.5	17.5	34.6	17.5	18.3	13.8	13.3	44.0	20.2	20.4	9.8	21.1	15.5	22.2	50.2	15.6	13.2	15.9	26.6	20.5	19.3	18.3	28.3	17.9	49.9	20.2	12.6	14.3	35.2	20.8	14.4	26.2	15.9	17.8	15.1	10.8	17.2	30.3	25.6	17.2	28.7	18.8	22.6	20.5	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1	17.9	13.4	25.1	43.8	57.7	23.4	39.6	20.4	16.0	17.0	10.4	13.7	29.3	29.9	22.3	12.2	23.2	13.4	0.0	33.9	37.0	34.9	39.0	25.3	38.5	21.3	28.6	13.2	20.9	32.4	4.7	23.6	22.5	23.6	25.2	17.7	12.3	30.1	10.5	25.8	26.9	18.0	25.8	91.0	30.3	26.0	65.0	47.4	25.9	18.8	62.7
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA053424: AB_2682147"	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.4	23.1	5.1	8.0	2.6	2.7	26.2	8.6	4.4	10.6	5.8	18.8	5.9	19.1	9.5	4.4	6.3	11.2	9.1	9.4	2.3	7.5	25.0	12.8	7.6	12.3	6.8	14.9	15.0	4.0	6.5	8.3	6.7	4.0	7.4	14.7	21.7	4.4	4.3	14.6	14.2	35.1	15.0	7.3	18.4	18.5	5.7	16.7	5.5	9.2	12.6	10.0	7.3	10.0	6.3	3.1	14.0	9.3	9.8	6.3	16.1	10.1	14.3	11.2	6.9	16.7	9.7	12.9	13.3	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6	8.9	7.8	13.0	13.7	19.8	7.9	6.0	25.5	0.0	3.4	3.5	0.0	28.1	6.6	25.9	57.6	11.1	15.2	0.0	28.5	27.4	15.4	9.4	16.1	9.5	22.0	7.9	7.0	11.6	11.0	60.3	13.6	14.1	13.5	13.6	11.1	6.7	23.0	8.6	7.4	16.5	5.0	19.4	14.4	37.9	50.3	18.9	25.5	14.9	16.2	11.9
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570766-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 120.4;Late spermatids: 122.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	18.6	22.4	13.5	18.7	16.1	20.5	17.7	20.4	16.9	14.7	15.5	16.2	19.6	13.1	21.5	19.1	20.9	11.8	15.7	15.7	11.6	11.8	18.2	21.9	13.8	17.5	17.4	12.5	15.2	25.8	17.0	21.4	19.8	16.2	15.2	17.6	14.4	19.8	15.5	27.5	19.4	13.5	15.2	17.0	15.3	17.2	18.4	15.4	16.4	16.8	21.3	18.9	14.6	18.2	8.1	7.4	3.6	8.5	7.0	9.7	4.4	11.3	18.4	10.8	19.3	12.9	14.2	21.4	19.3	15.1	20.5	16.1	21.7	14.6	26.6	12.0	17.1	17.0	14.8	25.5	23.3	25.9	18.6	20.0	25.7	11.6	25.6	17.2	29.6	14.3	12.7	17.2	22.9	22.8	9.8	14.7	14.0	33.8	16.9	20.2	20.5	19.6	21.3	30.0	30.1	17.4	18.3	29.7	24.7	14.5	15.6	18.8	20.4	14.5	23.9	16.8	12.3	12.5	11.6	14.5	20.1	24.8	20.6	31.5	22.7	35.5	30.7	16.9	29.3	24.7	2.5	6.1	3.6	6.8	8.5	9.6	8.1	7.1	7.7	7.4	6.3	5.5	7.6	0.8	7.0	8.3	5.3	9.7	4.4	13.5	16.1	20.4	16.9	11.6	11.8	17.4	12.5	16.2	15.4	14.9	18.4	13.7	24.7	29.3	13.5	16.9	12.7	8.1	14.8	12.2	11.8	28.1	13.3	17.7	120.4	20.4	8.9	0.0	20.8	26.8	16.9	16.3	13.9	9.6	13.7	15.9	10.9	12.3	10.0	122.0	15.8	13.9	8.5	21.6	11.6	12.0	15.2	3.5	15.6	13.9	15.2	12.9	23.9	25.6	42.0	29.9	24.7	15.2	15.8	19.5
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717833-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	17.3	15.1	12.2	14.3	13.4	17.0	14.5	19.8	11.6	15.2	12.9	10.2	11.9	10.3	17.2	11.7	18.1	13.9	10.4	12.8	9.5	7.6	18.9	22.1	10.4	17.5	14.4	5.4	19.5	16.9	18.4	17.0	19.8	10.8	14.6	13.9	10.4	14.1	10.7	26.8	13.8	13.8	13.6	11.1	16.6	14.4	10.6	14.3	32.1	13.6	16.4	20.1	14.5	13.4	9.7	7.0	7.4	5.8	10.0	14.7	7.8	14.7	17.3	14.5	9.4	6.9	8.2	15.8	10.3	8.9	22.9	18.8	16.3	11.4	25.1	8.0	11.1	14.1	11.5	35.3	17.0	33.7	7.1	28.0	16.5	10.5	14.5	8.0	22.0	10.8	6.4	10.8	17.2	11.8	6.4	21.3	12.1	27.5	7.8	18.2	14.5	27.0	9.2	15.9	18.4	24.1	18.6	30.4	17.6	10.3	17.5	12.0	11.1	9.5	26.9	12.4	21.2	18.3	12.4	7.3	20.0	13.5	6.8	21.3	4.9	12.5	27.1	8.6	15.4	11.9	7.4	5.2	3.6	8.5	5.8	8.8	8.8	8.9	10.2	7.0	9.7	14.7	10.8	0.8	10.0	5.3	5.3	9.6	7.8	12.2	13.4	19.8	11.6	9.5	7.6	14.4	5.4	10.8	14.3	26.8	15.2	15.2	29.1	29.8	21.5	15.7	25.5	28.1	23.9	8.7	13.7	39.2	10.0	17.7	0.9	22.8	10.5	0.0	15.3	29.4	23.4	12.5	23.1	21.2	17.9	23.8	26.4	14.7	13.7	3.4	19.2	15.4	16.9	15.4	15.5	15.8	14.4	7.0	18.0	23.8	31.9	6.5	16.5	20.6	34.1	29.1	27.6	24.9	18.9	23.5
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615327-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	35.8	40.5	45.2	41.4	42.3	44.9	36.6	26.7	38.7	30.5	36.7	25.9	29.2	37.2	35.2	36.7	38.6	33.0	36.6	53.4	39.9	38.4	56.9	58.6	28.8	36.6	41.6	30.2	42.4	42.6	54.0	40.5	45.6	36.8	39.5	32.4	23.1	42.3	35.6	59.3	30.6	46.4	36.7	47.7	45.2	34.8	32.5	40.4	34.3	49.5	36.9	36.0	43.3	56.0	50.7	45.5	38.3	38.0	28.8	49.6	30.9	29.8	15.5	14.6	21.0	11.4	13.2	29.7	27.4	14.9	25.7	24.4	29.4	12.6	38.5	54.3	16.6	31.4	18.5	22.0	20.7	25.2	21.6	36.0	33.1	15.4	49.4	24.5	49.1	26.1	12.4	21.8	23.5	14.5	13.4	16.7	21.7	51.3	10.5	22.2	19.2	27.9	54.5	19.1	17.5	26.6	30.2	20.8	59.2	25.6	9.9	37.2	23.9	16.0	38.8	35.8	19.0	24.1	17.9	25.3	23.7	22.3	24.3	48.1	24.6	47.7	47.0	13.6	29.1	35.8	16.0	30.2	38.3	31.0	35.3	36.6	50.7	45.5	38.3	35.9	41.4	49.6	37.8	14.0	28.8	38.0	45.5	46.9	30.9	45.2	42.3	26.7	38.7	39.9	38.4	41.6	30.2	36.8	40.4	86.4	58.0	93.0	81.6	80.6	62.4	203.3	63.7	148.5	80.8	54.1	21.6	114.5	104.5	133.3	133.2	97.2	61.4	70.0	226.4	127.6	86.4	80.3	87.8	56.9	100.9	46.1	35.6	46.6	45.5	19.9	76.5	83.5	96.2	155.9	59.8	89.8	148.3	72.9	74.6	135.1	46.0	64.7	96.7	142.1	122.5	79.2	129.9	82.8	73.6	94.7
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	8.1	13.2	6.1	12.3	13.9	11.8	8.4	9.3	7.3	10.0	9.6	4.7	8.5	25.6	8.2	9.8	16.6	16.9	21.8	13.0	11.1	16.0	9.9	18.2	13.2	10.5	9.4	30.3	13.9	12.4	9.6	11.2	15.7	8.2	12.3	7.6	27.6	7.9	11.5	13.1	21.1	10.6	10.3	11.6	12.6	12.8	18.0	10.4	5.2	5.5	11.4	5.6	12.8	11.2	7.8	8.3	4.5	9.6	11.9	9.3	6.0	13.1	9.7	8.0	17.9	13.9	8.6	17.5	11.9	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8	17.9	33.1	27.4	15.8	11.6	18.5	25.6	12.7	32.1	23.9	10.4	9.8	16.1	13.3	20.5	9.0	20.2	8.8	23.3	11.2	17.4	13.2	11.2	48.8	9.6	23.0	27.0	8.6	20.3	16.1	6.8	29.7	19.8	10.1	27.1	14.3	13.7	15.3	7.0	22.3	12.4	16.8	6.5	13.4	46.1	37.9	13.9	12.2	15.2	17.9	9.6
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745522-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 374.2;Exocrine glandular cells: 855.6;Extravillous trophoblasts: 474.7;monocytes: 470.7;Pancreatic endocrine cells: 426.7;Syncytiotrophoblasts: 423.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7"	"Cell line enhanced"	"Detected in all"		"NB-4: 161.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	35.2	34.8	13.4	35.1	19.7	39.3	40.6	21.0	21.6	44.4	36.9	15.4	30.7	35.9	41.4	30.8	37.2	32.2	36.1	24.5	12.7	10.2	24.8	24.7	22.6	48.7	18.2	19.7	90.1	92.0	18.6	19.8	20.3	16.1	42.3	12.7	22.8	67.3	28.2	51.6	54.7	32.8	50.2	16.4	49.8	39.0	31.9	17.4	49.7	54.9	33.8	40.9	39.6	68.7	51.0	8.8	4.8	7.2	20.5	52.7	2.9	12.3	13.0	11.7	27.6	14.6	24.5	22.2	7.7	14.2	7.5	11.1	12.0	24.9	54.1	11.1	8.9	5.7	17.6	6.7	11.3	3.9	15.8	22.4	17.7	11.0	14.0	21.6	25.5	34.8	21.5	26.0	6.6	17.8	24.6	11.8	23.4	21.5	26.7	6.7	10.7	69.3	161.6	26.7	21.6	7.5	46.5	20.9	25.1	14.3	19.1	12.4	43.5	6.5	42.7	38.5	9.0	20.1	62.1	14.5	7.4	19.7	6.3	15.7	39.0	34.8	14.7	9.3	18.2	11.8	3.6	4.8	4.8	12.0	7.2	16.7	51.0	23.9	21.2	6.9	36.0	52.7	24.0	0.7	20.5	5.0	8.8	22.7	2.9	13.4	19.7	21.0	21.6	12.7	10.2	18.2	19.7	16.1	17.4	38.7	121.7	0.0	0.0	0.0	0.0	0.0	0.0	33.5	127.4	99.5	0.0	374.2	225.5	211.0	0.0	0.0	0.0	0.0	855.6	474.7	0.0	0.0	62.8	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	470.7	0.0	0.0	426.7	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.0	0.0	423.8	0.0	0.0	0.0
NOVA1		ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443093-26597754	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 25.9;ASC diff: 14.1;HAP1: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	17.8	6.7	17.5	3.4	17.4	1.3	32.9	54.7	49.2	12.2	6.3	13.3	5.0	2.5	9.4	6.9	4.0	6.2	6.2	3.0	17.1	25.1	7.0	2.2	2.7	4.4	19.2	17.8	6.3	2.7	4.4	14.1	1.3	26.4	5.4	6.5	4.0	2.8	17.5	6.9	3.1	3.4	9.9	22.5	2.1	3.3	10.3	14.9	0.0	4.1	2.7	5.2	5.6	9.4	0.3	0.3	0.6	0.4	2.2	0.5	0.0	0.0	6.1	25.9	0.0	14.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.4	4.2	0.1	12.7	0.1	0.0	0.0	1.0	0.0	0.0	0.2	5.3	0.0	1.2	9.4	0.0	1.9	1.9	9.4	5.4	5.4	0.0	0.0	4.1	0.0	5.3	0.1	7.6	0.0	6.1	0.7	8.6	0.1	3.6	4.9	8.3	4.8	0.0	0.0	0.0	2.6	0.7	0.0	0.0	3.6	4.2	3.1	0.7	0.0	0.0	0.0	5.1	0.0	3.8	0.6	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.5	0.6	2.2	0.4	0.3	0.4	0.0	17.5	17.4	54.7	26.9	17.1	25.1	19.2	17.8	26.4	14.9	0.0	1.0	0.0	6.8	4.6	198.3	0.8	2.5	8.1	0.0	14.0	3.9	0.0	8.3	0.0	14.7	6.2	0.5	0.0	0.3	0.0	12.1	2.1	0.0	0.2	0.2	128.7	63.4	35.0	1.2	11.2	139.2	1.9	3.3	0.0	2.3	26.6	3.1	10.5	61.9	20.4	13.0	6.5	19.8	170.1	57.9	2.8	0.0	0.0	3.7	0.6
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: AB_2680226"	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	2.0	0.2	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	4.0	2.4	0.4	0.2	0.1	4.8	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.9	0.2	0.2	0.0	5.6	0.0	0.4	0.0	0.0	0.1	0.0	14.8	0.1	0.0	0.0	7.5	1.8	5.6	3.4	0.0	3.2	3.3	0.0	0.0	0.0	0.2	2.6	0.4	0.0	1.6	1.1	0.0	0.0	3.7	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9	0.0	0.0	0.0	9.0	2.5	15.1	1.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.3	0.5	0.9	0.0	0.0	1.9	0.0	1.8	1.3	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.6	8.9	0.0	3.3	0.0	0.0	9.7	0.8	0.0	9.6	1.5	0.7	6.5	1.1	3.0	4.3	0.3	0.0	0.8	0.0	5.9
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193"	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.7	20.7	16.3	0.0	8.2	5.3	5.8	11.6	5.2	7.8	5.9	3.8	7.7	0.0	6.6	11.0	3.6	5.1	1.0	6.9	15.7	0.0	4.5	14.7	7.2	11.9	4.9	7.4	3.2	6.5	9.7	8.0	9.4	8.1	5.7	2.2	10.4	8.1	5.1	5.5	3.4	0.0	6.6	3.9	6.2	41.5	12.8	0.3	4.5	16.9	1.4	0.0	9.6	5.1	3.9	13.3	12.4	5.6	9.8	6.3	4.2	9.8	4.7	3.9	0.0	0.0	13.8	0.0	3.2	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7	44.7	32.8	11.5	54.8	16.6	33.5	15.3	17.8	18.7	61.4	27.9	47.1	13.0	8.3	20.2	11.9	25.5	34.2	0.0	23.8	109.4	21.7	35.8	29.1	42.3	36.7	20.6	36.1	28.3	37.6	14.4	34.8	26.2	8.5	33.3	38.8	58.9	25.8	40.3	25.5	33.6	60.2	32.3	17.0	9.3	2.3	16.4	11.8	7.7	42.0	78.2
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"U-138 MG: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA		11000000	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	6.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	48.6	0.9	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7	0.0	0.0	0.0	5.9	0.5	58.9	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	85.5	0.7	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.9	1.6	0.0	1.8	0.0	103.3	3.1	0.2	0.0	0.0	0.0	8.9	0.0	0.0	25.8	0.0	2.7	51.8	37.7	8.8	1.9	0.1	0.1	0.0	0.0	0.1
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.6	6.8	11.2	5.8	22.5	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	13.9	9.3	9.9	6.5	11.2	6.3	7.2	5.4	8.7	10.0	14.4	9.0	9.9	18.2	5.8	4.6	12.7	6.3	10.9	0.0	6.1	11.0	6.8	13.2	0.0	2.4	8.7	12.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.6	6.2	6.3	9.5	9.9	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6	14.9	31.3	19.1	10.7	7.4	22.7	83.1	40.8	16.0	18.2	19.2	7.9	18.7	58.0	20.4	59.4	30.8	62.9	23.3	32.8	21.8	21.4	14.7	18.5	95.7	54.0	41.3	24.3	84.1	138.2	27.2	24.5	46.3	16.9	14.4	61.2	10.0	23.8	50.3	37.1	92.4	18.3	25.8	23.7	17.6	5.1	4.6	6.1	20.8	42.4	14.7
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	11.4	7.4	16.0	10.8	9.2	10.6	9.5	7.0	10.1	8.4	9.4	11.1	8.4	15.8	7.8	4.3	9.2	8.5	9.9	9.5	12.5	13.9	5.4	19.2	7.8	20.8	8.7	13.2	12.6	8.3	14.0	8.1	27.9	7.6	5.8	20.5	24.4	13.6	9.0	17.1	21.4	15.5	15.1	72.4	4.9	10.0	14.0	15.4	16.6	6.3	16.8	11.3	6.6	6.7	23.0	12.8	11.8	12.2	6.0	8.7	10.3	5.6	12.1	18.0	17.9	35.3	7.2	13.4	7.4	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9	14.9	40.0	42.2	37.8	25.3	59.8	37.9	43.3	57.6	34.2	57.6	43.2	77.5	72.9	37.0	142.4	30.6	31.5	0.0	42.0	52.6	25.1	27.9	47.3	57.2	39.6	39.7	21.2	19.6	46.1	120.0	26.2	34.7	33.7	36.9	47.2	59.6	29.7	43.8	24.4	76.7	60.3	25.8	35.0	186.5	159.6	25.6	38.1	48.9	57.7	23.1
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930397-148021604	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: AB_2685287"	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favorable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	11.5	14.3	19.0	11.4	20.5	19.6	17.3	29.8	27.2	13.6	14.6	11.0	12.0	13.9	14.8	13.5	13.1	17.3	11.9	13.8	18.1	22.3	24.5	15.5	10.9	11.9	18.1	18.1	21.2	12.1	18.9	29.5	14.3	30.9	14.9	16.8	12.7	15.2	14.6	16.0	11.6	15.6	13.8	18.1	11.0	10.9	17.3	11.8	20.4	19.0	12.7	13.6	13.3	12.6	16.1	18.1	21.5	19.1	20.2	16.6	13.1	12.4	10.9	21.4	11.7	8.3	8.2	23.2	14.3	12.0	18.0	18.0	26.8	12.7	16.1	15.6	8.4	16.0	12.7	24.2	14.0	18.8	11.3	20.6	22.3	11.8	18.1	11.1	14.0	8.4	6.9	17.0	19.6	7.9	13.4	12.1	15.4	21.1	8.5	11.7	13.2	10.9	11.4	24.2	10.3	15.9	12.0	14.4	14.6	19.9	25.9	20.3	15.9	12.8	14.1	17.1	20.3	10.8	6.8	8.8	13.7	13.5	9.9	13.0	8.5	20.0	15.3	11.2	11.0	8.3	21.5	15.0	19.8	16.2	19.1	16.6	16.1	15.8	16.6	18.1	15.4	16.6	16.3	21.1	20.2	14.8	9.2	16.0	13.1	19.0	20.5	29.8	27.2	18.1	22.3	18.1	18.1	30.9	11.8	77.4	53.4	11.0	19.9	23.1	44.5	24.2	10.2	96.4	80.8	12.2	37.3	33.7	38.1	27.8	19.2	16.5	17.2	0.0	15.1	40.8	23.7	20.2	42.9	15.3	20.8	50.9	22.1	17.2	20.0	13.4	20.8	22.1	20.3	18.0	18.1	32.9	16.3	14.0	20.1	41.6	35.2	32.3	19.5	55.5	25.3	21.8	27.3	22.4	22.5	17.3
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 75.0;Club cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.7	4.0	3.0	5.5	6.8	13.7	6.7	16.7	18.7	7.9	12.5	10.0	19.7	8.2	2.4	17.9	10.4	13.0	9.0	12.6	12.2	4.9	3.7	1.9	5.9	7.5	9.7	5.6	44.0	6.7	10.5	10.2	12.4	10.1	11.7	7.2	10.3	11.5	13.3	0.0	3.4	6.8	5.8	14.1	5.2	2.7	8.3	3.3	7.9	10.5	0.6	6.2	11.4	8.2	2.5	9.3	4.2	0.5	13.9	3.5	7.0	18.9	12.5	8.0	11.5	20.7	7.6	9.2	38.7	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1	0.0	25.0	4.5	6.6	10.8	0.0	4.7	0.0	75.0	30.7	24.4	0.0	7.1	3.3	3.3	0.3	2.9	2.9	0.0	3.4	1.3	2.6	2.1	0.0	0.2	9.4	0.0	1.7	4.3	12.0	0.0	0.6	9.2	15.1	7.2	0.5	5.8	14.9	3.5	0.0	0.5	0.1	0.0	2.2	0.5	4.1	6.9	3.3	13.1	3.4	12.9
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.3	5.6	7.3	12.7	9.2	8.4	10.6	9.4	7.8	14.3	14.1	12.4	6.4	14.5	23.6	8.0	17.9	7.7	15.0	12.1	20.6	8.5	10.1	8.0	5.3	14.2	13.5	22.1	10.5	7.7	10.6	13.9	23.6	4.8	9.5	8.0	24.1	4.2	11.8	8.5	11.0	20.3	16.0	13.4	10.1	11.5	9.6	22.5	10.3	8.6	11.1	9.6	7.0	18.1	20.1	13.0	8.0	8.0	8.2	11.6	8.3	12.4	23.2	10.0	27.3	15.9	4.7	14.9	21.7	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9	17.9	10.5	28.3	38.3	59.0	12.9	16.6	17.8	22.7	36.4	10.4	3.9	22.4	16.6	36.8	10.2	17.7	5.4	0.0	23.3	24.5	23.5	36.7	34.6	18.1	32.0	12.7	5.2	16.0	9.9	8.3	19.8	14.9	11.8	19.0	10.5	11.8	25.6	3.5	19.4	17.9	10.1	6.5	25.9	23.4	49.7	43.5	14.6	12.5	19.9	26.0
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052003: AB_2681689"	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.3	14.9	23.0	17.2	7.6	7.3	16.7	22.7	12.4	28.9	35.8	14.1	19.5	15.1	10.3	7.1	25.8	19.2	30.6	10.4	34.2	12.1	14.9	13.8	18.1	23.5	6.8	28.6	7.9	5.0	8.9	18.0	19.9	8.0	14.8	18.5	14.6	20.7	19.8	12.6	14.6	12.3	12.6	23.2	23.3	18.3	31.3	9.8	11.5	10.6	16.0	11.0	25.3	14.1	6.6	15.3	13.0	9.7	10.1	17.6	26.7	12.1	18.4	19.4	24.7	20.1	7.3	12.7	19.5	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4	23.8	6.2	10.4	9.3	5.8	26.8	12.3	5.1	36.1	21.6	7.0	11.8	19.1	6.6	10.5	7.3	10.0	3.4	23.3	7.7	17.9	8.4	3.7	8.1	9.6	10.2	28.6	4.6	6.2	4.9	7.3	10.6	6.4	8.5	4.6	4.2	21.9	8.0	5.5	15.9	5.6	21.7	6.5	9.5	17.7	33.3	4.3	12.5	4.4	5.2	4.6
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.5	9.6	42.3	17.3	7.9	10.1	8.0	11.6	9.3	12.5	15.5	5.7	12.0	18.6	26.7	7.0	12.2	10.4	29.5	13.1	21.1	15.1	13.7	18.0	16.5	6.6	8.4	17.9	10.0	6.7	10.0	13.6	17.0	12.6	17.4	18.2	13.2	9.2	15.3	7.6	28.9	8.9	12.9	15.8	13.0	28.5	15.4	14.1	13.3	14.0	14.7	17.2	8.9	8.2	12.2	13.1	7.7	9.9	13.2	11.7	8.4	14.6	17.8	4.7	10.9	25.1	7.6	21.4	14.5	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4	20.8	17.3	24.1	12.5	11.6	21.9	13.7	7.6	16.0	13.6	15.7	17.7	9.9	19.9	12.5	2.6	14.3	7.9	0.0	11.8	6.8	11.3	10.2	23.2	12.7	13.2	17.5	10.9	19.6	12.6	2.1	19.2	15.3	6.8	19.0	13.4	25.6	12.4	15.0	14.5	16.5	18.2	25.8	9.2	4.6	17.9	10.0	3.9	22.0	16.6	11.0
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76033932	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 142.4"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1"	"Group enriched"	"Detected in many"	7	"monocytes: 2.5;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 65.6;RPTEC TERT1: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	13.2	15.9	9.4	8.4	12.1	9.0	13.5	6.4	15.7	11.5	4.5	11.1	4.8	3.4	7.1	3.1	33.3	5.1	20.0	9.6	8.2	7.9	13.8	33.2	14.2	3.0	8.4	5.6	10.8	8.8	2.6	6.0	7.1	10.0	4.8	5.5	24.9	142.4	6.5	3.3	6.3	7.0	7.6	9.7	14.6	10.8	2.3	10.1	2.5	18.0	13.2	19.9	17.0	17.8	0.3	0.1	0.4	2.5	0.3	4.1	0.6	12.7	15.3	12.0	6.6	5.6	11.7	0.8	10.8	29.2	4.9	6.8	8.4	15.6	0.0	3.2	4.5	16.3	6.5	0.3	18.1	10.6	1.9	0.2	0.3	0.7	14.3	8.2	0.3	3.3	3.6	13.3	20.4	40.6	65.6	11.8	0.0	1.0	0.3	25.1	1.6	0.0	1.6	4.4	7.7	23.6	0.0	3.1	0.3	51.5	28.9	0.8	2.3	1.8	0.1	35.1	15.6	7.7	0.1	10.9	16.8	1.6	19.5	10.6	0.1	0.0	0.0	28.4	0.1	20.9	0.3	0.1	0.2	2.4	0.2	3.9	0.3	2.5	2.5	0.0	0.2	0.5	0.6	0.4	0.3	2.5	0.1	4.1	0.6	9.4	12.1	6.4	7.7	8.2	7.9	8.4	5.6	10.0	10.1	11.9	17.2	2.7	1037.1	173.4	1.5	29.5	10.2	6.7	22.7	29.6	2.0	4.8	71.3	68.6	1.0	95.1	0.7	0.0	35.8	6.3	85.4	57.9	80.5	117.3	97.6	1.6	112.7	23.9	10.8	1.3	8.6	53.3	271.7	41.5	10.3	90.9	162.8	3.5	14.5	32.7	4.0	265.1	353.3	0.5	0.4	66.0	6.2	23.0	8.0	680.5
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Suprabasal keratinocytes: 199.7;Urothelial cells: 399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 35.7;HMC-1: 66.4;K-562: 30.6;U-698: 119.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.3	2.0	1.1	4.7	2.5	24.0	1.1	3.4	2.3	3.6	4.6	4.3	6.2	1.7	1.3	5.1	3.6	2.1	3.3	2.1	28.1	1.4	35.7	1.3	5.9	4.8	0.6	66.4	8.5	4.1	2.1	1.4	2.5	0.6	1.5	30.6	10.0	0.3	0.8	1.9	3.2	3.8	5.7	2.0	4.8	3.7	7.3	0.6	18.8	10.0	2.0	2.4	0.3	0.6	4.9	0.5	1.0	1.2	1.3	4.0	6.0	1.3	4.7	2.5	119.4	0.5	9.0	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6	20.8	23.1	27.2	134.9	113.6	4.2	17.3	12.7	4.0	22.7	8.7	0.0	27.3	5.0	30.7	3.8	14.3	33.2	46.7	15.5	92.9	73.9	69.5	46.4	27.1	44.8	14.3	35.6	9.2	40.0	10.4	7.5	45.8	42.2	101.0	11.9	4.3	37.7	17.5	2.8	13.0	0.9	0.0	57.5	3.3	34.5	199.7	67.5	126.4	6.6	399.5
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1"	ENSG00000254093	"PIN2/TERF1 interacting telomerase inhibitor 1"	Q96BK5	8	10764963-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			Nucleoli	"Nucleoplasm, Mitochondria"	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favorable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	14.3	14.4	9.9	16.0	13.9	14.8	13.8	14.5	16.5	12.6	14.2	12.6	7.1	11.5	15.7	8.9	19.3	10.7	9.3	11.7	10.6	10.1	13.1	19.4	11.2	19.2	13.2	10.9	16.1	17.2	7.6	10.7	13.3	17.6	11.4	12.0	15.6	14.9	8.5	21.2	19.0	11.3	15.9	11.1	14.8	11.7	24.0	9.7	18.7	12.4	17.8	19.6	11.5	14.3	9.8	8.8	4.4	8.4	8.9	16.0	8.4	6.4	8.7	9.4	8.9	8.0	6.5	10.8	9.9	4.5	10.9	7.4	9.1	5.7	17.4	3.5	5.3	13.4	13.1	23.8	18.3	14.1	7.0	7.1	7.3	6.1	9.8	9.0	7.8	4.6	5.4	11.7	8.6	16.1	3.9	15.1	11.9	23.1	10.8	10.7	7.7	25.5	9.8	21.6	28.3	9.7	20.9	11.5	15.9	8.1	8.0	7.8	8.1	6.6	7.9	21.7	12.0	8.4	9.7	9.1	6.6	14.3	8.4	12.7	4.9	12.7	31.7	6.8	14.8	14.9	1.5	6.8	4.4	12.5	8.4	16.0	9.7	10.9	13.1	8.8	9.8	15.0	11.6	0.4	8.9	7.3	6.8	12.3	8.4	9.9	13.9	14.5	16.5	10.6	10.1	13.2	10.9	17.6	9.7	3.0	4.1	9.9	14.8	23.7	5.2	3.3	7.6	10.7	9.1	3.5	11.8	14.9	10.0	0.0	29.6	11.4	4.0	0.0	0.0	9.6	8.0	5.2	13.9	6.6	14.3	3.2	8.1	11.6	4.0	22.3	8.6	9.6	6.8	0.0	3.9	6.2	0.0	4.8	6.0	8.2	21.5	0.0	6.2	24.9	25.1	25.0	40.3	11.7	7.7	8.0
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	13.0	8.8	8.9	14.0	8.5	6.6	14.5	21.1	10.8	9.8	8.6	7.0	17.2	8.5	6.7	6.4	5.7	10.7	3.2	11.9	5.8	10.9	13.5	14.4	16.6	6.1	6.4	13.6	19.3	6.2	6.3	8.9	5.8	8.7	12.8	10.7	7.0	17.1	12.7	8.3	13.7	10.8	8.3	13.5	18.0	11.7	8.2	17.1	10.0	27.9	10.6	17.1	9.2	27.8	4.7	8.1	4.8	8.4	18.1	19.1	11.7	4.6	17.4	18.9	7.6	6.9	17.3	6.1	15.2	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9	14.9	23.4	40.2	28.5	11.8	40.7	8.9	15.3	24.1	9.1	19.2	76.6	37.9	19.9	36.3	12.0	20.2	24.9	0.0	34.6	29.2	14.8	28.4	27.8	18.7	34.1	31.8	29.3	31.9	22.4	20.0	55.0	24.9	13.5	42.3	23.1	20.6	38.1	20.1	42.1	26.9	76.0	19.4	14.4	18.2	29.6	11.4	41.2	42.4	27.4	25.2
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.3	14.4	9.4	16.3	11.6	31.7	9.0	20.7	12.1	9.5	22.6	13.0	24.7	17.0	25.6	14.4	17.3	20.1	7.9	23.2	14.8	16.0	9.3	10.2	12.6	16.4	18.8	4.7	11.9	13.4	27.7	11.3	14.5	11.1	15.6	15.2	21.6	27.5	18.1	13.3	18.9	22.0	12.4	12.8	13.8	10.2	10.7	13.4	23.1	12.9	9.4	9.0	8.9	18.7	20.2	16.6	39.9	9.1	13.0	32.0	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9	14.9	10.4	31.0	31.3	73.8	22.7	10.4	12.7	33.5	46.6	7.0	11.8	34.1	16.6	26.1	20.1	20.3	4.2	0.0	25.8	33.6	22.6	19.3	30.1	14.3	23.5	17.5	16.6	13.5	10.6	4.2	11.5	23.3	11.8	20.8	9.7	13.7	24.7	7.0	15.6	27.9	40.1	6.5	48.7	23.9	42.8	49.1	39.8	20.4	13.6	22.3
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.7	7.7	8.4	7.7	2.9	2.1	5.6	10.9	9.2	11.4	8.5	7.9	8.3	9.0	15.8	7.9	5.5	8.5	24.2	10.8	12.3	6.5	10.2	17.8	6.1	5.3	1.3	9.4	11.3	1.8	2.0	12.6	5.0	3.5	8.9	4.3	9.7	8.1	10.7	10.1	13.6	4.8	6.3	14.9	10.6	11.3	4.9	6.5	8.3	6.8	20.0	4.7	5.0	8.6	3.8	5.0	11.6	3.5	12.0	10.0	7.2	12.6	21.6	8.1	7.6	19.3	7.9	10.2	8.8	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2	3.0	3.8	5.1	4.8	3.3	7.8	2.8	0.0	2.7	4.5	5.2	0.0	3.2	5.0	9.5	9.8	2.9	1.3	0.0	5.0	2.8	2.7	3.5	1.1	5.5	3.0	1.6	0.0	3.1	1.6	1.8	4.9	3.2	0.0	9.0	1.6	3.1	6.4	0.0	4.2	7.8	9.6	6.5	2.7	3.9	15.7	2.0	2.5	1.9	2.7	3.9
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.6	12.3	15.0	23.4	12.6	19.6	17.0	11.0	20.8	16.0	29.8	9.3	11.9	25.9	13.6	10.9	21.4	20.6	32.4	18.7	28.1	31.2	14.5	22.6	33.7	16.5	20.4	15.2	15.9	18.7	24.0	11.0	11.7	17.3	28.4	17.7	7.7	20.6	44.4	16.6	18.4	14.7	29.3	29.9	19.5	15.1	32.5	29.1	20.8	9.6	10.6	28.8	8.5	21.9	14.6	39.4	19.7	12.5	10.9	16.3	17.3	18.5	19.9	33.5	21.0	21.2	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1	11.9	25.1	40.9	40.5	17.4	19.6	53.8	40.8	25.4	37.5	73.3	13.7	49.9	131.0	34.2	1.3	26.7	23.2	23.3	38.8	36.9	22.4	23.7	54.2	46.1	46.0	17.5	21.2	23.9	18.3	2.7	33.4	31.2	47.2	27.1	27.7	54.1	31.5	24.6	35.3	99.7	28.3	19.4	28.8	19.1	33.4	21.7	14.8	37.4	37.5	25.7
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.6	24.6	9.9	17.5	5.3	5.1	19.5	14.0	6.6	15.6	15.5	35.9	16.0	20.0	23.6	6.1	17.2	15.7	14.5	16.5	7.7	18.2	43.9	9.0	16.0	34.4	9.0	13.8	11.1	5.9	6.2	15.9	15.7	4.4	8.6	14.3	31.9	17.9	8.1	70.0	34.6	47.3	30.5	15.7	34.0	26.2	10.5	34.0	9.3	13.6	20.0	20.3	11.3	34.9	16.6	9.3	11.5	14.0	8.4	21.6	26.0	42.4	27.5	7.6	20.6	35.9	13.6	23.9	23.4	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4	17.9	14.2	18.6	25.5	93.3	23.7	23.0	33.1	25.4	10.3	33.2	5.9	127.6	79.6	64.3	1.9	39.5	51.5	70.0	76.1	144.7	43.7	49.5	17.3	88.3	57.5	30.2	38.6	28.8	23.7	5.6	38.9	27.4	54.0	41.5	44.2	33.8	71.6	45.0	35.0	66.2	18.4	45.3	39.1	7.5	43.1	104.3	116.5	27.4	49.7	41.7
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.5	14.5	14.6	20.0	21.7	16.3	22.1	15.4	8.4	14.2	10.8	18.8	10.7	16.5	6.9	14.3	22.3	12.0	44.2	17.7	17.3	54.5	15.4	29.5	13.1	25.8	16.8	18.4	22.2	10.3	14.4	12.1	18.2	18.4	15.4	28.2	36.7	29.4	15.8	14.9	26.4	16.7	20.1	25.5	19.4	12.0	7.2	14.1	15.6	7.8	24.7	16.6	11.5	24.0	21.9	22.1	11.0	17.7	14.9	14.2	16.0	15.6	20.3	16.9	35.0	21.0	18.1	20.0	14.2	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4	6.0	12.0	18.8	25.3	9.0	24.6	50.0	28.1	76.3	33.0	26.2	21.6	33.4	31.5	34.8	23.6	25.6	19.0	0.0	20.1	39.2	21.3	25.8	31.2	16.1	36.7	71.5	18.8	18.4	11.0	15.7	19.0	21.8	13.5	63.1	22.9	21.7	26.7	21.6	21.2	24.9	25.3	6.5	30.2	78.8	76.3	10.3	39.8	27.4	24.2	17.2
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.5	6.2	5.3	4.2	2.6	8.0	4.3	2.9	2.8	4.0	5.6	1.6	7.9	3.6	3.0	1.1	3.0	4.0	1.8	3.8	1.4	8.8	5.7	5.4	6.5	3.5	2.3	4.4	2.3	2.9	4.2	2.5	2.3	6.4	3.4	4.1	3.3	3.0	26.9	6.2	3.4	2.7	2.6	4.3	7.6	7.9	4.7	2.5	3.4	8.5	6.2	5.7	1.9	1.3	6.9	2.3	3.1	4.7	3.7	10.1	2.8	2.3	5.4	5.7	6.0	1.5	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5	29.8	7.7	13.7	4.0	18.7	12.0	5.6	5.1	2.7	4.5	5.2	3.9	13.6	3.3	6.0	51.4	15.8	10.1	0.0	6.0	5.1	11.2	6.9	1.1	2.8	7.5	3.2	13.8	20.3	23.0	8.1	12.7	9.8	3.3	6.4	9.0	6.4	5.1	8.6	7.1	4.2	10.1	0.0	12.0	24.5	13.9	15.7	32.3	7.5	10.5	5.5
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 57.4;Late spermatids: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"eosinophil: 9.1;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	5.0	5.9	3.5	3.6	3.9	4.6	5.4	1.9	5.4	9.3	5.2	2.7	6.3	1.9	8.6	7.0	3.3	7.7	6.1	5.0	3.2	3.1	3.1	0.8	7.4	2.7	3.4	4.2	15.2	10.3	19.3	12.5	5.0	6.1	7.7	4.4	9.4	3.3	6.8	2.2	2.7	3.2	9.5	6.2	3.3	4.1	5.0	3.3	0.5	8.4	5.1	2.3	5.8	14.1	0.0	0.0	9.1	0.0	0.0	0.3	0.0	1.8	2.9	6.6	0.1	4.0	8.3	7.8	3.9	8.6	4.0	3.5	3.7	1.1	0.4	1.1	5.2	3.8	0.0	0.0	0.8	5.3	0.0	1.1	2.4	2.6	0.2	4.3	8.1	0.1	5.8	2.6	2.8	3.6	3.7	2.9	1.0	0.0	12.1	4.9	0.3	1.2	0.0	4.9	0.6	2.2	0.0	7.7	5.0	1.4	0.0	1.2	5.3	0.0	0.1	0.8	3.6	5.5	3.4	1.1	0.2	2.4	4.1	3.8	11.2	15.6	0.0	3.0	0.0	3.0	0.1	0.0	9.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.0	0.0	3.5	3.9	1.9	5.4	3.2	3.1	3.4	4.2	6.1	3.3	11.9	3.5	0.5	2.5	1.4	9.5	7.3	0.0	2.7	5.7	1.8	7.9	0.8	1.7	1.8	57.4	4.9	0.0	0.0	2.1	2.1	4.4	2.0	2.3	0.0	0.7	0.0	3.5	3.7	0.3	22.0	8.1	0.8	1.7	0.0	2.7	8.2	1.9	0.0	8.9	0.0	8.0	6.5	3.6	5.0	3.3	1.5	0.5	0.0	2.4	0.6
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059424: AB_2684012"	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.6	0.0	7.3	3.2	4.8	5.4	2.0	4.9	3.7	4.8	4.9	4.7	2.5	9.0	6.8	4.5	2.6	5.2	6.6	7.2	3.8	0.0	7.1	5.4	10.2	6.7	4.8	11.2	3.4	5.0	4.0	4.3	4.4	3.2	4.1	5.2	7.2	1.4	4.3	83.6	6.5	3.9	3.1	2.9	6.9	8.3	15.9	3.4	11.5	7.4	13.6	16.6	6.7	9.7	3.2	4.6	6.7	8.4	4.7	3.5	7.3	7.4	7.3	1.5	1.0	1.5	5.3	5.3	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6	0.0	4.1	8.2	6.2	3.9	12.5	2.2	0.0	8.1	2.3	14.0	0.0	16.1	23.2	9.0	0.9	4.2	3.5	0.0	6.5	11.9	3.9	3.6	1.1	0.0	8.5	14.3	16.8	4.9	7.0	2.3	8.1	3.6	1.7	1.8	8.7	6.9	4.9	7.0	8.5	15.2	4.3	12.9	8.4	8.4	8.8	5.4	5.9	5.4	9.5	5.8
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844241	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 73.4;HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.4	17.0	11.5	19.0	15.2	14.8	22.1	15.6	17.7	18.9	16.9	8.3	9.8	11.2	17.1	10.6	29.3	15.7	10.5	15.1	16.7	5.9	23.2	18.4	18.6	18.9	14.0	14.3	24.4	17.8	11.5	23.1	15.9	15.8	18.0	17.3	6.1	20.7	10.3	21.0	16.4	13.2	19.5	18.2	17.8	14.2	13.8	14.9	15.4	15.1	14.5	18.9	20.1	21.6	15.3	13.7	3.8	12.8	15.9	18.4	7.8	17.0	12.6	10.6	10.8	8.9	9.5	12.1	15.9	8.4	16.4	15.4	9.5	8.0	18.9	3.7	10.9	9.8	8.6	19.2	13.7	21.5	73.4	6.8	71.5	12.7	11.4	11.9	31.5	13.4	7.7	6.1	13.3	19.1	7.5	12.1	12.4	7.4	8.6	14.3	7.7	15.9	25.7	27.2	13.1	5.6	18.8	8.3	8.1	11.1	11.5	11.0	10.6	9.6	8.9	8.6	12.4	5.6	17.1	11.5	11.1	9.1	10.6	21.2	4.0	6.5	26.6	8.4	11.5	8.0	3.8	9.2	2.7	13.2	12.8	18.4	15.3	13.7	13.2	12.1	13.5	15.3	14.8	1.3	15.9	10.4	13.7	10.0	7.8	11.5	15.2	15.6	17.7	16.7	5.9	14.0	14.3	15.8	14.9	44.7	39.5	24.8	31.5	0.0	23.8	0.0	20.4	58.9	76.2	22.7	9.8	29.4	39.7	30.6	3.5	15.7	3.1	0.0	22.9	37.0	25.8	19.6	16.3	15.7	19.1	25.4	8.2	20.3	14.3	2.2	43.7	23.0	0.0	35.1	10.7	18.3	24.5	7.0	21.5	99.1	25.6	0.0	0.0	32.5	43.2	0.0	29.3	8.7	16.7	27.1
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 9.5;Smooth muscle cells: 13.4;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.0;Daudi: 26.8"									HPA024573	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.2	0.4	0.3	1.2	3.6	3.6	9.3	12.0	6.3	16.0	10.8	31.0	0.5	26.8	0.4	0.0	0.9	1.4	0.5	9.1	9.2	6.6	19.4	3.2	5.6	7.2	2.3	2.4	0.9	0.3	0.0	11.1	0.0	2.8	0.5	11.4	10.2	10.8	5.3	0.4	0.1	0.7	0.3	0.7	1.2	1.5	0.1	13.9	0.0	0.4	9.4	1.6	0.6	1.0	7.5	4.6	0.0	1.0	6.1	6.5	1.1	14.4	1.4	14.5	17.3	1.2	0.4	2.9	9.2	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2	0.0	1.3	0.5	0.1	9.5	0.1	3.4	0.0	1.4	2.3	0.0	0.0	0.1	1.7	0.0	0.1	1.4	2.6	0.0	0.0	1.2	1.0	0.7	0.0	0.0	1.7	0.0	2.4	3.1	5.4	0.0	1.1	0.0	1.7	0.0	4.7	0.2	0.0	3.2	0.0	0.0	0.2	0.0	13.4	0.6	1.7	7.4	0.6	2.9	4.7	0.0
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201485-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 130.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9"									"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		1100000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	11.6	4.4	3.6	16.7	4.6	22.4	8.6	3.6	3.3	8.2	26.8	6.8	4.1	38.7	5.4	7.9	20.7	6.8	8.5	6.6	2.4	2.6	5.6	6.8	15.0	32.8	6.4	1.8	6.6	6.1	1.3	3.2	6.6	4.0	9.7	4.4	4.7	9.6	5.6	3.5	31.2	29.9	3.5	6.4	34.1	13.3	3.7	3.3	20.6	5.5	22.3	26.3	7.9	11.8	17.1	66.8	130.8	90.4	16.0	16.0	53.1	5.7	13.5	0.1	0.0	1.3	3.0	0.1	2.8	4.0	1.8	1.2	0.0	7.2	2.4	0.0	2.7	0.0	16.0	0.7	10.7	0.0	17.3	0.0	2.2	1.6	4.4	4.6	20.1	16.0	4.0	5.6	0.8	0.1	0.0	3.9	0.0	9.9	3.7	0.5	34.5	0.0	54.4	3.7	2.3	0.0	17.5	0.0	7.6	0.1	5.6	0.1	0.0	2.4	0.0	2.7	0.0	3.3	40.1	2.6	0.1	0.2	2.4	0.0	0.1	0.0	0.0	1.4	24.9	0.0	37.8	90.4	71.4	15.1	87.5	9.5	17.1	12.7	15.5	66.8	15.2	8.9	12.3	130.8	16.0	85.0	61.0	16.0	53.1	3.6	4.6	3.6	3.3	2.4	2.6	6.4	1.8	4.0	3.3	20.8	28.2	73.7	67.5	65.8	0.1	2.8	28.1	36.1	29.6	24.4	0.0	46.3	5.0	83.5	0.3	38.6	312.0	23.3	50.3	8.9	26.7	26.8	108.5	3.0	375.8	0.0	56.6	41.7	516.6	1.5	43.7	364.0	92.8	16.2	110.6	0.0	56.2	271.9	21.2	1.4	0.6	25.8	23.3	0.3	1.1	143.2	14.9	75.0	247.3	42.2
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.5	14.1	20.6	11.4	12.5	16.3	33.8	13.0	15.7	12.3	10.4	20.5	21.0	22.1	19.8	12.5	5.7	13.9	15.8	27.8	9.9	17.0	11.8	18.0	12.0	25.2	15.3	20.8	16.5	14.7	17.9	13.8	20.8	15.6	13.0	9.9	15.3	24.6	14.4	26.5	13.3	37.2	35.9	20.1	7.3	12.0	8.2	25.3	25.2	25.0	13.9	16.0	16.6	22.3	11.6	20.0	27.1	44.1	10.1	7.4	10.5	11.5	9.4	13.0	19.7	34.1	12.7	14.5	11.6	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1	17.9	15.9	15.9	26.4	0.0	13.6	0.0	28.1	30.8	26.1	22.7	7.9	72.4	66.3	34.7	9.6	12.4	38.3	23.3	44.0	61.6	11.5	34.5	17.4	32.7	48.8	6.4	7.0	19.0	44.8	7.4	21.6	40.2	0.0	146.1	41.7	34.7	43.4	37.0	22.3	44.1	10.6	12.9	0.0	18.1	24.3	0.0	51.8	37.4	37.7	28.0
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.9;SK-BR-3: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.1	12.1	3.6	6.1	7.1	10.9	3.6	4.2	6.4	6.2	4.0	8.3	4.4	2.7	6.6	9.5	5.7	15.0	4.1	10.0	3.6	20.5	6.1	7.8	6.1	8.1	11.4	2.8	24.7	15.3	2.9	6.6	8.4	23.7	9.2	2.4	4.9	6.0	7.0	63.9	1.8	9.5	3.1	4.7	3.8	3.6	21.3	10.3	3.6	4.1	1.5	12.4	9.0	40.6	12.4	3.6	38.2	11.2	10.7	7.8	13.3	13.6	4.6	14.4	4.8	2.3	13.1	5.5	23.0	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9	3.0	9.5	5.6	22.6	17.3	24.2	3.2	10.2	4.0	2.3	7.0	5.9	1.9	11.6	14.3	58.0	20.4	52.7	0.0	16.9	5.1	23.8	11.2	34.6	22.8	11.3	3.2	9.2	22.7	35.4	50.8	38.6	37.4	27.0	0.0	14.2	9.3	16.8	24.6	21.5	11.8	8.2	32.3	33.0	2.9	6.9	16.6	4.3	11.5	13.2	19.2
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.7	11.4	11.0	13.0	15.4	8.9	12.0	10.2	8.8	13.1	13.1	12.0	13.0	16.8	7.9	7.5	10.7	12.4	18.3	6.8	15.6	14.2	9.8	14.0	11.6	9.7	10.0	17.5	11.5	7.1	8.9	12.2	10.4	8.8	10.5	12.1	27.0	17.2	10.9	9.9	16.8	7.5	17.9	9.4	19.0	15.1	23.5	20.9	9.1	7.9	17.3	14.0	14.4	15.3	13.0	13.8	16.5	9.9	7.9	10.9	11.7	15.9	13.4	8.5	11.7	20.6	9.7	11.0	16.7	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7	17.9	13.5	16.3	9.4	23.9	13.8	6.5	7.6	14.7	17.0	21.0	27.5	8.0	8.3	10.8	6.4	13.8	14.0	0.0	10.0	8.2	9.8	10.8	12.8	20.2	9.7	15.9	11.6	17.8	14.1	1.7	11.8	15.2	18.6	10.0	12.4	15.8	11.6	10.5	15.2	23.1	18.8	19.4	9.8	8.8	18.1	29.5	9.0	21.7	13.3	12.2
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966371	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	15.4	18.4	19.9	23.5	26.1	23.8	17.1	25.0	26.7	13.7	15.4	27.5	16.0	14.7	17.7	15.1	15.7	15.1	13.0	14.3	19.4	12.6	16.5	15.7	15.2	22.1	22.4	16.2	25.5	21.3	22.0	16.6	16.9	19.4	19.0	15.8	16.0	16.1	16.2	20.0	16.3	16.5	19.6	14.5	19.1	16.7	17.3	26.3	16.8	26.7	14.4	21.5	17.1	21.7	8.1	6.7	1.4	11.9	7.9	9.1	4.8	7.1	14.4	8.6	16.8	8.7	7.0	13.1	13.0	10.2	14.7	10.8	19.2	10.1	12.8	8.1	11.0	10.8	10.2	20.3	12.5	11.6	23.2	11.8	27.6	14.2	18.4	6.6	20.8	13.2	8.6	8.3	17.9	6.5	9.4	10.7	10.1	29.6	5.3	9.1	10.7	11.7	15.7	18.9	7.2	12.4	15.6	8.3	11.1	10.0	14.0	10.4	8.3	11.6	16.9	7.9	7.5	18.5	6.0	12.0	9.7	11.9	8.3	7.9	9.7	7.2	12.9	13.0	14.9	12.2	0.0	4.9	1.4	9.1	8.8	6.9	8.1	6.4	7.4	6.7	7.0	5.2	7.1	0.3	7.9	11.9	4.6	5.5	4.8	19.9	26.1	25.0	26.7	19.4	12.6	22.4	16.2	19.4	26.3	14.9	8.1	9.3	11.1	12.2	9.7	17.6	7.6	20.1	12.5	10.4	7.9	8.8	1.7	9.6	4.9	10.8	4.8	0.0	11.2	7.5	8.9	11.8	14.0	6.4	11.0	6.4	8.6	3.1	6.3	6.5	10.0	9.5	3.3	21.6	7.3	4.9	11.4	6.2	6.7	7.5	13.5	0.0	12.2	15.6	13.2	10.0	9.5	11.4	7.3	11.2
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161457	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	15.8	10.5	17.2	16.4	18.1	30.6	14.8	15.5	22.3	11.0	13.5	10.6	7.0	16.7	10.9	15.2	15.4	9.9	11.3	15.2	13.4	11.6	19.4	14.2	11.5	20.0	16.9	9.9	13.9	13.5	6.6	24.9	14.7	20.9	13.5	12.6	7.6	18.3	11.2	22.2	17.9	17.6	10.9	17.9	14.6	13.1	28.8	17.3	17.5	14.7	10.9	17.1	14.1	16.0	34.2	27.2	38.0	19.2	25.3	35.5	22.7	12.0	9.1	9.5	12.1	7.2	13.0	23.6	12.8	8.9	11.5	11.1	12.3	13.8	20.8	13.9	7.7	9.2	18.1	11.3	11.7	11.1	18.8	18.4	15.6	6.5	8.5	14.4	24.6	15.3	11.4	13.5	10.7	7.4	10.6	9.2	20.8	22.1	10.7	14.5	6.9	21.4	21.2	27.6	16.6	6.5	20.1	10.5	24.0	11.9	9.2	11.8	21.5	17.7	11.3	28.9	6.9	24.6	26.8	9.6	11.7	10.2	16.1	25.6	13.0	21.0	22.0	13.7	16.5	18.2	38.0	16.9	20.4	23.7	19.2	28.2	34.2	27.3	30.4	17.2	26.3	26.0	29.9	8.2	25.3	19.1	27.2	35.5	22.7	17.2	18.1	15.5	22.3	13.4	11.6	16.9	9.9	20.9	17.3	17.9	10.9	5.1	5.4	2.9	3.3	2.6	5.1	16.0	11.4	3.5	9.8	5.2	5.0	5.6	5.6	3.5	3.6	0.0	5.4	3.7	3.5	4.5	22.0	3.0	2.9	0.0	7.5	5.5	6.8	4.4	3.7	4.3	3.3	9.0	2.6	4.1	7.1	2.9	5.3	7.9	4.9	0.0	5.2	6.1	5.3	3.3	5.1	11.4	3.7	5.7
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Group enriched"	"Detected in some"	16	"Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: AB_2732769"	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	5.7	6.8	1.3	2.4	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.2	5.7	6.3	2.8	0.4	3.8	0.9	3.9	1.7	3.9	1.5	8.0	4.1	1.8	0.0	0.0	0.2	2.9	0.0	0.7	0.5	0.4	1.0	0.1	14.1	1.8	0.0	0.5	2.3	2.2	2.2	0.9	5.0	2.5	0.7	0.0	0.0	1.5	3.3	4.6	0.8	1.8	1.7	2.5	3.7	16.7	0.3	0.0	0.1	2.0	0.0	0.4	5.3	1.9	2.2	3.3	2.3	1.0	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3											0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.4	1.4	0.0	1.2	0.6	0.0	58.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.7	2.6	0.0	0.6	0.0	0.6	0.3
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	8.6	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	8.1	7.7	10.2	22.4	8.3	6.7	16.6	16.3	14.0	12.8	20.9	19.4	11.6	10.4	18.7	6.7	5.5	18.2	9.9	10.6	12.4	11.4	6.6	15.2	9.4	6.7	19.4	10.1	9.2	12.1	5.5	6.7	12.9	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4	20.8	16.7	29.8	15.4	22.1	25.1	8.3	20.4	10.7	5.7	24.4	21.6	30.4	16.6	26.8	36.5	13.7	23.1	0.0	24.7	31.4	12.1	12.4	17.3	25.5	18.7	15.9	12.7	14.1	16.4	56.5	26.7	12.6	6.8	50.5	19.2	14.2	26.4	17.5	22.6	14.7	29.5	19.4	11.7	39.0	65.9	24.1	26.3	27.7	26.9	11.2
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		390000	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	9.0	0.0	1.7	15.4	0.3	0.2	80.7	0.0	0.3	11.2	0.1	26.2	0.2	1.0	0.0	0.2	0.3	0.5	0.1	2.7	1.3	0.0	1.9	0.8	0.9	0.9	0.3	1.2	1.7	0.3	11.2	0.1	9.2	6.1	2.0	0.0	0.2	0.0	5.8	0.5	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.8	0.2	5.0	6.2	0.0	1.0	0.5	0.1	0.0	0.0	27.6	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8	229.3	54.7	23.2	621.5	76.8	0.8	12.0	0.0	38.8	47.8	3.5	2.0	3.9	29.9	0.6	7.3	237.2	0.3	303.7	0.0	5.3	88.9	288.4	49.5	0.8	320.9	0.0	81.3	31.9	23.8	7.0	7.5	180.3	183.9	0.0	7.4	1.4	0.3	3.4	2.1	0.5	1.4	122.9	80.2	14.1	4.1	57.0	9.3	44.5	6.6	105.6
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: AB_2682555, HPA067421: AB_2685836"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	4.0	5.1	10.3	7.4	3.5	2.7	4.3	4.3	3.5	4.5	3.3	4.1	2.4	1.0	2.7	3.8	6.6	3.9	2.0	13.9	1.5	0.1	1.6	0.4	2.9	10.0	3.1	0.3	5.7	2.3	9.5	2.3	3.2	4.1	9.9	3.6	4.7	0.2	4.1	3.4	0.7	10.8	4.9	2.3	4.9	10.2	4.0	3.3	2.3	12.0	11.7	12.0	2.7	1.9	9.1	2.6	4.7	6.9	7.4	8.8	5.8	1.8	4.6	5.1	4.0	2.3	5.1	6.0	6.2	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9	6.0	8.3	0.5	118.6	75.0	19.0	7.5	15.3	29.4	20.5	5.2	27.5	5.3	3.3	9.0	3.8	21.1	5.1	0.0	9.2	1.0	10.0	34.2	13.9	22.7	19.8	9.5	14.3	25.8	6.1	4.2	13.8	19.0	16.9	5.4	9.9	38.9	11.1	0.0	7.4	18.1	18.7	0.0	8.8	20.2	14.9	96.1	5.6	4.5	8.0	169.4
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.3	12.3	4.4	9.5	10.3	15.9	11.6	10.0	7.6	11.8	9.7	8.3	10.8	27.3	11.5	11.3	16.0	11.9	13.9	14.2	18.5	51.7	6.4	8.6	5.4	9.9	16.8	17.6	4.1	12.1	19.2	9.0	22.1	5.8	11.9	12.3	11.9	12.2	11.9	6.0	13.9	5.7	9.5	22.4	16.4	0.0	14.8	27.3	11.9	12.0	23.5	8.5	10.7	14.8	16.6	5.1	13.1	7.3	9.6	11.8	13.0	6.4	20.6	18.0	9.3	27.5	13.9	17.6	12.7	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2	8.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	7.0	0.0	30.5	41.4	14.2	0.0	0.0	0.0	0.0	11.5	36.7	0.0	0.0	2.3	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	12.6	0.0	0.0	10.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.3	3.9	6.8	6.3	5.6	7.2	5.8	5.0	3.5	3.3	2.7	2.8	2.9	9.5	8.7	3.7	4.5	4.4	5.6	3.2	5.1	6.5	4.0	5.8	7.0	3.7	3.3	10.0	5.8	3.7	4.0	4.2	4.1	4.9	3.5	5.9	5.9	6.4	5.0	3.3	8.4	6.3	5.3	3.6	4.4	6.3	9.0	4.1	4.3	5.7	6.4	4.7	8.1	7.5	4.0	5.3	3.9	7.7	6.1	5.0	6.4	5.7	7.1	6.2	7.1	5.0	3.5	6.3	3.4	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7	59.6	66.2	8.2	15.1	8.1	55.5	21.2	5.1	75.0	68.2	7.0	104.1	17.6	10.0	16.4	39.3	17.1	7.7	23.3	11.9	12.3	13.6	12.8	59.1	7.4	8.5	33.4	12.1	8.0	10.8	4.7	17.5	8.8	1.7	15.4	11.9	39.3	12.8	10.7	20.1	13.0	87.8	25.8	12.0	18.9	18.8	8.5	19.8	24.2	11.1	9.8
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84497790	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	20.9	20.4	21.3	25.1	36.2	42.7	26.3	14.8	24.7	21.3	24.8	12.8	18.8	18.8	25.5	27.4	26.0	20.8	18.2	39.8	17.9	16.5	33.1	33.8	21.3	27.2	16.7	15.1	23.9	21.3	16.8	25.7	19.8	16.0	23.7	24.0	14.1	20.8	26.2	56.8	22.1	22.7	20.8	16.6	33.9	22.8	31.0	20.3	31.8	29.3	27.9	30.2	30.0	23.1	36.9	23.1	29.2	26.0	31.8	33.9	26.1	18.9	13.4	17.0	14.1	13.3	17.7	19.2	19.6	17.3	25.6	22.8	10.1	8.2	14.6	22.1	15.4	42.0	14.4	25.4	20.1	28.3	21.0	26.7	36.8	15.1	17.4	18.4	35.3	12.1	14.0	30.0	26.7	19.0	14.6	20.4	27.7	35.5	18.8	22.3	9.9	33.2	23.8	42.3	19.5	29.9	21.4	27.2	11.8	24.3	22.3	21.4	19.9	11.4	24.4	46.7	16.3	13.8	24.2	14.0	19.3	19.2	30.4	40.4	13.0	15.3	32.3	9.0	31.9	17.2	29.2	21.3	19.6	26.6	24.6	29.3	36.9	30.4	26.9	22.5	31.0	33.8	33.9	8.9	31.8	26.0	23.1	31.3	26.1	21.3	36.2	14.8	24.7	17.9	16.5	16.7	15.1	16.0	20.3	35.7	39.9	29.5	37.1	30.8	16.6	33.9	28.1	56.2	31.8	15.7	15.7	30.8	63.0	50.8	38.7	32.2	14.2	0.0	55.7	26.7	25.8	24.7	62.5	32.6	39.0	7.9	32.1	25.2	28.4	6.4	30.2	41.3	27.0	25.2	25.0	24.4	43.8	28.1	32.9	47.6	20.8	45.3	26.9	66.1	60.2	28.5	23.0	49.8	33.6	38.2
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 83.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	8.0	3.9	4.4	17.4	7.7	12.1	11.6	11.6	6.9	10.3	10.3	15.7	5.9	19.0	11.1	5.8	15.3	9.2	14.6	11.0	23.4	8.0	13.4	12.4	4.9	9.1	9.3	18.8	6.0	7.3	8.8	14.3	29.3	6.9	8.2	8.8	33.0	10.5	12.9	7.8	13.9	19.8	12.8	13.1	7.1	13.3	8.4	13.5	9.9	8.1	7.5	9.7	5.1	6.8	19.1	6.6	6.2	16.1	5.3	8.5	7.5	83.2	31.0	4.5	7.0	23.7	11.3	23.8	17.1	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7	17.9	26.9	21.2	94.7	69.6	12.6	61.4	45.9	61.6	63.7	17.4	0.0	40.8	58.0	40.9	72.5	33.0	12.0	0.0	41.1	44.2	40.8	42.1	44.0	66.6	48.0	17.5	10.9	22.7	27.3	20.4	31.9	26.8	35.4	18.0	26.8	18.6	37.2	21.0	25.5	70.4	8.2	12.9	35.4	37.2	27.3	58.0	28.9	17.9	32.7	65.4
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	66.6	68.9	78.3	73.6	117.4	214.2	88.8	69.1	142.3	97.5	77.8	99.6	64.6	200.2	63.8	93.6	47.9	59.2	105.5	157.7	81.0	69.4	92.9	76.8	63.8	139.1	174.0	112.0	64.1	249.0	185.0	71.4	239.9	158.1	142.7	100.7	90.5	99.0	110.5	117.8	118.1	136.2	82.2	105.4	60.8	93.6	75.5	154.9	123.2	110.4	55.3	81.0	42.5	97.8	195.2	66.0	105.8	204.3	82.3	31.9	57.7	42.3	86.9	62.6	101.9	132.2	40.0	130.7	57.0	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1	497.3	826.2	3505.8	4941.4	4796.5	207.9	239.4	1668.8	799.0	1510.5	567.0	68.7	3327.1	2528.3	1289.0	177.8	1494.7	980.5	513.9	2845.5	4591.2	2345.1	3300.9	883.5	1243.6	1940.9	103.3	1454.5	1261.4	1687.0	354.9	2330.6	2284.0	2282.6	2326.4	2431.8	212.5	2052.4	1855.2	1390.9	2230.9	177.0	756.7	2794.2	210.8	382.0	5789.4	3433.4	2382.6	3597.4	4457.4
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.6"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 286.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	11.2	23.0	17.9	14.7	17.9	18.0	15.2	10.5	21.1	13.1	12.8	8.2	14.4	13.5	14.5	21.6	18.1	14.7	11.9	19.5	20.7	16.8	20.0	25.9	10.5	16.7	16.2	18.0	14.1	25.5	9.1	15.4	14.2	16.3	12.1	14.6	11.5	18.4	16.7	19.0	9.7	10.8	14.0	12.8	13.3	12.2	73.6	11.8	20.0	16.2	18.2	14.9	13.1	11.9	19.7	40.0	17.5	36.2	14.6	21.7	20.9	29.6	26.9	24.4	33.5	16.9	17.9	31.6	28.4	16.7	41.1	36.7	32.8	32.0	22.3	73.0	38.9	43.8	19.3	40.2	56.3	38.0	28.5	52.3	16.5	31.5	40.1	33.2	24.0	14.7	22.3	23.8	42.3	29.7	16.7	23.5	22.0	22.6	18.8	29.2	65.8	29.3	38.0	15.5	13.8	42.8	21.4	37.8	29.6	23.9	18.7	24.6	15.1	26.0	23.9	37.7	16.3	29.3	25.9	24.7	47.0	26.1	27.4	21.2	16.9	26.3	41.8	37.0	30.2	27.8	7.8	36.2	15.5	14.3	31.4	18.3	19.7	17.4	19.6	40.0	15.1	14.5	18.4	17.5	14.6	26.8	27.5	21.7	20.9	17.9	17.9	10.5	21.1	20.7	16.8	16.2	18.0	16.3	11.8	38.7	26.2	23.1	45.5	43.4	14.3	38.4	50.9	62.9	35.2	55.8	17.7	94.5	154.2	102.8	286.5	45.0	32.9	93.5	97.7	103.7	39.0	47.6	25.5	104.6	100.3	14.3	38.7	41.7	51.6	40.1	35.1	50.7	49.0	97.4	42.9	42.9	113.2	38.6	38.5	146.6	13.9	19.4	39.1	214.9	161.4	46.2	66.0	27.7	55.4	43.0
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.9	91.0	70.2	107.0	125.2	196.8	99.0	78.3	96.8	107.6	89.5	108.3	107.5	195.7	34.1	79.5	65.9	63.7	101.2	166.6	51.5	79.6	137.7	101.3	117.7	180.6	148.5	146.9	97.8	240.5	236.9	79.3	141.3	123.3	120.4	87.9	79.0	150.3	79.2	159.8	127.5	191.1	116.5	106.6	154.5	59.3	77.3	189.8	137.5	146.3	56.8	110.8	58.5	135.2	133.7	46.8	101.2	251.4	104.3	60.4	81.1	93.1	116.7	98.1	139.0	139.2	79.9	176.2	79.8	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2	175.7	330.0	3392.7	4367.8	3531.6	218.0	72.2	1398.7	310.5	437.9	675.2	96.2	2332.5	1848.6	1477.5	867.6	2040.8	1839.8	957.8	3975.0	4390.8	2112.5	3132.4	683.0	1270.4	2074.0	101.7	1376.0	1509.4	2270.2	3389.8	3344.0	2646.2	2103.8	1980.2	2585.2	359.2	2990.7	2489.9	1488.6	2639.2	288.1	1125.4	2454.4	526.4	450.8	4436.8	2053.3	2519.7	3632.3	5133.1
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA		120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	87.2	80.8	92.5	102.2	118.4	256.8	124.7	67.7	128.8	67.7	60.9	101.6	66.7	361.2	93.8	81.4	40.8	58.2	98.7	144.7	45.1	61.4	97.2	90.9	96.7	151.9	174.9	129.1	76.7	248.1	196.1	58.5	208.7	177.2	131.6	96.4	102.3	125.6	97.9	112.4	131.1	188.1	96.8	92.9	56.4	105.3	89.8	181.3	125.1	129.4	84.7	100.1	42.5	139.0	221.5	61.4	104.7	210.6	130.4	45.5	72.0	47.7	77.0	96.5	72.9	159.9	102.6	114.2	51.4	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3	914.2	2163.5	5410.7	7867.8	9248.8	998.0	126.1	2876.4	1092.1	2307.8	1367.8	400.5	4667.0	4993.6	2515.3	1583.9	3488.3	1382.2	934.5	5706.5	6677.9	4026.4	5687.6	1692.6	1824.7	2890.1	338.5	2624.6	2557.1	2528.9	3527.0	5167.6	3086.7	4841.9	3599.8	3269.3	905.4	3905.0	2588.2	3289.3	3749.1	924.0	1552.2	5807.1	1006.7	702.5	10743.1	4590.8	4458.7	5068.7	8140.4
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	59.2	43.3	78.7	111.9	170.9	270.5	77.5	91.6	116.4	75.6	63.3	109.7	105.5	180.4	55.2	89.0	37.8	42.3	84.6	142.9	99.3	66.5	135.5	75.3	91.0	167.9	143.9	188.8	84.4	240.5	204.2	61.7	140.4	146.0	135.9	100.8	131.9	103.6	124.5	115.1	115.6	230.6	90.3	132.9	87.7	106.2	84.6	109.2	157.8	100.0	84.5	108.2	37.4	218.5	128.3	65.5	72.6	172.7	100.3	51.9	70.4	54.2	80.9	77.4	100.9	145.4	70.7	118.0	63.4	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2	1313.2	2435.5	8127.2	9688.6	11162.7	321.1	1043.1	4914.6	1694.4	3137.0	2053.6	70.7	5336.7	5859.0	3087.8	1166.8	4211.1	1851.3	2850.1	7573.3	5633.2	3960.7	4740.0	3107.4	4896.8	3604.2	146.2	2618.2	5127.8	6804.9	1575.7	6923.4	6371.5	5538.7	4548.4	5463.9	625.8	5524.0	4699.4	3790.7	6994.4	382.0	1882.0	3701.7	706.0	481.2	13381.8	5336.0	5116.7	7038.7	7765.2
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"		Yes	No		830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	45.1	91.1	38.6	64.9	173.7	316.0	68.1	55.1	113.9	85.4	66.3	100.7	79.3	178.9	62.9	131.3	40.4	82.2	275.6	213.2	94.6	49.4	165.2	109.6	81.7	83.7	244.9	114.8	54.9	310.0	278.0	92.8	371.0	105.2	136.6	84.9	100.3	70.4	127.7	74.5	76.4	51.1	84.4	100.9	65.3	85.8	88.0	173.6	117.4	89.7	68.6	71.7	34.0	96.8	136.2	84.5	71.5	166.0	80.0	44.7	67.5	41.5	87.6	69.2	107.3	119.6	55.0	154.6	50.2	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0	419.9	882.0	1803.2	2287.0	2152.7	118.6	357.6	588.5	738.8	1063.5	324.5	76.6	1844.2	1399.3	929.4	510.9	791.2	291.1	327.1	1855.6	3103.9	1180.5	1227.4	901.9	616.8	1082.4	38.1	731.3	578.2	1045.6	1022.7	1235.2	1320.8	1032.5	1779.1	995.5	130.7	1271.8	480.5	936.2	1212.4	111.6	452.7	1291.3	308.9	412.0	2258.1	2005.7	1400.6	1218.5	2270.0
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nucleoli rim"	"HPA043717: AB_10964719, HPA054444: AB_2732584"	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	118.8	51.1	91.0	76.7	118.4	239.2	146.0	71.1	95.2	88.5	63.5	135.2	52.0	224.2	114.2	79.8	84.0	76.0	104.3	133.2	113.2	71.0	142.8	116.3	85.0	124.4	142.0	178.1	49.1	195.6	210.2	78.6	173.1	160.6	122.3	118.5	144.0	118.2	101.4	67.4	141.8	201.9	140.6	90.4	96.5	130.3	176.3	144.8	107.4	99.0	77.6	92.9	46.3	129.2	206.7	78.2	71.2	245.0	74.2	44.7	81.8	84.6	128.1	73.2	69.5	151.7	30.3	153.6	30.3	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7	607.4	848.7	2690.4	3540.6	2525.4	316.8	352.2	1200.0	674.6	1189.7	390.8	84.4	2237.8	1689.4	1278.7	1159.8	1643.6	564.1	537.3	2338.5	3530.6	1572.9	2535.7	1002.7	856.3	1297.7	138.2	1189.1	1198.2	1468.3	888.7	2620.2	1565.9	1334.5	1646.5	1585.6	343.0	1936.2	1164.3	2027.0	1766.3	226.7	1034.8	1885.9	531.9	457.4	2528.9	2185.2	1965.9	2487.8	3230.9
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.9	142.8	10.2	44.4	11.5	26.1	98.2	87.7	16.5	26.9	19.1	124.7	65.5	162.8	126.9	10.3	8.9	73.3	13.4	30.5	4.9	70.7	162.5	96.5	110.0	87.9	28.7	63.2	52.7	28.1	34.8	12.1	20.7	12.7	19.7	35.6	130.0	37.8	11.4	323.4	90.3	85.7	95.4	33.2	162.0	88.5	59.1	153.0	14.3	91.8	62.5	104.4	84.2	45.9	120.4	4.3	106.3	61.3	78.7	35.7	135.8	74.4	105.3	69.1	58.9	140.8	71.0	105.2	48.8	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0	792.1	1172.5	3639.8	5704.0	5720.2	400.0	926.5	1594.9	667.9	1239.8	975.3	253.3	3837.7	3756.8	1939.3	708.6	1998.1	1895.6	1261.4	5072.3	5914.7	2684.9	4292.9	1005.1	1181.4	2697.5	157.3	1633.5	1478.1	2282.6	2004.1	2891.5	2666.3	3338.7	2696.1	3081.8	500.6	3359.4	2949.4	1346.4	3180.5	483.0	1060.7	3222.8	573.1	569.6	7189.2	3651.1	2078.6	4568.6	6042.4
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.9	2.8	6.6	9.0	4.8	57.9	87.4	72.3	54.8	8.1	65.7	143.5	6.6	58.2	57.3	65.4	5.5	6.3	79.1	52.3	115.6	4.5	24.2	7.8	8.6	9.3	38.0	11.9	181.8	4.4	83.1	107.6	5.5	5.8	109.7	67.0	5.0	4.3	77.9	9.9	109.8	79.6	3.9	71.9	123.2	4.9	89.9	3.8	4.6	49.0	2.0	47.5	7.4	118.9	104.9	6.8	4.1	3.1	4.6	84.1	8.0	103.0	144.6	124.7	83.4	87.3	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9	616.4	695.5	3946.9	4635.1	3670.9	362.7	367.2	1765.6	426.9	687.0	673.4	151.2	2652.9	2316.1	1697.3	1288.9	2348.7	1394.0	817.7	3813.6	4743.2	2040.6	3407.8	885.2	1749.4	2435.4	187.5	1780.1	1927.4	2668.8	1161.7	4462.6	2606.9	1756.2	2952.2	2900.0	510.1	3233.5	2563.6	2250.5	2828.8	405.3	1487.5	2143.4	695.4	462.3	4086.9	2843.5	2427.5	4009.2	4396.5
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 439.8;Late spermatids: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	13.1	12.2	12.4	10.7	13.6	9.7	18.3	22.4	12.4	13.6	16.7	12.0	15.8	14.4	15.7	16.1	15.2	18.2	10.3	10.0	11.6	10.2	17.4	21.6	12.5	16.3	15.0	10.0	14.4	16.8	11.3	16.0	17.4	12.7	18.4	15.7	11.7	17.1	14.9	20.9	14.8	17.9	14.3	11.5	16.7	13.5	38.6	12.7	18.8	19.8	13.9	18.5	13.4	13.6	31.0	25.7	23.4	24.5	18.6	31.4	20.2	21.0	15.9	8.8	11.2	11.9	12.2	15.4	10.2	7.7	16.0	16.5	16.0	22.2	17.7	11.0	9.6	13.3	19.7	17.5	17.7	14.8	13.4	15.9	18.2	9.7	14.1	25.5	10.2	15.3	14.5	24.5	13.1	11.6	12.5	12.8	18.0	20.9	12.6	12.2	17.3	18.3	11.2	10.1	26.3	7.8	15.0	8.8	21.9	20.5	8.3	8.3	10.5	14.1	24.5	28.2	14.9	21.9	16.5	11.0	7.5	12.9	15.7	13.4	17.6	18.7	24.0	14.6	12.5	7.0	8.5	24.5	23.4	25.6	23.7	25.1	28.8	26.2	31.4	25.3	31.0	30.6	27.8	8.3	18.6	18.6	25.7	22.0	20.2	12.4	13.6	22.4	12.4	11.6	10.2	15.0	10.0	12.7	12.7	14.9	15.8	18.2	26.3	27.9	13.0	6.5	7.6	107.1	38.7	8.7	5.9	26.5	23.2	28.9	439.8	16.8	18.2	0.0	29.4	37.0	16.2	26.9	12.7	24.6	21.7	7.9	12.7	14.7	16.5	144.4	21.9	21.4	8.5	14.4	19.9	14.9	25.8	21.0	18.7	25.9	29.8	12.9	11.3	28.6	38.0	31.6	26.9	20.8	20.5	39.4
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	32.8	38.8	38.9	29.5	30.6	36.9	47.5	24.2	34.7	26.4	28.0	19.2	40.6	31.4	18.8	25.2	24.1	18.0	25.0	30.5	38.9	28.4	30.8	40.7	22.5	29.4	40.3	27.0	23.4	45.0	15.4	18.8	21.9	31.9	31.6	14.4	19.2	65.2	35.4	55.0	19.8	30.9	28.5	31.1	27.1	32.6	28.8	24.6	16.3	40.8	28.0	23.7	24.3	54.5	64.2	73.5	67.3	57.7	42.8	60.3	50.5	20.9	25.9	12.5	17.6	14.1	9.2	26.3	24.1	19.6	21.1	16.8	28.7	13.9	26.2	25.2	14.2	17.2	17.0	19.6	24.7	7.3	37.7	62.7	25.2	22.0	25.3	20.6	36.8	32.9	13.8	18.7	18.1	22.2	11.4	14.3	19.9	28.1	19.0	13.3	23.2	17.6	36.7	21.7	46.7	49.7	28.1	16.3	39.4	22.1	20.8	27.9	15.6	19.5	31.1	43.3	8.0	22.4	29.8	16.9	17.6	40.2	19.6	31.4	33.1	30.4	40.7	23.9	25.6	41.1	42.1	57.7	67.3	53.4	52.1	49.2	62.0	54.4	55.2	46.3	64.2	53.2	54.1	63.4	42.8	42.0	73.5	60.3	50.5	38.9	30.6	24.2	34.7	38.9	28.4	40.3	27.0	31.9	24.6	41.7	44.3	107.2	91.0	121.8	95.6	68.3	109.5	34.8	36.4	92.5	49.1	134.1	184.1	166.7	17.8	129.5	196.8	46.7	167.0	202.1	94.9	166.3	69.2	175.1	185.7	33.4	136.9	111.1	105.7	22.2	126.8	125.3	102.9	172.3	137.0	80.8	187.2	164.9	118.5	232.2	81.9	77.6	104.0	59.0	146.0	129.4	110.1	136.4	130.8	112.7
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	53.4	65.8	75.0	27.8	103.9	154.2	75.2	54.5	81.0	90.9	53.2	101.0	24.2	119.3	34.5	57.5	30.0	25.2	84.2	46.9	62.3	47.2	135.1	63.0	43.9	60.2	96.0	40.9	34.6	93.3	150.3	47.9	54.6	35.9	69.0	85.6	42.9	39.8	73.5	82.9	30.6	74.3	73.6	65.4	149.1	41.7	22.5	73.4	75.9	54.2	28.2	48.8	21.3	47.2	30.9	23.3	41.7	45.8	22.3	22.6	46.3	28.8	43.7	34.3	65.6	64.4	25.1	81.7	28.9	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5	208.4	201.5	1424.8	560.8	1563.9	119.2	23.8	1184.7	333.3	536.9	408.2	58.9	1212.8	824.0	801.2	63.2	800.7	1808.5	1004.5	2275.1	2554.3	1158.0	914.2	500.2	1753.2	1234.1	71.5	826.4	935.4	838.0	37.7	273.5	701.1	1386.7	874.7	1010.7	278.9	1348.0	1392.2	208.2	969.4	134.7	304.0	900.2	204.7	313.7	1585.9	1428.5	824.9	1127.8	1109.2
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373"	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	54.1	45.0	46.8	66.0	85.5	111.5	120.1	33.3	77.9	74.5	60.0	21.4	43.0	37.3	66.0	57.8	68.3	61.4	51.2	47.1	57.0	32.7	71.1	172.7	43.9	84.3	42.4	68.3	167.1	88.9	20.7	53.7	57.1	52.1	57.7	52.5	25.3	70.5	46.9	101.9	69.1	52.5	46.3	40.4	77.1	58.9	48.6	36.4	62.8	64.0	144.0	82.1	52.1	71.1	194.8	130.9	42.2	62.9	122.8	253.3	267.6	106.0	61.7	67.7	112.4	94.5	180.5	129.4	83.7	96.3	91.9	58.2	115.1	120.4	148.5	141.5	79.8	54.7	100.8	97.7	114.4	107.5	125.9	113.1	136.8	66.4	153.9	137.5	204.0	93.8	162.3	227.7	61.6	168.3	153.5	124.6	92.0	122.0	136.4	105.0	83.0	119.2	245.7	162.6	130.4	79.0	113.8	172.4	175.6	103.9	101.6	89.5	71.0	57.4	250.0	186.5	110.1	111.1	174.3	118.6	84.3	128.3	75.2	141.6	122.8	85.1	96.5	120.6	173.6	83.9	42.2	62.9	24.1	129.3	59.1	183.5	194.8	197.3	154.8	91.1	179.3	253.3	206.8	14.4	122.8	52.5	130.9	120.7	267.6	46.8	85.5	33.3	77.9	57.0	32.7	42.4	68.3	52.1	36.4	1182.1	2168.7	6366.0	7790.9	7391.5	428.3	362.3	2830.5	1535.1	2713.9	1326.0	202.2	4414.5	3436.8	2947.8	844.4	3491.0	1693.7	1752.0	6390.1	5764.5	3524.5	5396.1	2833.4	2701.0	3058.4	206.6	1979.6	3107.2	4338.7	1140.7	4705.1	4812.5	3451.8	4888.3	3292.1	886.8	4792.0	3026.5	2708.4	4047.2	553.4	1616.9	4201.8	922.6	805.1	7807.0	4507.9	4717.9	5337.4	6552.6
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Proximal tubular cells: 1955.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: AB_2685737"	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	46.8	64.2	21.3	19.8	29.7	18.2	53.6	16.3	23.4	29.4	58.5	15.5	30.4	46.0	30.2	49.3	40.4	27.0	38.3	47.1	22.8	22.2	61.0	75.2	31.7	23.4	32.6	19.2	26.5	65.9	19.2	38.8	35.6	43.9	56.2	55.3	18.3	99.8	46.0	47.1	18.1	80.4	54.8	39.9	28.2	41.9	15.7	27.3	19.4	53.9	25.7	19.8	55.0	36.3	34.5	30.9	51.5	47.6	27.2	75.4	38.3	16.5	46.4	42.1	11.3	61.6	73.0	42.2	52.4	37.4	11.5	28.2	8.5	23.1	15.6	18.8	50.1	20.6	6.4	14.2	25.8	19.5	11.5	19.2	12.8	39.2	60.7	70.9	10.2	35.7	57.1	34.7	26.1	19.8	87.6	65.3	9.8	11.8	15.7	96.0	23.0	13.1	15.9	12.4	21.2	13.6	10.2	20.2	17.6	32.4	33.6	6.1	9.3	19.0	8.0	37.1	88.4	17.8	23.7	69.0	61.2	57.6	13.2	23.2	17.7	15.0	13.8	64.9	28.2	55.1	51.5	34.3	40.0	27.5	35.9	33.9	34.5	41.6	32.0	30.9	26.9	32.9	33.1	11.4	27.2	47.6	30.8	75.4	38.3	21.3	29.7	16.3	23.4	22.8	22.2	32.6	19.2	43.9	27.3	89.3	200.0	257.3	226.5	226.9	32.3	318.9	598.7	234.2	153.6	389.0	45.2	244.0	766.0	754.9	35.9	230.2	819.3	233.6	678.9	1142.2	251.0	333.1	292.5	900.4	483.1	12.7	274.1	300.8	377.4	21.8	291.4	318.2	442.1	1587.0	624.8	110.3	1030.5	691.6	279.7	1955.0	68.4	258.7	357.4	142.8	82.2	216.4	196.7	234.3	638.5	176.3
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.9	22.7	8.6	4.4	8.4	14.8	2.6	11.2	17.1	8.4	11.6	25.7	16.7	8.5	3.9	11.8	12.3	9.2	9.8	9.5	15.7	7.1	7.8	10.0	14.3	69.0	8.6	19.5	10.4	9.4	7.6	13.2	16.7	7.4	30.4	9.0	6.6	24.4	8.8	6.1	12.6	6.0	6.2	16.9	13.7	6.7	18.2	9.8	7.3	10.9	4.0	3.9	15.1	4.6	16.4	11.2	0.0	5.8	16.9	9.2	6.4	29.1	6.3	19.5	11.9	9.5	17.4	9.7	21.7	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7	41.7	68.2	18.2	31.8	48.3	33.6	19.4	38.2	21.4	51.2	15.7	21.6	3.3	3.3	23.3	0.1	48.1	43.4	0.0	26.0	5.7	28.8	47.0	42.8	61.1	20.6	12.7	24.0	29.4	46.1	1.1	12.0	60.4	35.4	20.8	53.4	26.6	30.0	46.0	19.8	23.7	8.7	19.4	35.0	3.3	7.7	48.6	3.0	56.7	46.1	54.2
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595075-6603620	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA038487: AB_10672518, HPA057562: AB_2683468"	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	13.8	11.9	13.9	15.8	14.8	32.1	17.9	18.1	15.3	15.9	24.9	16.1	10.5	14.0	15.5	21.3	13.8	11.9	15.4	16.2	16.0	10.3	13.3	24.7	14.3	16.0	18.4	13.6	12.4	12.7	12.0	12.3	12.8	14.2	19.8	14.4	11.8	10.9	19.7	18.6	15.5	12.8	19.5	11.0	17.7	15.1	12.3	18.6	11.8	14.2	9.7	16.6	20.2	13.9	13.3	14.4	20.3	12.0	14.4	13.8	10.2	10.1	10.2	4.1	5.2	8.5	7.4	5.8	5.2	6.6	12.2	11.5	10.4	12.0	14.3	5.2	5.0	9.0	10.3	11.6	9.3	13.0	6.8	16.6	6.7	12.2	11.8	9.8	12.2	9.4	6.3	12.1	5.8	10.6	8.1	12.5	6.7	13.3	8.4	9.6	12.6	11.8	18.2	10.0	17.9	9.2	10.6	3.3	3.2	11.4	8.2	6.3	7.4	7.5	15.4	8.6	7.0	8.4	10.7	6.4	11.6	5.3	11.2	10.1	9.4	8.4	13.6	9.8	12.3	7.4	20.3	11.0	10.7	13.7	11.8	13.2	10.9	13.5	12.6	14.4	13.3	13.3	13.8	4.4	14.4	12.0	11.0	12.6	10.2	13.9	14.8	18.1	15.3	16.0	10.3	18.4	13.6	14.2	18.6	20.8	12.9	13.7	14.7	20.6	17.1	18.3	7.6	10.7	15.9	8.7	13.7	19.6	10.0	15.6	5.3	16.6	10.9	23.3	13.9	17.0	14.6	9.7	17.3	19.1	16.3	3.2	6.9	9.8	8.4	10.4	12.0	12.0	8.5	19.8	12.8	13.3	18.6	13.3	9.2	16.5	27.4	0.0	20.9	21.2	17.2	23.7	16.7	14.9	15.9	12.2
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator homolog"	Q15050	8	66429028-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Supported	Nucleoli		Yes	No			Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	12.0	11.2	8.7	14.1	12.4	7.0	9.9	8.5	9.8	8.5	9.6	7.1	7.2	10.3	13.4	6.6	12.2	11.2	9.8	9.6	8.5	7.5	9.5	18.0	6.7	14.6	11.5	7.9	19.0	41.4	8.3	5.8	7.6	11.1	9.0	7.1	6.4	9.8	9.7	31.7	10.2	7.7	14.0	7.8	9.5	12.0	4.9	9.9	8.6	7.5	19.2	11.5	13.7	13.1	6.8	15.2	0.6	11.8	11.2	17.8	6.8	22.8	28.9	5.9	12.5	6.4	5.2	9.6	14.4	6.4	11.2	8.3	12.9	15.2	31.1	5.0	7.6	15.8	21.5	14.5	16.4	12.4	17.0	24.5	24.7	8.7	22.8	9.5	14.6	13.1	6.8	13.3	12.3	16.5	4.6	7.2	9.5	21.5	13.2	8.1	26.5	29.1	26.7	38.6	25.8	34.0	6.2	7.6	12.9	15.6	18.9	8.1	18.0	7.0	11.7	16.0	6.4	20.2	13.1	12.4	20.9	18.7	17.5	33.2	23.8	21.2	24.0	9.7	23.2	14.1	0.0	8.9	0.6	10.0	11.8	17.8	6.8	12.7	11.7	15.2	6.7	11.9	13.6	0.3	11.2	7.2	7.1	9.1	6.8	8.7	12.4	8.5	9.8	8.5	7.5	11.5	7.9	11.1	9.9	29.8	15.2	9.7	26.7	62.2	9.6	27.1	2.5	12.0	25.0	12.2	11.8	18.5	10.0	21.9	0.1	14.2	1.9	0.0	24.3	16.0	12.9	12.3	7.0	13.9	18.3	6.4	6.4	11.6	9.1	0.8	17.5	10.2	21.9	2.8	12.4	7.2	19.3	7.0	16.3	20.6	11.3	19.4	31.4	5.7	14.0	52.2	32.3	20.0	17.7	24.5
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.0	8.7	3.4	10.2	0.1	0.2	18.5	2.6	1.8	2.8	1.3	16.4	7.4	16.8	8.6	1.3	2.6	22.8	10.8	3.0	0.6	11.5	12.4	7.3	9.6	18.3	0.0	8.3	12.7	0.0	0.5	1.0	1.8	0.7	4.6	8.6	10.1	7.6	0.8	37.7	2.4	22.4	6.4	37.2	19.8	25.6	13.1	18.6	3.5	4.6	17.9	10.6	10.2	28.6	3.9	0.8	23.1	15.8	2.9	2.6	8.8	7.7	13.0	2.6	7.6	8.1	6.0	9.9	8.1	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7	0.0	0.0	0.0	0.6	3.8	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.3	0.0	0.0	0.4	0.0	0.0	2.7	0.6	2.1	0.0	0.0	2.5	0.0	0.0	0.6	3.0	0.0	0.0	1.8	0.0	0.0	6.4	0.6	0.3	4.9	0.0	0.0	0.5	0.0	0.3	0.0	1.2	2.4	0.5	1.0	4.5	0.5
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.6	5.9	14.6	19.5	17.4	15.7	15.3	20.8	18.1	17.4	15.2	18.2	21.0	23.0	15.7	19.0	16.7	15.1	22.2	20.1	21.9	20.2	11.7	19.6	13.1	15.0	16.4	33.3	22.4	13.7	22.8	18.4	20.3	10.8	15.2	15.7	35.1	19.0	17.8	16.2	33.7	11.8	23.7	23.7	9.0	20.5	27.5	19.3	16.6	16.4	22.1	18.4	14.2	29.0	23.5	16.6	13.3	19.6	14.3	18.8	19.0	22.4	17.3	17.5	18.2	31.4	21.1	15.1	23.2	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9	17.9	26.7	35.6	21.5	24.5	19.7	10.6	15.3	33.5	50.0	21.0	5.9	26.9	29.9	34.3	86.0	21.1	13.9	0.0	21.5	26.1	23.2	22.2	48.5	20.5	32.6	12.7	21.9	16.0	23.5	81.4	23.6	29.5	23.6	39.7	22.8	22.4	28.9	22.9	31.1	37.2	19.7	19.4	24.5	58.5	94.3	29.0	20.9	32.0	26.0	19.7
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.3	8.0	0.4	38.5	15.4	2.0	1.6	0.8	0.8	1.6	4.3	1.3	0.0	7.4	2.6	0.0	0.0	0.0	0.1	0.6	0.0	3.7	28.5	14.4	6.9	8.1	0.0	0.0	19.8	0.2	1.3	0.0	0.1	4.8	0.0	2.8	0.0	2.0	3.2	0.0	0.0	6.4	23.2	8.1	0.0	0.4	0.1	1.8	0.0	0.1	0.1	0.0	68.7	0.0	6.8	11.8	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0	273.9	401.2	14.3	27.8	9.6	0.2	107.6	81.5	93.7	100.1	5.2	0.0	2.2	97.8	10.9	0.6	13.2	467.1	280.4	7.9	1.9	45.2	28.8	26.5	434.3	11.9	0.0	149.0	21.5	23.4	2.0	61.5	8.5	32.1	0.0	88.1	35.2	8.1	327.6	76.0	115.0	1.0	51.8	66.0	0.0	0.2	8.7	3.3	6.9	282.5	68.5
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.5	32.2	19.1	29.6	21.7	15.9	20.0	19.5	20.0	34.0	32.0	19.2	11.6	31.8	19.4	25.6	23.5	25.6	41.1	30.5	28.6	22.4	37.5	16.5	27.3	19.7	29.3	15.1	21.0	20.3	31.2	38.8	38.1	19.6	27.3	36.3	21.1	9.0	26.2	17.8	36.8	11.5	23.7	24.8	19.6	33.7	17.9	18.3	22.7	15.6	19.1	24.7	19.5	18.9	20.7	25.5	15.9	9.9	14.3	19.6	17.0	18.6	41.8	13.2	13.7	20.2	19.7	16.1	28.9	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4	3.0	4.8	2.7	5.7	7.6	5.8	5.9	7.6	1.4	4.5	1.8	21.6	2.6	0.0	1.9	1.1	4.5	2.3	0.0	2.1	1.9	3.9	4.1	1.1	2.6	1.3	6.4	6.3	9.8	6.9	0.4	3.7	4.1	3.3	1.8	2.5	5.0	1.9	0.0	2.1	0.7	8.0	0.0	3.6	2.8	3.5	10.2	3.4	4.9	3.4	5.6
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006575			Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	"Centrosome, Cytosol"	"HPA006575: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.3	6.1	9.8	8.8	8.3	9.9	7.8	8.5	9.1	9.3	15.0	10.6	5.3	12.5	23.8	9.3	15.9	9.2	10.1	4.5	15.1	6.7	6.6	16.9	9.1	7.4	9.6	14.0	8.0	8.5	12.3	9.5	10.1	6.7	9.0	11.2	11.2	19.4	10.8	11.5	13.1	8.2	7.6	7.3	12.0	8.5	7.9	8.5	4.5	7.6	6.1	8.1	9.5	10.8	10.5	10.3	18.1	10.7	10.1	9.1	9.3	12.4	17.4	20.8	36.3	27.0	12.2	11.3	10.3	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4	20.8	13.0	17.1	20.7	54.0	26.0	12.5	10.2	9.4	14.8	8.7	15.7	15.8	10.0	14.8	27.7	20.4	12.4	0.0	12.2	12.8	21.0	19.3	25.5	16.6	12.0	27.0	20.7	13.5	16.1	36.8	15.0	18.8	13.5	14.4	13.2	15.4	20.6	17.5	15.6	14.7	27.7	25.8	24.0	36.7	40.5	54.3	19.1	26.7	10.1	28.1
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523788-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	23.8	21.1	11.8	22.1	23.2	24.7	22.4	24.9	26.9	23.4	20.6	20.9	15.6	17.1	27.5	13.9	31.8	22.1	15.6	20.1	14.0	12.8	17.0	19.0	18.4	28.5	16.9	15.0	33.3	22.5	34.0	26.8	19.9	16.5	18.4	16.4	20.2	22.6	17.3	30.9	28.9	18.8	20.1	15.4	21.0	17.9	15.5	15.9	47.7	25.1	17.2	31.9	23.7	25.0	23.2	21.4	16.4	18.8	21.0	25.9	19.7	18.7	19.7	25.6	17.9	12.7	11.8	19.3	17.8	15.3	23.3	18.9	20.1	15.1	25.2	14.4	13.9	13.9	22.1	27.0	15.2	37.7	8.1	18.9	19.6	16.2	21.3	8.6	27.6	23.2	11.2	11.1	26.0	19.2	14.9	13.9	14.8	26.7	9.0	18.5	23.2	24.2	13.6	23.5	11.9	11.3	42.8	19.9	28.3	7.5	25.9	22.3	16.5	58.0	9.2	9.0	11.2	19.9	13.7	14.2	17.3	19.0	13.3	18.7	10.2	22.3	67.6	11.5	17.7	16.1	11.5	15.8	16.4	23.1	18.8	25.4	18.6	21.8	24.2	21.4	23.2	25.9	22.0	5.4	21.0	17.9	12.0	24.0	19.7	11.8	23.2	24.9	26.9	14.0	12.8	16.9	15.0	16.5	15.9	23.8	22.6	29.8	20.4	19.9	34.7	26.8	15.3	13.4	17.0	22.7	13.7	28.1	6.6	18.9	6.0	22.6	16.5	0.0	19.7	29.6	17.4	18.3	17.3	20.2	20.4	38.1	20.3	17.8	20.0	7.9	31.4	16.3	16.9	15.4	20.5	20.0	21.1	14.0	31.1	13.9	24.9	6.5	14.4	21.8	37.3	22.8	21.3	22.0	26.4	23.0
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in some"	19	"Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.9	0.2	11.9	6.9	8.1	0.1	2.0	4.5	2.3	2.0	0.0	3.8	0.0	1.1	0.4	1.1	2.7	3.9	3.6	0.8	0.0	9.5	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.8	1.6	0.3	14.3	0.1	0.7	2.6	0.0	53.4	1.3	0.0	0.2	0.0	0.0	4.8	0.0	29.2	0.0	2.3	6.5	1.1	0.1	2.3	0.1	2.4	0.2	1.4	0.2	6.8	3.2	3.2	3.7	3.0	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0	3.0	1.0	0.0	23.3	0.1	0.0	0.8	0.0	65.6	33.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.8	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.1	0.0	0.3	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	14.9
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Spermatocytes: 268.0;Spermatogonia: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	29.4	12.1	17.5	18.4	15.5	17.7	18.2	25.9	22.2	31.5	31.9	25.0	34.4	38.9	15.5	21.4	37.2	18.1	35.1	23.5	37.0	15.9	19.0	48.8	15.1	25.1	19.2	45.1	23.8	12.2	18.9	23.9	15.9	18.3	17.9	26.1	34.9	38.5	38.5	10.6	69.4	41.1	21.8	31.1	21.6	52.3	28.6	24.6	30.3	22.4	19.9	15.3	22.0	14.3	15.3	24.7	23.7	29.8	15.1	26.5	15.2	27.9	40.3	22.4	40.7	93.0	24.8	38.7	26.0	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4	14.9	16.8	53.9	86.5	93.4	17.7	7.1	25.5	8.1	7.9	34.9	23.6	121.4	91.2	43.6	64.1	31.8	21.2	23.3	27.3	39.1	59.3	64.3	23.1	26.1	70.1	23.8	34.4	29.4	34.0	32.9	40.9	44.4	62.4	61.3	27.5	27.6	30.6	23.0	41.4	37.4	11.4	12.9	49.1	268.0	323.2	92.5	37.4	59.9	37.5	71.2
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: AB_2685803"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	38.5	39.2	29.0	26.2	25.9	19.6	31.4	19.5	28.9	28.8	34.2	29.4	28.9	21.5	26.6	26.3	33.5	28.8	25.7	31.1	26.1	27.1	26.4	20.9	28.3	23.8	30.9	24.3	36.6	28.1	25.7	24.4	34.8	28.6	27.8	29.8	31.7	29.7	28.7	33.9	28.0	26.4	34.6	35.4	34.1	26.3	29.2	26.2	60.7	46.1	23.6	31.5	35.1	35.7	12.0	21.8	28.9	24.7	24.5	25.9	19.7	22.2	32.0	19.5	18.9	31.2	38.2	22.3	24.3	29.2	25.4	29.7	12.2	21.4	34.6	17.5	30.8	35.6	24.6	21.9	27.1	34.1	37.6	11.2	29.4	48.3	19.8	36.4	40.8	30.1	28.2	35.0	21.7	50.3	29.6	28.0	28.2	13.6	29.0	31.2	14.5	28.0	19.6	9.6	1.1	7.6	20.5	28.5	23.6	57.0	38.4	18.1	21.2	29.2	20.1	23.8	19.9	15.2	27.2	31.3	37.7	21.8	10.2	17.6	28.5	27.3	30.2	26.1	27.9	27.5	28.9	22.6	25.0	16.9	24.7	21.2	12.0	23.1	20.9	21.8	9.4	25.8	19.8	22.7	24.5	20.8	15.5	25.9	19.7	29.0	25.9	19.5	28.9	26.1	27.1	30.9	24.3	28.6	26.2	41.7	29.7	22.0	39.2	48.3	44.4	40.0	40.8	30.8	45.5	73.3	200.3	37.8	33.2	31.7	53.8	44.7	32.0	46.7	38.2	33.2	34.3	51.4	20.8	22.6	38.9	33.4	49.0	57.7	52.1	97.0	38.6	38.2	49.0	44.1	42.5	37.9	37.5	24.6	50.2	32.1	82.1	32.3	35.9	26.3	39.6	54.1	58.1	38.1	35.7	55.8
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.3	14.2	16.0	14.8	3.4	5.0	15.0	17.0	8.1	15.3	12.9	12.3	14.3	35.2	8.3	8.7	13.2	31.2	23.1	11.0	20.7	22.3	9.7	21.2	22.7	7.9	0.9	12.8	21.4	3.2	2.3	20.7	8.4	5.2	10.8	22.7	17.0	29.0	13.8	8.9	33.3	6.6	13.8	14.9	11.2	22.3	45.9	13.2	6.5	6.7	15.1	11.7	20.3	9.5	5.0	7.0	19.1	8.7	8.6	18.6	19.6	25.7	21.2	10.6	35.7	20.6	12.1	18.8	22.5	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7	23.8	11.0	20.1	9.5	24.3	34.1	38.9	7.6	10.7	14.8	15.7	7.9	30.9	29.9	16.5	27.3	15.5	6.5	0.0	17.9	78.9	14.2	5.9	21.9	6.8	37.8	27.0	4.7	19.6	12.1	20.4	17.3	20.0	6.8	27.1	11.4	14.5	14.2	7.0	11.7	13.3	18.4	12.9	17.5	56.4	96.0	20.3	21.6	14.9	24.7	6.7
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.2	12.7	18.4	11.9	19.9	16.1	9.5	13.4	14.8	15.3	13.0	15.4	4.2	8.7	4.8	19.6	7.0	12.1	13.4	11.4	16.0	8.7	8.4	8.5	6.8	7.5	11.4	4.5	6.1	22.8	8.5	12.3	10.9	24.9	13.9	8.7	7.0	10.7	11.4	6.5	11.4	3.7	5.9	5.0	6.6	11.8	11.7	3.4	8.8	7.6	3.1	9.4	14.0	4.1	5.8	13.5	6.4	3.3	18.2	14.1	7.8	14.8	14.0	9.3	5.5	4.1	11.2	5.1	8.2	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5	20.8	17.3	9.3	12.4	7.0	32.9	5.6	12.7	14.7	9.1	14.0	70.7	13.6	5.0	12.0	17.3	13.2	10.7	0.0	11.1	9.3	13.6	11.7	10.4	6.6	8.9	44.5	4.1	12.9	6.3	25.4	15.5	9.2	8.5	19.8	8.0	26.2	13.2	14.4	18.7	6.3	49.0	25.8	13.3	51.6	47.3	7.5	14.5	14.9	8.8	11.2
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123457641-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	15.3	15.4	18.7	14.1	20.5	14.1	17.7	25.4	23.1	14.1	15.2	22.8	14.8	14.3	16.0	15.1	17.1	14.8	11.4	22.4	18.5	18.1	16.3	19.3	16.4	16.8	21.2	18.5	13.6	12.9	20.9	19.6	15.6	20.4	16.3	17.1	17.5	21.8	12.9	64.0	24.1	15.0	15.6	20.3	21.0	15.1	14.5	23.6	14.1	20.2	23.7	17.7	12.4	14.2	35.1	24.8	37.5	24.7	23.3	40.4	19.1	12.2	13.1	15.7	8.0	11.5	10.8	13.8	10.7	15.8	11.3	8.3	8.1	8.5	24.3	7.9	15.5	8.2	12.7	13.5	19.2	9.8	17.7	10.9	11.4	11.7	18.5	8.0	11.6	18.3	13.0	13.5	10.1	9.7	20.6	15.4	7.7	14.5	4.9	15.8	25.8	12.5	26.4	11.0	16.5	12.5	9.6	6.9	12.9	25.9	24.8	13.5	19.9	9.5	20.2	14.7	16.4	24.3	15.8	17.8	7.6	13.7	9.5	9.6	12.4	12.4	14.2	12.3	11.4	10.3	37.0	24.4	37.5	24.3	24.7	24.0	35.1	30.8	27.3	24.6	30.7	24.4	25.9	36.7	23.3	22.7	24.8	40.4	19.1	18.7	20.5	25.4	23.1	18.5	18.1	21.2	18.5	20.4	23.6	47.6	19.0	23.0	18.4	12.5	26.4	25.2	20.4	28.1	22.7	31.4	11.8	43.7	43.1	28.8	27.9	20.4	25.4	23.3	29.2	33.0	17.4	16.4	12.7	24.6	28.4	14.3	14.3	25.2	16.2	6.9	22.5	17.5	15.1	45.1	18.2	32.3	29.3	23.0	24.4	33.6	27.7	32.3	11.4	16.1	21.5	12.7	35.1	25.4	15.9	22.7
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9.0	20.8	17.6	6.8	8.5	14.3	10.6	11.0	10.8	11.0	9.1	28.0	23.0	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23.0	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16.0	21.4	21.0	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20.0	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7	0.0	0.3	0.0	0.8	1.0	0.0	7.0	2.5	0.0	1.2	5.2	5.9	3.0	0.0	0.2	0.1	0.1	0.7	70.0	0.0	13.5	4.0	0.3	5.7	0.0	11.2	0.0	2.4	2.5	2.8	1.7	0.6	1.3	0.0	0.0	1.1	0.9	0.2	0.0	0.4	0.4	0.3	0.0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4
SPG11	"FLJ21439, KIAA1840"	ENSG00000104133	"SPG11, spatacsin vesicle trafficking associated"	Q96JI7	15	44562696-44663678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	23.8	24.6	16.6	26.4	22.2	25.8	23.4	21.2	21.2	20.8	26.0	31.7	25.8	17.9	18.6	28.1	22.9	19.0	20.2	19.3	16.1	15.2	22.0	25.1	22.6	26.9	26.3	15.6	20.5	25.5	33.4	25.9	15.7	22.1	22.3	21.6	18.7	22.7	26.6	19.0	31.8	26.2	21.5	22.1	39.2	22.8	22.1	23.1	35.8	30.9	12.6	26.0	23.0	19.4	12.8	7.1	13.6	13.0	6.7	8.3	3.8	8.0	5.5	14.1	13.7	22.0	21.7	10.1	8.5	10.9	8.3	10.7	6.6	7.9	5.9	10.6	11.3	14.4	18.5	9.7	13.0	8.2	17.8	5.9	13.6	13.0	10.0	15.5	13.6	12.6	16.5	14.9	6.8	19.7	13.1	11.7	10.5	17.3	15.4	11.7	7.0	6.0	12.5	7.4	24.9	7.5	8.0	11.8	6.5	17.7	21.1	9.2	10.8	9.3	14.8	7.9	12.1	14.1	18.6	12.8	11.1	5.5	13.7	10.2	15.3	13.5	11.9	11.4	18.0	11.3	6.0	8.8	12.3	7.8	10.2	8.3	10.9	6.5	5.8	6.9	12.8	5.4	6.4	13.6	6.7	13.0	7.1	6.6	3.8	16.6	22.2	21.2	21.2	16.1	15.2	26.3	15.6	22.1	23.1	41.7	17.4	28.3	13.4	8.2	22.1	15.9	17.8	44.2	29.6	26.2	45.2	13.6	5.0	16.4	24.2	10.8	26.7	0.0	14.7	8.5	12.9	17.8	26.5	19.5	17.6	15.9	19.3	23.9	45.3	24.1	16.4	30.5	13.5	84.8	28.1	15.6	16.1	17.3	13.1	14.6	21.7	6.5	8.9	40.8	24.7	9.7	7.8	23.0	25.1	17.9
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.3	20.0	18.5	30.8	18.5	28.5	16.9	23.8	23.7	23.2	33.0	49.1	25.7	8.6	21.1	14.9	32.7	18.5	37.3	22.7	64.1	9.5	27.5	14.4	18.9	43.6	27.6	19.5	11.9	59.6	18.6	54.9	25.1	20.4	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	49.1	8.5	26.1	12.3	13.9	22.9	32.6	11.7	16.8	10.7	17.3	22.8	31.9	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6	11.9	24.3	29.0	62.3	63.0	20.3	2.8	68.8	34.8	44.3	64.6	53.0	35.6	21.6	29.9	2.5	26.3	110.9	0.0	47.8	36.3	36.7	53.4	18.4	22.9	24.7	9.5	40.9	27.0	68.7	3.4	24.7	40.1	54.0	16.2	70.9	22.1	67.8	59.4	28.7	31.9	11.4	38.8	29.0	1.8	3.6	71.8	16.7	21.8	51.8	117.9
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 165.5"	"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	22.1	18.3	36.4	34.1	22.2	39.5	22.9	38.7	28.2	35.1	32.4	26.5	35.0	11.2	27.0	26.7	35.9	15.1	30.5	31.7	47.3	46.8	28.1	37.7	44.7	50.2	31.5	65.6	51.6	27.6	27.5	37.2	26.7	19.4	26.2	43.1	43.7	165.5	30.9	19.7	61.9	104.8	24.0	26.3	37.6	27.5	47.6	71.7	34.8	20.1	19.8	16.4	60.0	28.3	27.5	24.0	31.3	61.0	27.1	38.0	41.3	32.0	29.1	64.8	111.6	19.6	35.0	71.3	23.1	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8	134.0	164.3	396.8	516.1	519.5	114.4	178.2	247.1	151.3	121.7	294.8	41.2	431.0	855.4	544.4	65.7	278.7	291.1	256.9	284.6	652.5	391.4	435.3	302.3	359.4	432.3	81.0	269.9	203.1	322.6	51.2	222.1	419.5	501.0	571.7	258.1	146.4	357.5	396.3	323.9	714.8	66.1	200.5	303.1	377.2	414.8	494.2	699.8	467.7	329.5	537.0
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.7	17.1	62.4	33.1	34.8	37.2	27.9	35.9	45.4	44.8	59.5	36.8	43.0	23.1	33.4	41.4	41.9	24.7	51.1	49.9	70.5	21.6	39.2	42.7	33.6	43.2	25.2	48.1	40.7	28.6	48.3	35.1	26.8	42.2	41.7	46.2	39.3	37.6	47.9	28.7	60.5	80.0	75.0	34.8	36.4	39.2	35.0	40.7	54.3	28.1	43.4	47.4	29.3	28.5	48.0	70.7	25.6	46.1	29.2	33.1	33.4	30.3	31.7	32.8	64.7	58.6	36.9	34.3	29.0	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1	104.2	49.5	141.2	176.9	375.0	93.7	54.1	96.8	83.0	78.5	179.7	60.9	228.3	407.8	216.2	44.0	153.6	150.3	46.7	152.2	246.7	239.6	215.1	91.1	181.0	182.5	82.6	136.7	118.4	134.8	20.6	120.3	156.9	200.8	294.0	123.6	118.9	175.8	178.5	120.2	378.6	73.5	109.9	205.0	172.2	119.7	371.1	175.4	191.9	139.7	207.2
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies"		"HPA057436: AB_2683439"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.3	12.7	12.0	13.7	6.9	8.9	12.3	14.0	12.4	17.2	20.8	9.6	8.1	31.3	10.8	8.7	14.7	12.7	17.8	8.0	28.0	11.0	17.3	21.7	10.8	6.9	8.2	34.1	22.3	6.2	9.1	17.1	13.2	10.4	10.5	15.0	20.9	43.6	14.7	5.0	40.5	19.8	6.8	10.1	7.8	24.2	30.8	25.4	10.1	14.0	15.4	12.0	22.5	7.3	13.5	8.7	21.1	28.5	7.7	13.7	12.5	16.3	21.5	23.8	29.6	38.8	10.0	21.1	12.3	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5	38.7	37.9	23.1	41.1	52.0	74.2	24.8	35.7	28.1	37.5	33.2	102.1	49.4	14.9	23.6	8.9	34.9	15.6	23.3	19.1	45.9	33.8	46.2	15.1	37.5	27.9	58.8	28.3	38.6	41.9	10.7	24.7	37.6	23.6	86.6	31.9	41.7	22.6	10.5	24.1	24.5	76.3	12.9	32.5	100.7	141.1	62.7	58.1	39.9	33.0	48.2
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.2	12.2	16.9	5.2	8.5	13.1	27.3	13.4	13.4	14.7	12.7	11.3	9.9	14.4	7.1	10.9	14.3	7.0	14.7	16.6	16.3	14.0	16.0	15.5	5.2	15.1	11.0	12.2	17.4	10.3	9.7	10.8	15.9	11.6	22.0	7.9	10.3	15.4	14.7	8.1	9.1	10.4	20.4	7.9	9.0	5.5	14.3	4.5	14.9	11.0	7.2	18.4	11.5	15.6	11.8	11.7	5.4	9.7	10.2	17.7	20.9	17.3	18.5	7.5	9.0	20.5	10.7	14.1	15.1	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2	17.9	19.5	12.3	24.6	14.3	21.2	3.7	2.5	40.2	38.7	12.2	25.5	22.4	11.6	17.0	4.7	12.8	1.6	0.0	16.3	29.6	12.8	9.4	8.1	4.9	11.3	14.3	1.7	8.6	12.9	1.5	17.5	12.3	0.0	14.4	2.9	23.3	13.4	3.5	12.4	19.9	20.2	19.4	13.4	35.8	32.4	11.5	19.8	13.1	4.0	20.2
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236221	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601"	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	35.9	23.6	17.2	32.0	21.1	43.0	34.2	17.7	16.8	19.6	22.3	11.7	18.0	15.8	20.6	21.8	23.2	20.9	25.1	18.4	16.2	17.2	22.7	37.2	35.4	28.8	20.1	12.7	19.7	15.4	17.0	33.3	41.7	18.2	26.0	21.5	15.7	21.9	15.5	49.5	21.4	22.6	32.2	21.3	42.1	18.2	13.5	19.1	29.2	29.0	25.1	29.0	37.3	38.6	22.4	20.7	54.0	27.9	13.3	28.1	14.7	12.1	7.7	10.2	11.6	29.9	39.5	14.7	17.4	27.5	12.7	19.3	9.5	15.9	17.3	12.7	20.7	8.7	8.7	6.3	13.6	19.3	39.9	6.6	9.3	7.5	24.2	24.4	15.4	10.4	31.6	21.9	19.3	15.1	22.4	32.6	9.9	9.3	22.7	24.4	9.2	9.2	15.5	5.9	13.0	7.0	5.4	15.1	11.2	28.8	19.8	8.7	10.2	11.3	13.4	18.8	15.1	5.6	18.9	34.3	16.1	9.8	8.1	10.4	15.4	14.2	26.2	21.3	12.2	12.2	28.1	21.6	26.4	12.1	25.1	18.5	22.1	19.5	17.5	20.7	22.4	12.9	13.2	54.0	13.3	27.9	12.1	28.1	14.7	17.2	21.1	17.7	16.8	16.2	17.2	20.1	12.7	18.2	19.1	53.6	61.0	77.0	96.8	53.1	31.6	23.2	20.4	58.9	56.9	43.6	11.8	35.7	51.4	53.0	11.7	37.9	37.3	23.3	35.6	75.1	64.1	65.4	57.8	52.3	41.5	20.6	45.5	25.8	73.5	7.0	48.9	97.6	69.2	219.2	26.2	31.1	45.1	43.2	24.8	37.4	33.3	25.8	47.6	43.1	31.7	53.2	112.8	82.3	27.5	129.1
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.6	13.9	9.3	18.1	20.7	11.1	14.0	13.1	17.2	15.1	12.2	17.6	14.9	9.4	17.6	10.7	10.4	7.6	18.9	22.7	13.1	21.7	17.2	10.1	12.9	25.3	10.9	9.1	14.9	6.0	9.8	23.4	11.7	11.8	12.4	13.3	20.8	15.0	18.3	11.4	8.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.2	11.8	15.8	6.2	7.9	19.8	14.6	32.6	24.2	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.6	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2	8.9	11.5	2.2	4.2	9.5	13.3	8.1	5.1	4.0	7.9	8.7	37.3	6.7	1.7	7.6	3.1	27.6	23.3	0.0	10.2	4.8	9.3	5.8	3.5	9.7	8.4	9.5	12.6	44.2	12.4	2.1	11.5	5.5	6.8	4.6	14.9	8.7	12.7	14.2	12.0	6.4	19.2	6.5	7.6	21.1	17.2	8.4	10.1	9.2	13.3	5.7
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257546	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		740000	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	21.8	24.2	13.6	18.5	18.3	15.5	19.7	14.1	12.3	14.4	20.7	17.2	27.0	17.7	17.5	19.2	25.0	13.3	15.0	11.3	13.5	11.9	24.9	29.2	20.0	25.3	22.6	9.2	15.5	23.9	18.4	19.0	21.9	16.3	14.2	21.2	13.3	21.0	27.9	12.5	16.7	23.4	17.0	24.9	29.1	18.1	12.9	17.9	37.5	23.5	17.6	17.4	20.2	19.9	9.4	17.0	9.6	17.5	12.6	12.5	13.3	13.7	12.7	17.7	9.5	14.1	11.1	19.0	17.4	14.1	17.6	22.6	12.9	25.4	19.7	16.3	11.6	8.3	13.6	31.2	11.4	32.1	19.8	10.7	14.4	11.1	12.6	12.3	33.0	14.6	13.3	10.5	11.8	8.7	12.7	15.5	16.3	11.8	13.6	16.7	17.0	14.7	17.8	20.1	21.5	16.0	15.6	32.0	11.9	17.0	18.0	11.2	8.3	13.9	9.3	12.4	12.2	13.6	14.7	10.0	18.6	17.3	13.1	15.8	12.0	12.0	16.2	8.2	18.8	17.4	9.6	15.4	7.2	10.2	17.5	12.5	9.4	10.9	10.5	16.2	7.4	10.8	12.0	5.7	12.6	12.6	17.0	12.1	13.3	13.6	18.3	14.1	12.3	13.5	11.9	22.6	9.2	16.3	17.9	35.7	23.2	35.8	51.8	96.5	10.8	6.7	48.4	37.5	36.4	33.2	11.8	67.4	8.3	51.3	2.1	45.4	23.8	0.0	59.1	119.6	52.3	42.1	41.7	33.6	66.6	9.5	16.7	39.3	52.2	3.1	23.0	71.7	52.3	61.3	31.4	24.3	42.4	52.6	26.9	27.4	31.6	58.2	50.9	43.2	74.1	85.1	48.3	58.6	44.9	56.5
TP53TG5	"C20orf10, CLG01, dJ453C12.5"	ENSG00000124251	"TP53 target 5"	Q9Y2B4	20	45372563-45407889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.4"	"Group enriched"	"Detected in some"	98	"Early spermatids: 648.4;Late spermatids: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 5.3"					"Low region specificity"	"Detected in all"			"HPA041979, HPA058510, HPA077455"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		NA	NA			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA041979: AB_2677778, HPA058510: , HPA077455: "	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-3)"	"unprognostic (3.10e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.72e-5)"	"unprognostic (2.09e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.41e-1)"	0.1	0.1	0.2	0.2	2.0	0.8	0.1	0.1	1.5	0.1	0.1	1.9	0.0	0.0	0.1	0.5	0.1	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.1	0.4	4.1	1.0	0.2	0.1	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.0	0.8	0.2	0.2	35.4	2.1	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.4	0.3	0.1	0.0	1.1	0.0	1.0	2.0	1.1	3.1	0.0	0.0	1.0	0.5	0.0	0.0	0.0	5.3	0.9	0.8	0.8	0.0	0.7	2.1	0.0	0.0	0.0	0.3	0.9	1.2	2.5	1.6	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.7	0.0	1.2	1.1	0.4	0.0	1.4	1.0	0.9	0.3	0.8	0.8	0.0	0.6	0.7	0.0	1.2	1.3	1.0	2.8	1.2	0.7	0.4	3.0	0.3	2.0	3.9	1.2	2.4	0.7	0.9	1.0	0.1	2.0	0.7	1.2	0.0	0.1	0.0	0.3	0.1	1.1	0.0	0.3	0.0	0.1	0.3	0.3	0.4	0.3	0.0	0.1	0.4	0.2	0.0	0.2	2.0	0.1	0.9	0.4	0.1	4.1	1.0	1.2	2.1	0.0	0.0	0.0	0.5	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	648.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	205.9	4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	4.2	0.0	1.0	0.0	1.7	1.8	2.0	1.0	0.0	0.0	0.0	0.8
TRA2A	"AWMS1, htra-2-alpha, tra2a"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: AB_2682344"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	23.4	29.4	27.8	29.5	34.1	70.6	27.4	38.1	27.5	30.3	22.9	29.0	31.6	19.8	32.7	34.5	29.4	25.9	17.6	18.7	28.6	29.3	21.3	21.8	28.6	32.2	35.8	18.5	36.8	27.4	14.9	46.6	24.4	28.2	26.4	30.1	23.7	21.9	26.7	15.7	31.6	22.6	35.2	30.4	33.8	21.1	25.9	37.3	35.6	24.7	20.5	38.0	25.0	31.8	15.5	23.9	20.4	23.0	14.7	21.7	8.2	19.3	21.4	33.3	52.1	17.9	11.3	21.5	24.7	11.7	24.8	20.5	17.6	26.6	36.6	14.3	18.3	29.6	32.2	39.9	23.0	31.3	22.0	23.3	22.4	23.7	27.8	18.7	26.1	21.1	13.3	15.9	18.7	23.5	22.5	28.2	16.3	43.5	18.0	28.1	18.9	31.5	43.8	29.9	24.0	22.2	36.1	26.3	21.9	28.7	28.0	28.9	23.5	23.1	26.7	16.5	25.7	21.0	29.4	25.4	19.8	28.3	18.1	28.6	20.1	25.1	30.0	17.0	35.6	26.3	11.5	14.9	18.5	21.7	23.0	18.7	15.5	20.3	19.8	16.8	14.4	17.7	20.9	20.4	14.7	20.4	23.9	20.0	8.2	27.8	34.1	38.1	27.5	28.6	29.3	35.8	18.5	28.2	37.3	56.6	68.2	70.3	85.9	92.7	49.7	37.0	48.4	77.6	60.3	83.7	49.1	76.6	21.6	48.0	48.5	63.2	67.9	70.0	38.1	71.1	87.2	68.2	83.3	62.7	48.6	35.0	113.5	70.0	86.5	17.7	60.1	73.9	54.0	60.5	57.4	42.4	49.0	80.7	63.6	32.1	101.0	71.1	79.3	92.3	54.5	98.9	98.6	97.5	61.7	73.5
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"		NA	NA			"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.3	4.6	7.6	5.4	5.4	10.8	6.9	3.7	5.1	4.8	10.3	7.1	7.9	11.3	4.7	9.5	8.9	4.7	16.5	2.8	39.0	15.1	9.0	12.1	5.8	5.2	6.6	6.2	4.7	8.5	6.3	2.3	4.9	2.9	12.3	11.2	9.9	2.8	16.8	9.9	7.4	4.3	3.5	5.9	9.4	7.0	10.3	2.9	7.5	7.1	6.7	6.3	7.5	9.6	2.1	15.0	7.5	6.0	7.0	4.7	4.1	5.2	21.7	13.7	11.2	7.3	7.8	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3	3.0	14.3	11.3	9.2	7.1	18.9	11.3	7.6	20.1	10.3	10.4	17.7	12.2	10.0	7.4	5.5	9.2	10.7	0.0	10.6	7.8	6.2	7.5	2.3	19.5	7.7	27.0	12.2	11.6	12.3	2.6	4.9	6.7	8.5	8.2	12.0	14.5	8.9	10.1	11.0	6.7	27.6	0.0	7.5	32.2	19.0	9.8	10.9	12.7	10.6	5.8
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 76.6;Spermatogonia: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.7	4.8	9.3	4.8	5.5	7.8	6.7	8.2	3.2	5.8	4.3	3.9	8.4	9.3	3.2	4.8	5.2	3.9	10.8	5.2	8.9	11.8	4.8	6.4	4.1	6.4	5.3	16.2	6.9	4.9	13.4	5.8	12.7	3.4	5.8	8.5	14.7	8.4	4.9	7.8	13.6	3.3	5.5	12.1	4.6	7.9	8.9	5.9	7.8	5.5	5.8	5.1	4.5	24.9	8.2	8.1	8.1	7.0	4.2	5.9	6.1	4.8	9.3	5.8	9.8	8.5	4.5	9.5	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1	3.0	9.3	6.0	5.1	7.2	4.6	5.9	12.7	20.1	4.5	10.4	3.9	14.6	36.5	11.9	34.0	6.7	10.7	0.0	16.6	14.7	5.4	5.0	8.1	24.2	7.1	4.8	6.9	9.2	7.9	11.7	6.1	4.7	5.0	5.4	9.8	7.8	14.8	11.0	7.1	17.0	5.9	12.9	7.1	76.6	51.2	8.3	14.6	4.8	9.6	5.9
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.2	13.0	16.8	30.6	29.8	19.7	14.1	21.3	21.3	19.6	22.5	16.8	9.7	28.4	26.8	24.6	17.6	23.5	13.2	36.4	21.0	11.5	34.4	11.4	19.3	30.4	18.9	18.7	6.9	23.0	28.5	20.1	19.6	20.4	18.6	12.6	20.1	22.1	27.2	29.1	12.4	11.0	8.3	12.7	12.2	11.5	14.5	15.5	33.8	25.9	14.8	14.6	17.7	23.8	10.2	19.9	31.3	23.3	22.4	13.2	11.8	10.6	23.0	12.1	13.1	15.6	21.8	12.2	8.5	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2	32.8	41.6	47.2	90.2	147.6	76.3	93.6	53.5	20.1	39.8	99.5	25.5	48.1	131.0	34.9	24.0	35.6	43.4	0.0	38.5	23.1	50.3	71.7	31.1	71.3	35.6	36.5	71.6	63.3	55.3	16.8	69.9	47.1	82.7	28.9	56.9	82.6	40.7	56.1	89.8	169.2	50.8	129.4	74.1	48.1	24.5	141.5	49.9	52.4	55.2	61.6
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.7	7.3	9.2	8.4	6.5	9.8	7.2	7.3	8.3	12.3	7.1	6.2	11.2	18.0	11.2	6.5	10.6	7.9	7.8	5.6	10.7	5.5	5.6	15.0	9.2	4.4	7.7	8.5	6.3	7.8	8.4	20.4	11.2	10.8	7.6	11.2	34.6	9.1	18.6	13.3	11.0	22.1	14.0	14.6	7.8	6.1	9.0	15.4	11.8	9.0	6.0	10.1	11.0	8.0	8.0	16.1	9.9	13.5	9.8	5.1	14.4	15.0	9.1	12.3	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7	23.8	16.3	52.5	19.7	8.8	26.4	37.0	20.4	24.1	13.6	17.4	56.9	21.3	16.6	23.7	13.3	29.0	11.8	46.7	18.3	18.6	14.6	18.1	22.0	7.3	16.3	28.6	11.6	25.8	18.6	5.6	21.9	22.5	1.7	22.6	13.5	19.1	21.2	20.3	24.4	12.9	53.5	25.8	18.4	48.9	61.5	7.4	21.1	34.9	16.6	19.5
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.1	7.8	14.9	12.3	15.0	22.4	14.1	14.4	24.2	15.6	17.3	9.9	8.5	6.8	2.2	21.2	13.3	7.7	8.8	9.3	18.1	8.8	6.5	4.1	9.7	6.3	19.4	4.3	4.7	13.1	11.0	23.6	32.3	19.2	12.0	8.7	3.8	6.4	13.0	8.2	6.4	3.8	20.1	7.3	5.8	6.9	14.6	2.5	9.8	7.7	3.8	10.0	12.6	7.5	8.2	28.4	9.4	4.3	9.6	11.5	13.9	23.3	13.9	2.0	2.4	5.9	11.6	2.4	17.5	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8	6.0	8.0	4.2	14.7	18.0	5.6	5.0	12.7	52.2	17.0	1.8	2.0	7.8	19.9	14.2	2.5	13.6	3.2	0.0	6.4	8.8	23.1	19.1	0.0	3.8	4.6	38.1	3.5	19.0	2.2	2.4	37.7	4.7	18.6	9.0	5.0	46.7	9.7	0.0	23.3	13.5	9.5	38.8	23.7	30.7	52.5	17.7	9.7	5.3	5.6	11.1
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	33.5	21.3	0.0	27.2	85.8	12.7	19.2	0.0	0.0	0.0	0.8	38.9	1.0	0.2	0.3	2.2	9.3	0.0	2.9	0.0	1.6	0.1	5.7	0.0	0.6	4.9	1.2	6.1	5.1	1.5	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.3	4.7	0.5	0.9	33.2	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5	0.0	1.6	0.0	14.2	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	25.5	2.5	1.1	0.0	2.0	0.0	0.0	4.3	0.0	0.2	44.5	0.0	1.7	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	5.1	0.5	1.7	1.5	1.4	0.0	0.0	3.0
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263081-159286040	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	17.1	16.0	16.7	18.4	19.7	16.7	16.3	20.2	33.0	18.5	12.5	12.2	11.4	9.8	22.5	13.1	22.2	14.7	14.5	13.1	20.9	19.1	17.5	14.4	17.8	24.1	19.7	22.7	16.8	12.6	18.0	23.9	19.6	36.7	14.7	14.7	10.9	15.4	17.6	15.3	14.2	13.8	19.5	20.4	22.2	13.3	24.2	15.4	26.8	14.4	16.1	30.1	18.8	16.8	11.9	10.8	21.9	13.9	25.5	19.2	8.2	14.6	10.7	22.2	24.1	23.1	21.4	13.1	16.0	24.5	16.5	22.0	8.7	10.2	13.1	17.7	20.0	23.7	11.2	13.7	30.8	28.8	26.2	13.5	10.1	9.4	7.9	29.2	22.8	15.9	18.9	28.9	14.9	29.9	13.2	15.6	13.9	13.8	17.8	22.9	4.7	12.3	6.9	15.4	7.3	6.5	15.7	21.8	15.3	16.3	11.3	11.8	15.7	16.2	10.8	37.7	14.0	11.4	15.2	16.7	17.0	14.2	8.8	20.2	14.3	14.3	20.0	18.0	15.8	25.1	21.9	6.5	16.1	16.6	13.5	18.6	11.9	15.8	17.3	8.5	10.9	18.5	19.2	19.4	25.5	13.9	10.8	16.9	8.2	16.7	19.7	20.2	33.0	20.9	19.1	19.7	22.7	36.7	15.4	11.9	38.2	22.7	8.2	14.2	9.9	12.2	10.2	34.8	30.7	14.0	3.9	27.7	29.9	18.9	3.4	20.0	9.5	46.7	21.7	14.9	21.7	11.4	43.9	14.0	33.1	19.1	10.3	30.7	42.1	2.2	19.0	27.8	16.9	25.2	14.0	17.9	18.8	8.6	23.3	23.8	13.4	19.4	14.4	70.2	48.5	18.1	14.9	21.7	13.9	7.9
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	15.7	18.3	20.1	16.1	26.2	16.0	18.2	30.1	34.8	10.9	17.7	11.5	12.6	19.0	12.5	14.7	26.1	10.7	11.9	22.0	21.6	20.6	21.6	28.3	12.4	19.9	21.3	29.4	13.4	24.8	15.6	16.2	17.8	33.3	17.8	18.8	10.3	19.3	12.9	29.1	16.7	18.0	13.9	20.1	17.3	14.0	9.9	17.5	20.0	15.1	19.1	23.0	14.8	14.8	22.5	20.8	23.8	21.1	35.6	30.9	20.9	33.6	18.7	16.2	16.6	9.5	9.6	19.3	19.8	10.1	19.0	16.5	17.7	22.9	26.4	19.2	11.0	11.5	20.9	21.6	25.6	25.2	27.2	15.5	31.3	24.2	23.4	15.2	49.1	17.6	8.9	11.4	27.3	24.2	8.7	18.7	26.6	68.6	21.6	16.1	27.2	36.1	18.2	15.0	23.1	11.8	21.0	18.2	51.4	17.7	19.8	16.5	20.3	17.8	25.8	27.6	17.9	21.0	24.8	12.2	17.8	5.4	18.0	31.5	16.8	26.0	29.8	10.7	30.6	30.3	23.8	16.5	19.0	28.3	19.5	30.9	22.5	25.9	26.9	19.4	18.0	28.2	30.5	10.0	35.6	21.1	20.8	24.8	20.9	20.1	26.2	30.1	34.8	21.6	20.6	21.3	29.4	33.3	17.5	8.9	24.6	13.7	12.3	21.6	18.3	68.2	15.3	26.8	29.6	26.2	41.2	31.3	38.1	21.6	1.8	20.4	19.5	0.0	24.6	27.1	16.4	17.3	53.3	22.2	24.8	23.8	10.4	18.4	20.3	3.4	13.8	24.5	16.9	19.8	18.3	25.7	20.3	7.0	16.3	30.8	41.8	19.4	17.0	14.0	16.8	26.2	21.1	27.7	20.6	10.5
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.9	7.2	15.1	12.2	6.9	4.5	9.7	11.5	6.5	9.0	8.0	13.5	8.6	21.5	9.8	4.8	12.9	11.4	19.5	6.9	11.5	12.2	14.3	19.9	24.0	7.1	7.9	21.5	9.9	3.9	5.3	15.4	18.8	8.2	8.3	12.9	19.2	18.0	7.5	14.5	15.1	27.0	29.1	15.3	19.8	14.8	17.3	15.8	7.3	6.0	20.1	13.9	23.5	9.5	17.2	16.4	5.0	12.6	7.2	9.4	7.2	15.0	24.3	9.9	11.0	29.1	7.5	31.7	10.9	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0	29.8	25.5	28.9	28.2	33.5	47.9	17.1	15.3	42.8	47.8	24.4	53.0	33.2	5.0	27.3	107.2	24.5	27.1	0.0	22.8	39.7	29.2	18.5	57.7	19.2	25.4	27.0	26.6	20.3	15.4	17.6	28.1	32.2	23.6	49.5	21.8	39.5	18.6	31.7	30.8	12.4	94.7	12.9	36.2	32.2	32.4	33.2	53.8	34.8	32.2	21.3
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.3	16.0	8.6	22.6	14.5	14.8	14.5	15.9	12.2	16.0	12.8	16.3	14.2	34.0	32.1	11.5	17.5	18.4	34.4	17.3	19.7	11.3	17.1	19.4	13.7	12.3	16.4	27.4	14.9	18.1	15.3	21.7	23.0	10.4	12.6	12.7	19.3	10.7	13.8	23.6	19.7	20.9	17.9	27.4	18.0	15.5	13.0	23.3	11.1	11.0	9.0	23.8	9.0	16.7	18.8	11.9	9.0	16.0	10.9	7.1	9.2	19.7	30.5	13.4	15.5	30.3	10.7	34.1	15.9	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7	11.9	10.4	11.5	13.1	7.4	5.4	8.1	15.3	12.0	29.6	0.0	3.9	19.7	11.6	16.5	0.3	7.4	2.9	0.0	10.9	16.6	8.7	7.6	13.9	4.0	12.0	1.6	7.5	6.2	7.8	0.2	5.8	9.4	5.0	17.2	7.3	6.0	12.1	10.2	6.7	6.7	4.4	12.9	10.8	1.4	2.4	6.9	34.0	10.2	10.1	9.5
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15, small subunit processome component"	Q8TED0	5	73565443-73583377	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Approved	"Nucleoli,Endoplasmic reticulum"		No	No			"Nucleoli, Endoplasmic reticulum"		"HPA044697: AB_2679050"	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	17.1	11.8	6.5	9.4	11.7	38.6	13.2	8.7	12.5	7.5	8.6	10.4	9.3	7.0	11.3	8.7	13.6	10.4	6.7	8.8	12.9	5.6	9.3	12.9	10.2	12.1	11.0	8.0	11.0	9.7	11.8	16.4	8.8	12.5	10.1	10.9	7.5	10.9	6.6	14.5	18.3	10.7	9.9	10.3	11.4	11.9	10.1	10.0	11.4	10.3	13.2	12.8	9.5	9.4	8.3	9.0	4.6	8.0	8.8	10.8	5.4	10.7	11.6	7.9	23.7	6.9	8.2	15.0	12.8	7.4	14.5	16.1	13.0	14.4	24.2	13.0	8.6	16.8	9.0	13.5	23.8	22.5	11.8	9.8	11.1	12.3	10.6	8.5	10.1	9.1	8.3	10.8	16.4	18.5	4.3	10.0	10.5	17.0	13.4	12.3	13.5	15.3	7.2	10.7	3.8	6.7	12.3	12.1	23.4	8.7	14.7	8.1	8.7	11.5	9.5	13.4	7.0	12.1	7.5	8.1	8.6	11.9	10.1	24.9	9.8	13.0	31.2	13.6	17.4	12.5	2.5	7.0	4.6	9.7	8.0	9.7	8.3	9.8	10.6	9.0	7.2	10.5	10.8	3.8	8.8	7.3	6.5	7.9	5.4	6.5	11.7	8.7	12.5	12.9	5.6	11.0	8.0	12.5	10.0	0.0	5.3	2.9	10.8	13.1	3.9	6.4	2.5	0.0	4.5	5.2	5.9	6.8	3.3	8.1	3.5	4.9	2.3	0.0	6.8	7.3	4.9	5.6	6.9	6.7	6.0	1.6	2.4	3.1	7.3	2.2	2.8	4.3	6.8	1.8	3.6	3.5	5.7	3.5	4.9	4.9	4.4	6.5	8.5	6.3	13.6	14.9	5.5	4.4	6.0	9.0
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18, small subunit processome component"	Q9Y5J1	17	51260528-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 146.3;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear membrane"	"HPA052378: AB_2681805"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	15.6	16.1	14.4	18.0	20.5	26.9	20.2	23.3	20.9	15.0	13.6	14.5	12.4	13.6	13.0	13.4	17.7	14.0	11.1	8.9	14.2	13.9	17.1	16.9	14.0	22.9	17.0	20.5	19.4	18.1	17.3	19.4	28.3	16.1	13.1	15.0	12.8	14.9	11.9	19.1	25.7	13.0	10.2	14.4	22.0	13.5	42.5	16.9	21.6	19.1	15.6	25.3	15.2	17.9	26.1	26.4	12.4	22.9	17.4	28.1	24.9	26.5	26.4	16.8	15.4	11.1	16.7	43.9	14.7	12.2	25.8	24.9	16.5	14.9	33.7	21.1	10.9	27.6	14.5	27.3	15.7	38.5	22.0	35.6	35.4	16.0	28.7	15.2	37.4	17.4	10.6	12.2	21.9	17.8	13.1	15.4	16.8	28.7	15.5	19.4	16.4	33.5	25.5	24.1	37.9	28.0	30.5	38.3	26.4	18.8	17.7	18.8	23.8	17.1	20.4	33.4	21.9	25.1	19.1	13.4	26.6	22.3	21.9	30.5	30.1	55.4	39.0	16.5	26.1	19.0	6.8	22.9	12.4	20.5	21.6	24.9	26.1	25.8	24.7	26.4	24.4	28.1	26.2	4.0	17.4	21.1	16.6	25.7	24.9	14.4	20.5	23.3	20.9	14.2	13.9	17.0	20.5	16.1	16.9	14.9	25.5	32.0	48.3	53.3	16.3	3.9	17.8	48.2	22.7	14.0	13.7	61.4	33.2	24.4	146.3	25.4	10.5	0.0	40.8	58.4	26.5	24.1	31.1	16.6	54.8	9.5	15.4	8.6	38.6	145.5	24.7	35.4	21.9	38.7	19.4	20.6	29.1	17.8	20.8	29.8	10.3	12.9	16.5	115.2	106.7	46.0	66.6	27.7	22.5	46.3
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.5	11.3	8.6	4.0	7.7	9.1	10.6	7.9	6.2	12.6	7.0	13.0	3.3	12.1	4.2	8.7	9.5	9.5	19.0	8.1	16.4	5.4	7.7	12.8	6.1	9.7	4.3	21.2	5.9	5.9	4.2	17.4	6.0	4.8	8.6	6.2	20.1	2.5	9.1	5.9	9.2	6.0	22.6	6.3	11.9	10.5	14.1	9.4	5.3	13.8	9.9	6.7	14.7	9.3	8.9	7.4	9.8	4.7	9.7	14.9	7.3	10.3	15.2	4.6	6.8	20.3	8.1	9.7	22.8	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7	8.9	6.9	6.5	7.6	9.0	9.5	9.8	7.6	8.1	14.8	3.5	9.8	6.7	5.0	5.6	1.3	9.0	1.3	0.0	9.7	7.0	7.8	8.4	12.7	6.7	5.1	20.6	6.3	7.4	6.3	0.9	8.9	3.8	3.3	1.0	4.4	3.4	6.1	0.0	7.8	2.3	8.0	6.5	6.2	15.6	22.4	9.7	2.4	5.7	8.0	7.5
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: AB_2677488"	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.3	12.1	16.2	13.5	23.1	17.5	13.9	25.7	16.6	14.7	14.4	15.7	16.5	54.4	16.2	21.9	16.9	10.4	23.7	35.2	21.5	16.8	13.6	20.7	16.2	16.8	25.1	31.2	18.4	23.7	21.2	18.0	17.8	16.4	19.7	16.0	23.6	18.4	23.8	25.5	28.9	17.5	11.3	25.5	17.7	12.4	22.4	22.2	26.6	20.0	13.7	18.7	10.9	25.0	15.9	18.6	13.7	12.6	21.9	15.1	25.6	14.3	16.4	26.9	19.8	39.6	18.4	15.4	13.1	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3	53.6	50.4	14.5	40.4	20.4	18.4	17.9	10.2	60.2	61.4	12.2	5.9	22.5	16.6	25.7	0.7	22.8	13.4	23.3	25.9	12.8	18.2	14.0	28.8	23.7	19.4	15.9	14.5	19.6	29.5	1.5	16.1	25.1	11.8	14.4	12.3	26.4	20.3	8.6	23.7	25.4	21.9	12.9	25.5	11.6	9.3	22.3	18.1	21.8	12.7	31.6
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	30.6	12.3	8.2	15.4	12.2	17.5	15.2	14.5	14.6	15.9	12.2	9.3	10.2	9.6	19.0	11.8	18.4	13.9	11.5	11.7	8.2	9.7	14.8	24.6	12.4	18.7	8.8	11.1	20.6	15.0	14.8	19.1	15.3	13.5	15.0	12.8	9.3	13.6	11.0	17.0	15.2	13.7	14.5	8.9	21.7	12.2	11.3	9.4	24.3	16.7	12.9	18.4	13.8	14.7	6.7	9.9	2.5	10.1	6.0	9.4	6.4	10.1	11.5	8.1	21.1	12.7	17.8	13.5	8.6	8.8	12.9	19.1	13.3	12.1	30.6	11.2	6.9	16.6	11.2	16.6	20.0	22.6	10.9	9.2	16.8	11.3	10.3	13.3	15.3	30.9	10.2	11.0	22.6	22.6	19.5	15.0	12.1	20.1	15.6	13.8	8.5	20.1	11.7	10.4	9.0	10.2	16.5	18.8	23.8	8.9	13.4	14.4	10.9	11.5	8.3	12.6	9.6	9.6	10.3	10.5	16.8	11.1	12.4	17.7	12.7	11.8	33.0	12.9	20.5	13.5	0.2	6.4	2.5	7.8	8.6	9.2	6.7	6.7	8.7	9.9	5.9	9.4	7.8	0.4	6.0	10.1	4.3	9.0	6.4	8.2	12.2	14.5	14.6	8.2	9.7	8.8	11.1	13.5	9.4	17.9	14.4	16.0	8.0	54.3	8.4	13.3	17.8	14.7	25.0	15.7	5.9	8.0	6.6	9.3	5.0	17.3	5.2	0.0	11.7	8.0	12.8	8.7	13.9	27.2	12.8	11.1	5.8	15.4	17.7	2.6	8.1	12.6	20.3	16.2	13.4	5.6	7.9	7.0	10.6	9.8	8.3	19.4	11.3	16.9	14.5	50.6	4.5	9.6	11.5	8.8
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Group enriched"	"Detected in many"	4	"Club cells: 168.4;Early spermatids: 612.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.4	19.8	7.7	12.8	6.4	8.8	24.0	9.2	10.0	20.1	13.4	28.9	20.2	28.9	26.3	7.6	16.2	22.0	23.7	18.4	15.8	18.4	17.5	14.6	21.8	25.0	18.8	28.9	9.6	8.5	20.7	12.8	42.6	6.6	9.8	21.1	31.8	8.6	9.1	31.6	27.6	46.0	31.5	18.9	26.3	28.2	13.3	50.4	14.2	9.4	17.2	19.4	10.7	22.0	29.7	7.8	15.5	22.4	7.0	11.8	14.2	26.3	23.1	21.4	29.7	35.1	13.0	17.7	15.3	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6	35.7	64.8	46.3	33.6	92.8	13.9	1.4	33.1	44.2	168.4	15.7	15.7	47.5	36.5	39.1	612.8	32.3	22.2	0.0	34.8	40.2	35.6	20.1	41.7	28.4	34.0	3.2	39.4	17.8	30.3	74.1	30.5	38.9	28.7	18.0	28.7	13.4	36.2	26.6	20.1	37.0	11.0	19.4	37.3	14.7	27.4	95.5	29.1	57.9	38.1	31.5
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.7	11.0	30.7	15.0	33.6	32.1	25.7	27.7	31.7	27.0	22.3	27.4	28.6	0.0	22.9	36.2	20.1	20.8	15.2	39.5	28.7	3.4	5.4	0.0	15.0	18.6	25.7	0.0	0.5	25.6	26.0	29.6	48.3	30.2	8.4	1.4	0.0	0.0	30.5	5.6	0.5	0.0	14.5	28.3	10.5	0.0	17.3	0.0	19.9	21.0	0.1	1.0	32.6	12.3	9.2	29.4	22.2	0.1	9.2	38.5	15.1	19.3	11.6	0.0	0.0	0.1	11.2	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7	32.8	51.8	1.7	40.6	101.0	0.3	34.4	76.5	24.1	35.2	87.2	0.0	79.0	10.0	28.8	3.9	26.3	16.2	0.0	15.8	14.7	61.4	50.8	0.0	36.0	9.2	0.0	7.0	24.5	1.3	2.7	35.1	2.3	42.2	1.8	13.7	26.2	23.1	20.9	38.2	20.0	1.0	38.8	48.4	2.7	0.9	107.6	51.5	0.0	24.7	55.2
ZBTB14	"ZFP161, ZNF478"	ENSG00000198081	"Zinc finger and BTB domain containing 14"	O43829	18	5289019-5297053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050758, HPA070819"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA050758: AB_2681226, HPA070819: AB_2686316"	"unprognostic (5.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.72e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.90e-2)"	11.2	9.1	13.1	11.6	13.4	6.8	10.8	24.3	12.8	8.7	8.7	10.7	10.8	7.2	12.5	14.9	10.8	9.3	10.3	7.1	13.1	10.2	9.8	11.3	11.0	19.5	14.5	7.6	14.2	12.1	12.8	8.7	8.5	7.3	9.8	8.7	10.3	9.8	11.1	6.9	11.8	12.7	7.5	16.4	17.4	9.8	10.8	8.2	30.8	15.9	7.0	18.1	11.2	11.8	10.1	8.6	14.3	8.2	7.5	13.4	7.6	7.1	9.5	12.5	9.2	9.4	12.4	8.3	7.1	10.6	10.1	8.9	9.1	9.4	25.1	6.3	8.6	11.6	6.7	9.1	10.7	10.2	4.9	4.9	9.9	8.7	8.3	6.6	12.4	12.0	9.9	9.1	7.0	6.6	10.9	15.6	18.2	6.3	8.3	10.2	7.8	18.6	8.3	11.0	8.9	4.9	11.1	8.0	7.2	8.5	8.8	11.1	10.9	10.9	7.2	11.5	13.0	8.6	14.3	8.7	13.1	10.9	10.1	10.6	5.3	5.3	15.5	13.8	10.7	11.5	10.9	5.7	14.3	9.9	8.2	9.9	8.3	12.7	11.4	8.6	10.1	13.4	12.7	1.3	7.5	7.3	6.5	7.9	7.6	13.1	13.4	24.3	12.8	13.1	10.2	14.5	7.6	7.3	8.2	6.0	4.1	11.1	1.3	2.2	6.5	2.8	2.5	1.4	1.2	5.2	0.0	4.0	5.0	4.2	0.8	6.3	4.0	0.0	2.9	4.9	4.5	2.5	16.1	5.7	6.2	4.8	1.2	9.2	5.9	1.7	5.5	5.2	1.7	4.6	5.1	8.2	3.2	4.2	5.3	4.0	5.8	0.0	4.1	0.7	11.7	2.6	1.8	4.4	4.4	0.6
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301590-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	14.4	12.9	11.7	16.1	10.5	8.9	15.2	14.3	11.5	21.1	19.7	7.4	14.5	13.9	18.4	16.4	21.4	13.9	14.3	11.9	10.0	10.7	23.0	36.3	10.7	16.2	11.1	10.1	19.6	13.8	10.9	22.6	23.0	10.4	23.1	14.6	13.6	12.2	18.1	14.4	15.2	27.7	22.5	12.2	18.0	14.5	14.8	10.0	17.9	19.6	19.1	16.4	26.8	23.5	14.9	17.5	12.8	16.2	11.6	19.1	7.3	10.3	7.3	18.1	9.5	15.7	14.9	24.4	15.6	18.6	12.1	16.9	16.1	14.3	9.6	6.5	7.8	20.9	7.7	14.3	14.3	19.3	21.5	13.5	9.9	8.2	18.9	18.5	12.5	8.2	11.5	12.5	10.3	25.8	9.4	10.1	10.6	16.5	9.4	12.4	14.1	20.7	18.9	13.1	5.8	9.4	12.4	23.3	14.1	9.4	10.4	8.8	8.4	12.4	7.5	55.7	13.7	9.3	20.3	6.9	7.6	9.3	13.5	17.0	13.5	13.9	14.7	13.4	18.3	16.2	12.8	12.3	11.9	12.8	16.2	16.3	14.9	17.2	15.5	14.8	13.2	16.7	17.1	12.0	11.6	14.0	17.5	19.1	7.3	11.7	10.5	14.3	11.5	10.0	10.7	11.1	10.1	10.4	10.0	8.9	15.2	18.2	10.8	8.0	16.3	10.0	38.2	34.8	18.2	29.6	13.7	24.6	26.6	18.8	41.9	12.3	15.4	0.0	17.9	44.7	16.4	11.3	12.7	47.4	31.3	25.4	7.5	32.5	16.7	12.8	30.2	22.3	3.3	32.5	18.1	18.2	22.3	18.7	27.3	37.0	28.3	19.4	24.8	64.6	31.5	8.2	19.2	17.5	18.1	11.4
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 99.5;Early spermatids: 98.1;Endothelial cells: 105.0;Late spermatids: 111.0;Peritubular cells: 95.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 47.1;RH-30: 27.8;TIME: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	18.8	7.4	14.4	13.9	14.4	6.1	11.4	15.5	24.1	31.3	31.2	7.1	8.0	4.9	32.9	14.1	17.3	12.0	16.0	27.9	12.9	14.7	5.9	8.1	12.5	7.0	13.7	11.9	11.5	3.4	2.7	9.3	13.3	13.1	20.4	11.0	4.8	5.9	24.2	36.2	5.1	8.3	40.4	20.4	6.6	14.8	7.3	14.9	22.6	8.3	18.7	8.0	53.1	20.7	5.4	3.8	11.5	0.0	7.2	10.2	2.2	0.0	6.1	15.4	15.0	21.6	47.1	0.0	13.4	18.7	2.5	4.9	0.0	0.0	4.3	6.4	16.2	3.6	0.0	6.5	0.0	4.6	8.2	3.2	0.0	3.6	2.7	18.0	3.4	0.1	21.8	0.0	8.0	8.1	8.2	23.7	3.6	3.0	5.7	16.7	0.0	11.9	1.8	0.9	0.0	3.1	4.3	27.8	1.7	4.4	0.0	0.4	5.7	4.6	0.0	0.0	3.0	0.0	2.3	36.2	15.2	3.6	3.4	6.4	2.8	2.3	5.1	4.3	0.0	1.7	5.1	0.0	6.6	3.6	0.0	4.8	5.4	4.5	2.3	1.5	4.7	10.2	4.5	11.5	7.2	0.0	3.8	5.8	2.2	14.4	14.4	15.5	11.9	12.9	14.7	13.7	11.9	13.1	14.9	0.0	11.4	18.0	2.5	10.0	38.8	99.5	2.5	1.4	5.7	1.8	43.2	0.2	0.0	1.8	98.1	105.0	0.0	0.0	2.2	0.4	37.0	2.6	1.1	11.3	1.2	9.5	0.0	44.8	5.3	111.0	28.4	5.0	25.3	17.2	0.0	3.1	1.9	0.0	95.8	1.4	39.7	77.6	47.8	16.3	15.3	7.5	0.6	14.9	0.0	3.7
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144524583	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 76.6"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;THP-1: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	30.2	23.7	48.0	27.8	42.4	55.5	16.6	6.7	36.6	29.4	12.3	72.9	3.4	11.3	15.6	11.1	14.4	11.1	22.6	22.5	52.5	28.8	9.9	11.6	20.7	19.6	54.4	26.4	37.5	3.6	5.0	3.1	31.5	37.6	10.9	16.3	15.7	5.7	12.5	9.6	7.7	12.8	17.2	76.6	32.6	9.3	8.2	38.7	1.9	8.3	7.5	12.4	21.5	14.8	5.0	12.7	9.7	21.6	3.6	10.7	7.4	0.4	0.5	22.5	0.0	26.9	13.7	0.0	9.2	9.4	10.4	10.1	0.0	0.2	1.7	0.0	10.0	2.8	0.1	3.8	0.0	13.0	9.6	2.6	39.1	1.6	0.0	6.1	6.7	31.1	11.2	0.2	12.9	6.2	8.8	7.8	0.0	10.9	1.1	12.2	0.0	0.0	20.5	3.2	0.0	0.5	11.5	15.5	0.0	0.1	0.2	0.2	5.9	1.1	0.0	24.3	7.5	0.0	46.5	12.1	12.0	0.2	23.3	2.9	12.7	0.0	1.9	17.9	20.2	32.2	9.7	21.6	5.7	10.7	20.8	1.0	4.4	1.4	5.3	12.7	5.0	1.1	4.0	7.5	3.6	19.5	10.2	0.3	7.4	48.0	42.4	6.7	35.6	52.5	28.8	54.4	26.4	37.6	38.7	6.0	25.8	45.8	1.2	22.0	178.1	50.1	2.5	6.7	18.2	5.2	3.9	1.3	1.7	0.6	2.0	23.8	0.0	23.3	0.7	1.6	146.0	1.5	150.5	2.1	126.8	626.1	0.0	81.0	357.2	4.0	111.7	271.2	97.8	46.9	0.0	84.2	0.2	0.0	62.6	7.3	8.6	181.1	167.0	2.3	7.0	17.1	3.9	99.2	0.0	2.0
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238774	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	20.6	17.2	24.5	23.5	40.4	8.6	33.0	25.7	27.9	28.9	20.7	28.4	23.5	17.9	30.0	18.2	22.3	23.0	18.0	21.5	25.6	20.0	21.1	25.0	18.1	25.0	46.4	23.7	33.7	20.3	32.5	45.2	25.1	32.0	25.2	25.5	13.4	19.6	23.9	38.3	21.1	17.7	26.2	30.9	19.9	19.2	9.9	36.3	33.6	27.1	24.0	28.3	25.8	20.5	13.7	9.8	5.9	14.6	10.2	18.3	10.3	21.7	30.4	26.1	25.0	19.3	21.7	13.9	19.3	17.9	18.7	18.6	13.7	16.0	21.2	31.2	17.8	12.2	10.2	33.0	22.5	33.9	32.8	18.4	35.5	11.7	16.5	22.5	55.7	24.6	17.6	35.0	18.0	51.4	19.7	23.1	23.2	37.6	23.4	22.4	14.2	25.8	13.2	35.2	38.4	18.6	30.0	26.2	18.1	22.7	21.5	33.1	20.9	23.8	30.2	20.4	28.0	13.4	28.6	17.5	21.1	25.3	16.5	33.7	16.4	19.3	30.3	14.8	27.7	26.8	4.9	8.2	5.9	12.2	9.9	17.4	13.7	14.1	12.2	9.8	12.1	18.3	16.6	2.0	10.2	14.6	4.9	12.1	10.3	24.5	40.4	25.7	27.9	25.6	20.0	46.4	23.7	32.0	36.3	41.7	25.3	20.4	25.2	20.9	10.1	40.2	22.9	30.8	33.0	19.2	9.8	29.2	29.9	24.6	14.9	20.6	8.5	0.0	15.6	40.2	22.4	23.6	19.7	17.3	16.6	11.1	13.9	20.3	18.6	13.5	23.3	13.5	10.1	10.0	23.8	9.1	20.1	5.8	18.0	16.5	9.4	6.5	35.3	7.7	12.4	26.1	19.7	21.8	24.5	24.3
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: AB_2684621"	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	8.1	6.0	8.9	7.1	9.0	3.4	9.7	8.1	10.1	9.7	10.1	7.8	7.1	7.2	13.8	11.1	9.4	11.2	13.3	6.5	7.5	4.9	8.5	5.9	5.7	5.0	6.4	7.5	17.4	12.1	15.9	7.0	6.0	6.5	8.9	7.3	7.7	7.4	9.2	12.4	14.0	10.8	10.3	4.9	6.4	7.7	10.9	5.3	6.7	10.8	5.3	6.8	9.1	10.1	5.6	6.4	3.5	4.0	12.2	7.8	4.1	4.9	4.4	8.7	4.8	7.5	10.5	6.3	4.5	10.0	9.1	8.3	3.3	5.1	7.9	6.0	5.8	4.9	4.0	6.1	10.0	8.3	3.3	5.1	9.0	4.9	4.9	12.5	3.3	5.3	12.8	10.1	5.8	15.3	9.1	5.0	6.0	6.1	5.3	7.2	6.7	6.5	3.3	5.4	7.6	10.0	8.2	5.1	5.0	7.7	7.5	7.3	5.4	9.5	5.8	7.7	7.0	10.8	6.1	5.3	4.1	8.8	4.8	5.0	3.9	3.2	7.2	4.8	4.5	6.5	3.5	4.0	2.7	6.9	3.7	7.8	4.1	5.5	6.3	6.4	5.6	5.6	5.1	0.5	12.2	3.7	3.5	7.2	4.1	8.9	9.0	8.1	10.1	7.5	4.9	6.4	7.5	6.5	5.3	3.0	4.1	0.0	5.7	2.4	10.8	3.6	7.6	2.7	0.0	8.7	11.8	4.6	1.7	5.6	8.1	3.1	4.5	0.0	3.8	2.9	3.8	3.2	6.9	3.4	3.1	6.4	4.1	6.2	3.2	1.9	5.8	2.6	1.7	4.6	4.7	6.0	3.5	3.5	6.0	3.6	23.7	0.0	2.0	14.0	12.4	4.0	4.6	5.3	4.9	4.7
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli		NA	NA			Nucleoli		"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.7	9.6	11.6	9.2	20.9	18.9	16.4	21.0	12.1	13.5	12.8	12.9	15.0	33.4	12.9	13.2	7.6	6.3	20.5	13.6	20.8	15.4	13.4	15.5	14.8	18.1	22.4	38.9	12.5	18.9	16.0	12.7	18.6	16.5	14.1	20.7	31.4	22.8	17.2	17.6	30.1	18.3	10.3	24.1	18.3	24.6	16.7	21.1	14.5	8.7	20.3	9.4	7.3	16.9	20.6	13.7	8.4	10.7	15.0	17.3	11.7	10.4	14.9	38.2	27.4	31.7	14.5	24.4	12.3	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3	50.6	29.6	27.4	41.1	43.7	64.5	140.4	22.9	20.1	23.9	8.7	13.7	30.9	49.7	27.5	163.4	28.7	21.1	23.3	44.0	30.7	29.8	28.9	23.0	63.5	61.1	15.9	16.1	33.7	48.2	40.5	36.2	41.2	43.9	17.2	22.7	29.8	35.0	24.6	26.9	67.2	23.1	12.9	36.8	47.3	16.1	45.0	28.7	24.9	26.0	54.1
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.3	3.4	7.1	18.8	12.4	10.1	29.4	5.0	6.7	7.0	7.5	5.0	7.3	5.8	6.6	4.5	12.9	8.6	2.6	21.3	10.8	7.7	8.1	1.7	4.2	0.6	9.4	0.0	4.9	7.9	13.7	6.1	12.5	9.0	6.6	7.9	1.4	0.0	10.1	8.7	8.7	5.8	6.2	4.0	8.8	6.5	1.2	3.6	6.5	4.4	7.8	8.5	6.3	7.2	9.7	9.8	5.9	8.5	5.1	7.9	5.2	4.5	4.2	1.9	4.0	3.6	0.2	1.3	9.9	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4	11.9	6.1	3.2	10.0	4.4	8.9	5.5	0.0	12.0	10.3	7.0	13.7	10.6	11.6	9.8	9.2	8.0	2.1	0.0	6.6	10.6	6.1	5.3	5.8	0.8	8.0	6.4	4.6	6.2	8.2	3.2	6.4	7.8	10.1	3.6	2.2	7.4	6.7	0.0	9.9	13.5	9.7	6.5	9.2	22.3	9.8	4.8	10.2	10.9	4.3	6.9
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872363-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.6;U-2 OS: 31.2"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	0.9	2.2	4.6	0.7	4.8	0.1	2.6	5.8	4.8	1.5	2.5			0.2	2.0	10.9	1.2	3.7	2.2	6.0	4.6	4.4	1.5	1.0	1.8	3.1	6.0		7.5	0.8	2.6	8.2	2.6		4.6	1.6		2.6	2.2	1.5	2.9	1.0	1.8	7.0	3.9	1.9	3.4			2.6		1.2	1.5	1.1	1.9	0.9	1.9	0.4	2.1	1.9	0.6	2.3	0.3	2.4	0.3	6.0	8.6	1.4	3.2	1.6	2.0	2.8	0.2	0.8	0.0	3.4	1.5	0.0	0.3	0.4	1.6	2.8	0.3	2.3	0.8	0.0	0.9	2.2	0.2	0.6	5.1	3.9	1.5	1.4	7.0	1.7	0.0	0.1	0.0	1.9	0.2	0.0	0.0	1.9	0.1	0.5	0.0	1.3	0.4	2.0	1.5	1.3	1.0	1.3	0.6	1.6	4.5	0.1	0.9	0.7	2.9	31.2	2.6	1.8	4.1	5.3	0.0	4.1	0.0	1.6	0.0	0.3	1.9	0.7	0.0	0.8	0.9	1.4	0.0	0.4	1.9	1.9	1.5	0.0	2.1	0.4	0.9	1.3	0.6											0.0	5.6	0.0	0.5	0.0	3.7	4.0	0.0	1.4	0.0	0.0	0.0	1.2	0.0	0.5	0.9	0.4	0.2	0.0	0.2	1.0	0.8	0.6	6.9	0.0	0.6	4.8	2.4	1.3	0.3	0.0	0.9	0.1	0.0	0.0	0.6	3.5	0.2	0.0	3.2	0.3	2.5	0.0	1.0	1.6	1.9	0.0	0.8	0.0	0.8	0.6
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: AB_2680864"	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.3	18.6	13.8	8.6	9.1	14.3	11.2	8.4	8.2	7.7	8.7	10.7	7.3	13.8	10.4	8.0	8.4	5.4	20.1	10.4	14.9	10.7	18.3	14.2	8.9	7.2	10.9	11.8	7.8	9.0	8.0	9.9	16.1	8.0	10.3	11.6	20.8	11.2	8.1	5.8	12.7	3.9	14.8	13.8	5.9	13.2	16.1	5.6	4.7	10.4	11.4	9.9	11.1	7.5	9.1	11.5	5.9	8.5	11.0	12.4	13.3	7.2	10.8	10.9	12.6	14.3	8.7	8.7	11.1	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0	8.9	15.3	7.3	5.9	2.5	19.9	12.6	2.5	22.7	11.4	0.0	13.7	8.0	1.7	5.1	13.1	6.3	8.1	0.0	4.8	4.4	5.7	9.3	3.5	9.6	2.9	55.6	8.6	12.9	0.3	8.2	8.6	1.1	1.7	0.0	14.3	19.5	4.9	10.5	6.7	3.5	25.0	0.0	7.2	20.4	16.2	2.4	7.3	8.7	11.2	6.8
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 33.2;Early spermatids: 47.8;Late spermatids: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	4.4	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.8	2.8	4.3	9.6	5.0	4.4	1.3	9.5	1.5	0.0	2.7	0.0	3.8	0.0	7.8	3.6	7.6	0.0	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	7.0	1.3	3.1	1.0	5.5	7.7	1.6	2.7	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9	0.0	1.6	6.7	3.0	3.9	11.1	7.8	5.1	1.4	1.2	17.4	9.8	6.0	33.2	3.1	47.8	6.0	2.7	0.0	1.0	4.5	5.5	6.1	4.7	1.5	4.7	6.4	2.9	4.3	2.4	35.6	7.5	5.1	0.0	5.4	5.0	14.0	1.2	0.0	12.0	4.2	9.3	0.0	6.6	10.7	14.4	4.5	3.8	2.5	4.2	2.1
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.3	7.6	15.7	18.7	16.0	27.7	20.0	15.2	16.3	20.9	28.8	10.3	13.0	27.1	15.8	22.0	14.7	12.2	15.6	13.2	17.5	16.6	11.9	43.1	20.6	26.9	23.0	14.3	24.6	19.8	15.2	14.4	12.7	11.4	7.8	16.0	12.9	17.9	18.7	12.0	22.5	13.4	10.5	24.1	9.5	9.3	11.1	15.1	16.7	10.6	11.9	27.9	21.0	32.4	13.9	11.6	17.9	15.5	18.3	13.9	17.7	12.6	18.7	16.7	18.2	15.9	20.0	12.7	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3	20.8	24.5	31.7	36.6	53.9	21.6	68.8	12.7	22.7	19.4	14.0	9.8	53.3	23.2	49.8	98.2	21.5	74.9	0.0	58.2	46.3	35.5	23.5	50.8	21.9	45.1	15.9	94.5	9.8	15.4	46.0	16.7	31.7	32.1	49.5	33.2	20.1	47.9	129.6	18.7	30.7	15.9	19.4	31.6	40.3	26.2	37.8	34.0	30.9	34.7	29.6
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	9.1	4.8	5.7	9.8	8.2	11.0	5.4	8.9	10.5	9.2	8.9	4.4	8.8	15.6	5.5	8.4	9.9	6.7	9.2	9.5	12.7	13.7	5.4	10.0	4.9	4.1	10.3	13.7	19.3	9.3	8.8	10.1	13.7	7.7	9.7	9.7	12.4	16.1	9.9	7.0	15.2	9.9	4.7	8.5	6.4	9.5	7.9	10.3	6.7	11.6	8.1	8.5	8.8	34.9	11.3	8.1	4.1	9.4	10.4	15.5	4.9	10.2	10.4	19.4	8.5	22.6	11.5	12.5	12.8	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8	35.7	19.7	27.4	41.3	39.8	25.9	12.6	15.3	16.0	21.6	12.2	21.6	9.7	10.0	20.7	27.0	23.3	24.9	23.3	16.7	8.6	17.5	40.1	28.8	12.9	12.9	73.1	15.5	23.4	26.2	8.6	25.0	26.7	27.0	27.9	22.6	16.6	19.9	25.9	29.7	10.5	26.1	25.8	25.8	97.4	48.6	41.9	18.4	33.8	20.0	57.6
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.6	4.8	13.7	11.7	14.9	14.3	3.1	11.2	11.2	14.8	15.3	3.5	4.1	3.2	17.4	7.1	11.1	4.3	6.3	8.2	16.3	6.8	6.8	8.5	6.7	7.5	10.3	7.0	5.5	11.9	7.8	11.3	10.3	19.1	14.9	5.0	7.0	6.8	11.6	4.7	7.4	9.6	4.0	3.0	7.3	7.5	11.9	5.4	12.5	5.8	9.9	7.7	6.9	2.9	9.3	11.6	4.8	4.8	9.7	11.9	8.7	4.2	13.6	7.2	9.6	6.2	4.3	7.9	10.3	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6											0.0	3.5	10.4	2.8	0.0	8.6	8.7	0.0	2.7	11.4	0.0	3.9	3.8	3.3	4.2	3.2	6.8	2.6	0.0	4.4	2.7	3.5	3.0	5.8	1.5	5.0	1.6	6.4	4.3	5.0	1.7	8.3	1.9	0.0	1.0	2.3	11.7	3.0	4.0	12.4	4.9	9.7	19.4	2.7	5.5	8.1	0.0	1.1	7.5	2.7	0.9
